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Abstract
This research is a qualitative study examining the communication surrounding the
issue of genetically modified food in the UK and the UK from October, 2011 through
September, 2012. Material from biotechnology industry organizations, industry-funded
non-profits, groups campaigning against the continued use of the technology, and
mainstream media coverage of the issue in both countries during this time was examined
using thematic analysis. The issue is analyzed through the lenses of Herman and
Chomsky’s propaganda model, agenda building and framing theory. The research finds
support for agenda building as well as a modernized understanding of the propaganda
model, which the researcher argues are complementary theories.
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Chapter 1: Introduction
As global wealth is amassed in the hands of a few1 and global food prices have
continued to spike and dip, generally rising over the last twenty years 2 and exacerbating
food shortages in much of the developing world, food riots have broken out among the
poorest populations and public debate is very heated regarding how food will be
produced, regulated and sold.3 Every year five million children die from illnesses related
to under-nutrition4 while huge amounts of food are wasted daily in the US5 and in other
parts of the developed world. The 21st century has also seen the rise of the organic food
industry as a response to the more developed world’s anxiety about contamination,
pesticide use and genetic modification. All of these factors, when assembled as a
snapshot of the state of the global food system, indicate that there is something wrong
with the mechanisms that control food access, food quality, how and where food is grown
and who controls it. The ability to feed oneself is a basic human right according to the
United Nations Universal Declaration of Human Rights,6 but 925 million people are
deprived of it every day, 98% of whom are in the developing world.7
The US government plays a significant role in promoting the ideology of free
trade in the international marketplace, especially with regard to the global food system,
while also pursuing policies that arguably undermine the actualization of truly free
markets. One ready example of this is the US government subsidization of the production
of corn, while leading the way and signing on to the North American Free Trade
1

Agreement, ultimately sabotaging Mexico’s ability to compete even in its domestic
markets for corn, let alone international markets.8 While politicians give lip service to the
idea of a free market, the reality is clear that truly free markets do not exist anywhere, nor
are the mechanisms being put in place to implement such a system by those who promote
the idea most vocally. This seeming contradiction is at the heart of the problem of the
global food system.
Some questions that present themselves, then, are who benefits from the
promotion of this ideology by the same players whose policy implementation is in direct
contradiction to its basic tenets, and how does the ideology of free market capitalism still
hold sway in global discussions of how to solve the world’s food problems?
Some of the most powerful forces in the global food industry are those
corporations that are on the forefront of the technological frontier to genetically modify
and patent seed. Corporate giants such as Monsanto, Dupont, Syngenta, Bayer and Dow,
have not only worked to patent hybrid and genetically modified seeds and created seeds
that do not reproduce in order to prevent seed saving and reseeding, but they have been
progressively buying up smaller seed production and distribution companies, resulting in
the global market dominance of these few major seed producers.9 There is a growing
body of research that examines the scientific complexities surrounding genetic
modification of crops, seeking answers to such questions as whether they are safe to
introduce to the biosphere, if they are safe to consume, if they are effective in increasing
yields and decreasing the use of agricultural chemicals, as well as the social effects and
ethics of patenting genetic material in the first place. But the US and much of the
developing world are not waiting to learn the outcome of this scientific debate. Although
2

scientific research does play a role in the important decisions that are made with regard to
food and agriculture policy, scientific analysis takes longer than most policy makers,
corporations, consumers and markets are willing to wait.
New technologies are consistently introduced in many countries including the US,
Argentina and India, before their effects on human health and the environment can be
effectively assessed, and it is frequently unclear what harm will come to the environment
through human actions until that harm is already done. As David Leonard Downie
articulates in his analysis of global environmental policy, “new environmental issues
often exist, almost by definition, at the edge of current knowledge of chemistry, biology,
physics, and natural systems.”10 An obvious example of this phenomenon is the
multitude of cases in which exotic species have been introduced into a foreign
environment, either accidentally or deliberately, with disastrous unintended ecological
and economic consequences. For example,
in the case of cotton, the total accumulated cost of the boll weevil, which arrived in
the U.S. from Mexico in the 1890s, now exceeds 50 billion dollars. Leafy spurge,
an unpalatable European plant that has invaded western rangelands, caused losses
of $110 million in 1990 alone. In eastern forests, losses to European gypsy moths in
1981 were $764 million,11
and the list goes on.
The introduction of GMOs into the various and endlessly different ecosystems has
clear parallels to the many cases of the optimistic introduction of exotic species without
specific knowledge of exactly how it will change that environment until the damage (or
benefit) has been irrevocably done, such as. The questions of how GM crops will crosspollinate with their conventional counterparts, or if herbicide resistant genes could spread
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from food crops to weeds, and what the consequences will be of this potential gene-flow,
remain unanswered.12 13
Reminiscent of the endless cases of environmental damage from exotic species,
the cases in which products were thought to be safe for human consumption but were
later discovered to be damaging to various degrees, are equally numerous and
catastrophic. One example is thalidomide, which,
because it was believed to be nontoxic and to have no side effects, it was widely
prescribed to pregnant women for relief of morning sickness and insomnia.
However, thalidomide proved to be anything but nontoxic; more than 10,000
women who took the drug during pregnancy gave birth to children with severe birth
defects.14
Time and time again a tacit scientific consensus is on one side in an issue, only to be
proven spectacularly wrong by the test of time.
Other factors, then, must greatly affect the decisions that are made by
governments and consumers on a daily basis. What matters as much, if not more, than
scientific evidence in such cases is the ability of the corporations that produce these
products to convince governments and consumers of the benefits of their approval and
consumption. This process is a multilayered one that involves lobbyists, media,
government organizations, NGOs, farmers, scientists, and individual consumers.
Therefore the various ways in which this public discussion takes place is what determines
how the global food system has been and will continue to be shaped. This issue affects
the entire global population, and thus a developed understanding of how these decisions
are made is essential to comprehend how the food system will be affected by decisions
made now, and how it might be improved for the benefit of future generations.
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The manner in which such decisions are made in modern democracies depends
heavily on how the media portray food related issues. As the literature review below will
demonstrate, a significant body of research has made important connections between how
the media portray an issue with how much and in what ways citizens think about various
issues. Additionally, an extensive body of literature also reveals a strong correlation
between policy and media coverage. Media coverage of biotechnology and GMOs is then
highly relevant to an understanding of how different societies think about and regulate
the food system. A critical analysis of the narratives that are predominant in the media
regarding GMOs reveals important aspects of societal attitudes about food as well as the
basis upon which policy is shaped and defended.

This research will contribute to this goal by examining the following question:
How are the biotechnology industry, its products, and activist groups promoting and
disparaging this technology covered by the mainstream media in the United States and
the United Kingdom, and how is activist rhetoric on both sides incorporated in this
coverage?

This inquiry will be directed towards examining the ways in which US and UK
media contribute to shaping communal understanding of what food is, how it is produced
and who legitimately benefits from its production and distribution. Examining the manner
in which the industry and its products are portrayed by the media and how different
parties attempt to influence this portrayal will help form an understanding of why the
food production system operates in the way that it does and how the inequalities
5

discussed above are justified and perpetuated by media coverage of the issue. The
following section will examine the background of GMO research and evidence provided
by the industry as well as independent researchers regarding their safety for human
consumption and the environment. This background will serve to set up a scientific and
political context in which the media coverage of the issue can be examined and
understood.

6

Chapter 2: GMO Food Research
Biotechnology corporations produce and patent chemical herbicides and
genetically modified (GM) seeds, which are predominantly engineered to be insect
resistant or herbicide tolerant.15 The public discussion regarding industrial food
production, especially with regard to genetically modified organisms (GMOs) is
confusing and full of opposing claims, emotional arguments, and a level of mystery about
which products contain GMOs and which do not, as well as what that means for
consumers and the environment. US regulation relies on the principle of substantial
equivalence, meaning that GMO foods are not substantially different from their nongenetically modified counterparts, allowing “existing food safety and environmental
protection laws and regulations to” be applied to them.16 At the same time, biotechnology
corporations operate on the assumption, accepted by the international community, that
the genetically engineered seeds and subsequent food products are unique inventions and
thus they are protected under international intellectual property rights regimes. The
organic food movement appeals to a growing number of consumers who doubt
substantial equivalence and who are concerned about potentially negative health and
environmental effects of GMOs as well as the health risks associated with synthetic
chemicals used in conventional agricultural production, among other concerns.17
The European Union, in contrast to the US, bases its GMO policy on the
precautionary principle and “has adopted a directive controlling the deliberate release of
7

GMOs into the environment and into the market.”18 The precautionary principle is an
alternative to a bias that, Rosie Cooney argues, exists
in many societies, jurisdictions, and contexts, there has long been a general
presumption in favour of development [emphasis in the original]. . . . Under this
presumption, where there is uncertainty or ignorance regarding the impacts of
activities such as release of pollutants, fishing, construction, or mining, the ‘default
state’ is that activities can go ahead.19
The precautionary principle operates in an alternative manner, shifting the burden of
proof towards showing that environmental harm is unlikely to come from development
operations, making room for policies that monitor and attempt to prevent potential
environmental damage. The basis for the use of this principle is that
in recent years, faced with the increasing scale of human changes and impacts on
the human environment, and with growing awareness of its complexity, it has
become increasingly clear that science, and human knowledge generally, cannot
provide definitive evidence of all forms of harm in advance.20
Jacqueline Peel describes the precautionary principle as “the most radical of
environmental principles.” Peel explains, “Some invoke it to justify preemptive
international legal measures to address potentially catastrophic environmental threats
such as climate change. Opponents however have decried the principle, arguing that it
promotes overregulation of human activities.”21
The European Union uses the precautionary principle to justify strict regulation of
GMOs, and in June 1999 the EU passed a moratorium on approvals of biotech products.22
In May, 2006 the WTO ruled on a dispute put forward by the US, Canada and Argentina
against the EU’s moratorium on approval of biotech products, stating that “the general de
facto moratorium . . . [is] inconsistent with the ‘sufficient scientific evidence’ and ‘risk
assessment requirements’ under the SPS agreement.”23 The decision, which ruled the
8

moratorium inconsistent with WTO rules, calls into question the efficacy of invoking the
precautionary principle in environmental regulation decisions when international trade
issues are at stake.
The conflict between European Union GMO policy and US GMO policy has not
only affected EU-US relations, but also contributes to the attempts at GMO regulation by
the developing world. The US regularly donates GMO food and seed in its international
food aid contributions. In 2002 Southern Africa faced the worst famine crisis in ten years
and the US sent food aid in the form of whole kernel corn. None of the corn could be
guaranteed GMO free, and as a result six Southern African countries refused the aid,
sending back the shipments.24 This was in part as a result of the concern, voiced by
Zambian president, Levy Mwanawasa, that the food is “poison,” but another crucial
factor in the dispute was the fear “that southern African nations could lose lucrative
export markets in Europe if they cannot certify that their crops are GM-free.”25 In this
way the EU’s restriction and labeling practices regarding GM foods in combination with
the active promotion of GMOs on the part of the US is affecting global trade not only
US-EU trade.

Biotechnology Industry Arguments
The major arguments made by biotechnology corporations to promote GMOs and
synthetic chemical pesticides are that this technology will be necessary to address poverty
by increasing the available food supply to feed the ever-expanding world population, that
they will do so in a more environmentally sustainable manner, while aiding the quality of
life of farmers along the way. 26 Monsanto’s website, for example, states:
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In the hands of farmers, better seeds are helping the world grow more, while using
less. Researchers around the world, in both the public and private sectors, are
working to improve seeds through the use of advanced breeding and
biotechnology. Together with better farming techniques, these advanced seeds can
help farmers meet the world's demand for food, clothing and fuel -- while also
helping to reduce the need for water, land, pesticides and fossil fuels.27
Monsanto also claims that the corporation is working towards the goal of “helping [to]
improve the lives of farmers and the people who depend on them, including an additional
5 million people in resource-poor farm families by 2020.”
The first step in understanding how these claims fit into the public dialogue about
the two major products that these corporations are promoting--GMOs and agricultural
chemicals--is to look at how some of the most recent literature that is produced
independently of the biotechnology industry on these topics evaluates the success of these
stated goals.

Goal: “Helping to reduce the need for water, land, pesticides and fossil fuels”

The Rodale Institute has been conducting side-by-side studies comparing organic
agriculture with conventional agriculture for 30 years, the longest running trial of its
kind. The Institute’s 2011 report on the findings of these trials find that organic farming-differentiated from conventional farming in that it does not use synthetic chemicals-produced a number of benefits over conventional farming techniques: Organic methods
used 45% less energy than the conventional methods and emitted a 40% smaller volume
of greenhouse gasses; the soil health from the organically farmed areas increased over
time, while remaining essentially the same in the conventionally farmed areas; and yields
10

reached the same level for both conventional and organic agriculture under prime
conditions, but in years of draught organic outperformed conventional agriculture.28
These results, although they do not address GMOs, challenge the fundamental
assumption that agricultural chemicals are necessary to efficiently produce food.
The importance of this finding is emphasized by a plethora of studies that show
the human health impacts of the presence of agrochemicals in the environment. One such
study exposed human liver cells to different formulations of glyphosate-based herbicides
(the most commonly used in the world, and that which the “roundup-ready” soybeans
produced by Monsanto are engineered to be tolerant of). The study “tested subagricultural dilutions and noticed the first toxic effects at 5 ppm, and the first endocrine
disrupting actions at 0.5 ppm, which is 800 times lower than the level authorized in some
food or feed” The study concludes that “glyphosate-based herbicides present DNA
damages and CMR effects on human cells.”29
Another study analyzes the concurrence between birth defects in the US and
levels of agro-chemicals in surface water.
A significant association was found between the months of increased risk of a birth
defect (April–July) and increased levels of nitrates, atrazine and other pesticides in
surface water. Critical time periods before and after conception may link seasonal
peaks in environmental contaminants to certain birth defects.30
Philip Howard, in an analysis of seed industry consolidation, introduces the idea of
3 distinct “treadmills” observable in the agriculture industry. One of these that he
discusses is the pesticide treadmill.
As the use of synthetic pesticides increases, populations of natural predators are
reduced, and selection pressures lead to pest populations with resistance to these
11

compounds. This encourages applications of larger amounts of current pesticides,
or the substitution of more toxic pesticides.31
Indeed GM seeds have resulted in an increase in pesticide resistant weeds.
Dr. Vandana Shiva reviews evidence of increasing pesticide use around the world
as a result of the adoption of various GM crops, highlighting the phenomenon of weeds
that are closely biologically related to plants that have been genetically modified for
herbicide resistance acquiring these herbicide resistant genes, producing a whole host of
herbicide resistant “superweeds.” According to Shiva,
as a result of this weed resistance farmers are being forced to use more herbicides
to combat weeds. As Bill Freese of the Center for Food Safety in Washington
D.C., says ‘The biotech industry is taking us into a more pesticide dependent
agriculture, and we need to be going in the opposite direction.’32
The resistance to glyphosate that these weeds are acquiring results in the return to
the use of “tillage and more toxic herbicides for weed control.”33
Due to a lack of additional available land for conversion to agricultural uses in the
US, Asia, and Europe, Latin America’s Southern Cone is the area in which GM soy
production is expanding most quickly.34 Argentina was one of the early adopters of GM
technology, which has lead to the domination of Argentine agriculture by the mechanized
production of soy, which “now occupies more land in Argentina than all other crops
added together.”35 Genetic modification of soy is heralded as a technology that will
reduce overall pesticide use, but the experience in Argentina challenges this claim.
When genetically modified herbicide-tolerant (GMO) soy was introduced in 1998,
it was rapidly adopted by Argentine farmers. The resistance of GMO soy to
glyphosate facilitated weed control and by 2002, the adoption of GMO soy neared
100%. Between 1994 and 2003 the use of glyphosate rose from 1 to 150 million
litres. The widespread and often indiscriminate use of glyphosate has caused
dozens of cases of intoxication and is blamed for the destruction of soil microbial
life, leading to sterile soils where crop residues are no longer decomposed. Weeds
12

that have developed glyphosate resistance require cocktails of highly toxic
herbicides such as atrazine to control. Intoxication of rural workers and
neighbouring communities have been reported throughout the soy producing
provinces.36
While it could be argued that the increase of the amount of glyphosate used is a logical
result only of the expansion of the agricultural sector,
the fact that the GM crops may require fewer distinct applications of herbicide
does not change the fact that their widespread adoption in the developing
countries, where chemically intensive agriculture is not the standard, will increase
the total quantity of chemicals entered into the environment.37
Additionally, the increase in chemical use is not proportional to the increase in soy
cultivation in many instances such as in Brazil, where “soy area has increased 71 percent
but herbicide use has increased 95 percent,” and where, “in 2009, total herbicide active
ingredient use was 18.7 percent higher for GE [genetically engineered] crops than
conventional.”38 The increase in pesticide use has lead to dangerous levels of water
pollution in Argentina and elsewhere in the Southern Cone: “Pollution of surface water
with pesticides threatens human populations and aquatic life. Indigenous populations
depending on fish for sustenance and river water as drinking water source are especially
vulnerable.”39
It is clear that the adoption of GM crops is increasing the amount of pesticides
used in agriculture, not reducing them. This result isn’t surprising in that it is in the
interest of companies such as Monsanto to increase, rather than decrease, the
consumption of its products. Monsanto promotes the idea that its GMO seeds are
environmentally friendly because they reduce pesticide use. While this claim remains
contested based on the research, including that discussed above, revealing an increase in
pesticide use with the adoption of GMO crops, the company represents the claim as
13

undisputed fact. An internal Monsanto document dating from 2002 describing the basis
for the “Good To Grow” campaign launched by the company at that time cites requests
by growers and the food industry to build support for biotechnology in order to reduce
anti-biotechnology pressure on the industry, as well as noting that “Monsanto’s future is
inextricably linked to global acceptance of biotechnology” and that “pesticide reduction
has shown it is a powerful message.”40 This line of reasoning shows the more pragmatic
side of Monsanto’s claims of the environmental benefits of its products, that messaging
regarding pesticide reduction was not implemented as a result of field studies providing
evidence that pesticide use has been reduced by the use of GMO seeds, but instead as a
result of the discovery that the message was proven to be effective in garnering public
acceptance of GMOs.
Argentina is in a unique position in that farmers do not pay royalties on
intellectual property rights since national laws allow for farmers to save genetically
modified seed from previous crops. This practice is illegal in the US and elsewhere,
requiring farmers to buy GMO seeds each year, rather than implementing the previously
common practice of saving seed from one harvest for use in subsequent planting seasons.
This exception has made the cost of using this technology very low in Argentina,41 and
combined with the increasing global demand for soy, has lead to the domination of soy in
the Argentine economy.
To this end, the introduction of GE crops in Argentina and elsewhere in Latin
America’s Southern Cone has lead to enormous deforestation.
By 2000, Argentina had lost 46% of its original closed canopy forest. At that time,
7.4 million hectares (ha) or 2.7% of the total land area remained. The deforestation
between 1990 and 2000 has been estimated at 10%. In 2000, Fundacion Vida
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Silvestre indicated that soy is a major threat to biodiversity in the Chaco and
Atlantic rainforest ecosystems.42
Not only does the expansion of GM soy production lead to increased use of
agrochemicals, but it is also a major contributing factor in deforestation in areas where
the soil is not ideal for agriculture, resulting in a situation where “the most marginal (and
often most vulnerable) lands will be abandoned shortly after having been cleared”43 The
reality of unnecessary deforestation, an increase in the use of toxic agrochemicals, and
water pollution resulting from farming practices associated with GM technology and the
use of synthetic agro-chemicals, combined with the Rodale Institute’s findings that
organic agriculture uses much less energy and produces equal and sometimes better
yields, brings into question Monsanto’s claims for the environmental benefits of its
products.

Goal: “Helping improve the lives of farmers and the people who depend on them”

Biotechnology corporations claim to be “helping improve the lives of farmers and
the people who depend on them, including an additional 5 million people in resourcepoor farm families by 2020.”44 Such claims are complicated by evidence that genetic
patenting directly negatively affects farmers worldwide in that
the price for soy and corn seeds more or less doubled between 1996 (when GE
seeds were introduced) and 2007. In comparison the prices of seeds for wheat and
rice (for which genetically engineered seeds are not prevalent) were increasing
much more slowly during that time period of time.45
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While farm incomes remain stagnant, seed and chemical corporations, most notably
Monsanto, continue to report increased profits.46
Howard puts forth a set of theoretical treadmills to provide an explanation of how
farmers are affected by the increasing industrialization of agriculture as well. The
technological treadmill was originally developed in 1958 by Willard Cochrane, according
to Howard.
Cochrane suggested that because demand for food is relatively inelastic, any
increase in production is likely to reduce the prices farmers receive for their crops.
. . . Practices that increase production (which are tied to off-farm inputs) may
initially accrue financial benefits for a small number of early adopters who are able
to stay slightly ahead in this process. For the majority of farmers, however, the
result is that they must constantly increase yields in order to simply maintain the
same revenue.47
Howard uses this concept to explain why farmers accept the increasing subjugation to
seed and biotechnology companies despite the trend of farmers becoming more and more
dependent on these corporations, with little or no material benefits for themselves.
Additionally, Monsanto has waged economically devastating legal wars on
farmers who choose not to use Monsanto’s genetically modified seeds, but whose crops
have been contaminated by cross-pollination with genetically modified crops cultivated
within range of pollination by insects and wind in countries such as the US and Canada
that support the industry’s claims to intellectual property rights for seed.48 The aggressive
legal action taken by Monsanto contradicts its self-reported interest in improving the lives
of farmers.

16

Goal: “Feeding 9 billion people”

The 2009 analysis of GM crop yields entitled “Failure to Yield,”49 produced by
the Union of Concerned Scientists, challenges the industry’s claim that GM crops provide
higher yields. The report reviews an extensive body of literature that compares yields of
genetically modified soy and corn with their conventional counterparts. Distinguishing
between the concept of intrinsic yield—the highest that can be achieved under ideal
conditions—and operational yield—the actual yield produced in the field, the authors
find that “there have been no apparent overall yield increases, operational or intrinsic,
from [herbicide tolerant] corn and soybeans.” The pest resistant (Bt) corn trials revealed
some yield increase as a result of the technology, but this increase accounted for “only
about 14 percent of this overall corn yield increase, with 86 percent coming from other
technologies or methods.”
The argument made in the report is that conventional selective breeding
techniques and other non-genetic engineering methods have historically accounted for
great yield increases and continue to do so above and beyond the small contribution that
genetic engineering has made to these efforts through some of the GMOs that have been
produced. The authors suggest that it would be prudent for
the U.S. Department of Agriculture, state and local agricultural agencies, and
public and private universities [to] redirect substantial funding, research, and
incentives toward approaches that are proven and show more promise than genetic
engineering for improving crop yields.50
The report recommends that these other approaches include “modern methods of
conventional plant breeding as well as organic and other sophisticated low-input farming
17

practices.”51 Although the biotechnology industry claims that its technology will be
instrumental in feeding the expected 9 billion people, its products have been shown to
contribute much less significantly to increasing food production levels than this claim
would imply.
An examination of the direct social impacts of the spread of the cultivation of
genetically modified crops further challenges the credibility of the biotechnology
industry’s claims that it is helping to feed the increasing world population. The reality of
the expanding world population is that expansion is occurring almost entirely in the
developing world, while population growth in the developed world is stagnant or actually
negative in many cases.52 Thus in order for Monsanto to be contributing to feeding this
growing world population the contribution will have to be towards feeding those in
developing countries, who are already most in need of increased food supply.
Debbie Barker points out, “even though we currently grow enough food to feed
the world, more than one billion people still go hungry.” Her argument is that “the
current system of relying on global markets and import/export models has dismantled
food security at the household level where it must begin.”53 A further analysis by Marcela
Valente describes the social inequity created by the evolution towards industrial soy
based agriculture in Argentina:
While soy output has skyrocketed, so have poverty rates in that region, which is
home to four million of Argentina's 37 million people. Between 1998 and 2002,
the proportion of the population living in extreme poverty increased from eight to
29 percent in Catamarca, from 20 to 36 percent in Jujuy, from 12 to 43 percent in
Salta, from 15 to 32 in Santiago and from nine to 34 percent in Tucumán.54
Although a direct causal relationship between increase in soy production and increased
poverty rates would be difficult to prove, it is clear that what benefits from the mass18

production of soy in these areas may exist, they are not contributing positively to the
quality of life of the majority of the population.
Richards adds to this argument by pointing out that Monsanto’s “biotech
revolution” has been focused on corn, soybeans, canola and cotton—highly
commercialized crops that are grown primarily for commercialized processing and not
for direct human consumption. As a result of the expansion of these crops in the
developing world, more of the food produced in these countries is exported to developed
countries and land that was previously dedicated to growing crops for local consumption
is being taken over for industrial agricultural production, while crops for local
consumption are being rendered economically unviable by market mechanisms.
Richards points out:
Far fewer resources and effort have been invested in crop varieties that have
markets centered on the less developed countries themselves. Crops such as
cassava, sweet potato, millet, tef, and yams have high nutritional value and are
grown in the harsh kinds of environments frequently encountered in the Third
World. Agribusiness TNCs like Dupont, Monsanto, Cargill, and Pioneer, however,
have an interest in actually transforming the agriculture of less developed countries
in a manner such that it comes to resemble as closely as possible that of the
developed countries. In so doing they create markets not only for their patented
seeds, but also for all manner of capital and chemical inputs that complement the
seed technology.55
Dros makes similar conclusions in his analysis, pointing out,
the combination of economic crisis and expulsion of small farmers and rural
workers by mechanized soy farming has led to a decrease in food sovereignty,
increased poverty and hunger. Food and dairy production for the domestic market
dropped, the use of agrochemicals, human intoxication and water pollution
increased.56
The products and agricultural model promoted by the biotechnology industry are thus
doing more to exploit the resources of developing world in the interest of producing
19

profits and any increase in food production is going to the developed world rather than
making a contribution to the quality of life of the growing population in the developing
world that the industry claims to be working towards feeding. This contradiction between
stated goals and the complicated reality of the effects of the actions of these global seed
giants on the ability of the global agricultural system to effectively function raises
important questions regarding how government and society monitor and regulate the
balance between the interests of citizens and corporate giants like Monsanto.
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Chapter 3: The Rhetoric of GMO Food
It is important to recognize that these instances regarding the loss of land and
resources by small farmers in the developing world in favor of large-scale production that
goes towards feeding wealthier populations of the developed world are not unique. They
are part of larger ongoing trends that many scholars discuss in terms of a North-South
dichotomy, perpetuating dependency relationships that define a new type of colonialism.
In a 2003 article addressing global human rights, Vandana Shiva frames the issue in this
way:
The North has dominated the South by systematically denying full human status to
the Southern peoples. This was first done through the West’s ‘civilizing
mission’—the white man’s burden [emphasis in the original]; now it is done
through globalization and free trade.57
Shiva describes free trade as having “substituted corporate for personal freedom. , and
passed off increased freedom for corporations as the expansion of democracy and human
rights.”58 Shiva develops an argument that the right of trade is trumping the human right
of access to food and livelihood. This concept highlights the values that lie behind
arguments made in discussions of food access and production in the global market. When
GDP and total crop production figures are used as evidence of the success of certain
technologies or policies, often the quality of life of large portions of the population can be
overlooked. Social and health issues are outweighed by big picture financial statistics
that are by their very nature blind to other costs. This analysis will look at media
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coverage of GMOs and biotechnology corporations with a focus on these value
assumptions that underlie financial, health and social assessments.
The issue of the safety of consuming food that is produced by GM seeds and
application of synthetic chemical pesticides is also of relevance to this discussion. The
biotechnology industry may be feeding some section of the growing world population,
but if the food consumed by that population is contributing to illness and is dangerous to
human health, then the value of this contribution is highly questionable.
The safety of GM food for human consumption has been an especially
contentious part of the public discussion of this technology. Dr. Shiva reviews a study
done on rats fed GM potatoes whose pancreases became enlarged, brains shrunk and
immunity became damaged. She also discusses data from Monsanto’s own feeding trials
that were accessed by a European Council order that demonstrated that rats fed GM corn
had damaged kidneys, livers, hearts, adrenal glands, spleens and haematopoietic systems.
The analysis goes on to detail a list of other studies that display the organ and immune
damage observed in rats and mice as a result of consuming GM foods. Shiva also states
that “The Biotechnology Industry attacked [the scientists who executed these studies] and
every scientist who has done independent research on GMOs.”59
This last point is further reinforced in much greater detail by Jeffrey M. Smith in
his book, Seeds of Deception, in which he discusses a number of cases in which studies
were halted and scientists were silenced by Monsanto and other industry players. Smith
asks “how does the biotech industry do it? How do they continue to virtually dictate
policy to the U.S. regulatory agencies in spite of such serious and blatant past
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transgressions?” Smith proposes that the industry accomplishes these goals through
campaign contributions and lobbying:
In 1994, 181 congressmen co-sponsored a bill that would require labeling of GM
foods. But the twelve member Dairy Livestock and Poultry Committee stalled the
bill until the end of the 1994 session—effectively killing it. In testimony before an
FDA panel, Robert Cohen said ‘I investigated these twelve men and found that
collectively they took $711,000 in PAC money from companies with dairy
interests and four of the members took money directly from Monsanto.’. . .
Lobbying is another way the biotech industry exerts influence. According to the
Center for Responsive Politics, between 1998 and 2002, the industry spent $143
million on lobbying. This includes the Biotechnology Industry Organization (BIO),
which lobbies and advertises on behalf of the whole industry.60
Smith and others have also suggested that Monsanto goes to great lengths to suppress
negative media coverage of its products. For example, a 2007 Fox news story delved into
why Monsanto (the creator and manufacturer of rGBH growth hormone, for increasing
the milk production of dairy cows) sued dairies for trying to label their milk non-rGBH.
Producers of this same news story investigated claims that the corporation threatened the
jobs of Canadian health regulators and tried to bribe them into fast-tracking the drug for
approval. But the story was produced and then never aired, and the news anchors were
fired for objecting to the censorship. The change of plan was the result of intervention on
the part of Monsanto’s lawyers that threatened costly litigation against the television
network, Fox, on which the report was set to air.61 Fox lawyers were quoted as having
told TV reporter Jane Akre and investigative reporter Steve Wilson “ ‘you guys don’t get
it. It doesn’t matter whether the facts are true. This story isn’t worth a couple of hundred
thousand dollars to go up against Monsanto.’ ”62
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The Propaganda Model
In Manufacturing Consent: The Political Economy of the Mass Media (1988),
Herman and Chomsky63 lay out what they call “a propaganda model,” which
focuses on [the] inequality of wealth and power and its multilevel effects on mass
media interests and choices. It traces the routes by which money and power are
able to filter out the news fit to print, marginalize dissent and allow the
government and dominant private interests to get their messages across to the
public.64
Herman and Chomsky set up five basic “filters” through which this process occurs. These
filters remain a relevant basis for considering the way in which the mainstream media is
influenced by societal structures, and are thus individually elaborated below.
The first of these filters is “size, ownership and profit orientation of the mass
media.”65 Here the authors present the manner in which start up costs and costs of
operation serve to limit who is able to produce media on a mass scale, resulting in the
concentration of media ownership in the hands of a relatively small elite. Additionally
Herman and Chomsky go on to point out that the fact that media conglomerates are
publicly traded results in a greater focus on turning a profit than in providing a public
service.
In order to turn a profit, media companies rely on advertising revenues, which are
selectively withheld if news content is unsatisfactory to advertisers. This leads to the
second filter: “the advertising license to do business.”66 The authors argue,
large corporate advertisers on television will rarely sponsor programs that engage
in serious criticism of corporate activities, such as the problem of environmental
degradation, the workings of the military industrial complex, or corporate support
of and benefits from Third World tyrannies.67
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Since news of this kind will not sell advertising, and may offend significant sponsors, it
would have to be run at a financial loss, an unlikely move for a publicly traded
corporation with a responsibility to shareholders to maximize profit. Media content, in
that it is a commodity for the purpose of creating profits, is also more effective for
advertisers if it maintains what the authors call a “buying mood.” Advertisers “seek
programs that will lightly entertain and thus fit in with the spirit of the primary purpose of
the program purchase—the dissemination of a selling message.”68 In buying advertising
time or space, advertisers are not only interested in the size of audiences, but also the
quality of audiences--their power as consumers. Thus news outlets that succeed in a free
market tailor their content to more affluent demographics, inherently marginalizing
publications with messages that are more relevant to working class and less affluent
members of society. The authors attribute the death of working class-targeted
publications in the UK, The Daily Herald, News Chronicle, and Sunday Citizen, to
“progressive strangulation by a lack of advertising support,” noting that the Herald had
“almost double circulation of The Times, The Financial Times and The Guardian
combined.”69 The authors use this evidence to argue that the dependence on advertising
to support the news industry renders advertisers more the target audience of media
content than the general public.
“Sourcing mass-media news,”70 is the third filter theorized by Herman and
Chomsky. This is based on the time and money constraints put on the mass media by the
need for a constant reliable flow of news material. The credibility culturally inherent in
government and corporate association makes sourcing news from these “experts” more
efficient than going to other sources that would have to be fact-checked and corroborated
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much more exhaustively. The White House, the Pentagon and the State Department are
also reliable sources of a large quantity of relevant news and thus are regular news beats
for reporters.

Flowing in the other direction, these large bureaucracies have a strong interest in
getting their messages to the public and dominating public dialogue on certain issues, and
thus they dedicate massive amounts of money to provide the mass media with easy to
process press releases and sound bites. This is the basis of a bureaucratic symbiotic
relationship, according to Herman and Chomsky, that favors the perspective of the
government and the private sector over less easily accessible and less wealthy actors.
Additionally, as part of this filter Chomsky and Herman explain the process by
which the corporate world co-opts the experts, in that to avoid highly respected
academics and scientists from undermining corporate messages in the media,
corporations put these valuable spokespeople
on payroll as consultants, funding their research, and organizing think tanks that
will hire them directly and help disseminate their messages. In this way bias may
be structured, and the supply of experts may be skewed in the direction desires by
the government and ‘the market.’71
The fourth filter is “flak and the enforcers,”72 and consists of legal, political or
social objections, either direct or indirect, from powerful actors, regarding the content of
mass media coverage. “The ability to produce flak, and especially flak that is costly and
threatening, is related to power. Serious flak has increased in close parallel with
business’s growing resentment of media criticism and the corporate offensive of the
1970s an 1980s.”73 The authors discuss the corporate sponsored growth of institutions
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specifically organized for the purpose of producing flak, such as Freedom House, the
Media Institute the American Legal Foundation, Accuracy in Media, the Center for
Media and Public Affairs and others.
Herman and Chomsky’s fifth filter, “anticommunism as a control mechanism”74
refers to the “national religion” of anticommunism, which serves to dichotomize the word
into an “us vs. them” mentality, and is used loosely as a term to vilify populist leaders
abroad and put liberals in the west on the defensive.
The anti-communist control mechanism reaches through the system to exercise a
profound influence on the mass media. In normal times as well as in periods of
Red scares, issues tend to be framed in terms of a dichotomized world of
Communist and anti-Communist powers.75
This framework is then used to justify US intervention abroad as well as support for
fascist dictators who are “lesser evils” than their communist alternatives.
Herman and Chomsky conclude their dissection of these mechanisms of influence
with a number of predictions based on their model. They premise these ideas on how
victims of foreign dictators will be portrayed in the news, as these are the nature of the
subsequent case studies that they analyze, but their concepts can be usefully extrapolated
to a broader context. They propose that the press covers the victims of foreign dictators
differently when it is useful to US politics to condemn them, termed by the authors
“worthy victims,” versus when the US is friendly with those dictators, termed “unworthy
victims.” They predict
we would not only anticipate definitions of worth based on utility, and
dichotomous attention based on the same criterion, we would also expect the news
stories about worthy and unworthy victims (or enemy and friendly states) to differ
in quality. That is, we would expect official sources of the United States and its
client regimes to be used heavily—and uncritically—in connection with one’s own
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abuses and those of friendly governments, while refugees and other dissident
sources will be used in dealing with enemies.76
These distinctions of who is quoted when and with what level of criticism, in conjunction
with their subsequent predictions regarding uncritical acceptance of certain premises,
“such as that one’s own state and leaders seek peace and democracy, oppose terrorism
and tell the truth,”77 will be useful in creating a nuanced framework of how
biotechnology and the groups that have a voice in the debate are represented in the mass
media.

Updating The Propaganda Model
Many scholars have used the propaganda model as a basis for media analysis
since its introduction in 1988, going beyond the application to foreign policy by Herman
and Chomsky. For example, in 2008, Jennifer Ellen Good78 analyzed how mainstream
print media in the US, Canada, and other international news sources cover global
warming. Good found that Canadian papers are three times as likely as US American
papers to include articles about climate change, and that international papers are almost
30% more likely to print such stories, using this evidence to make her case that “it would
seem that the underlying message from newspapers in the United States is that climate
change is not all that important.”79
Good found that U.S. media frame climate change stories with a science-oriented
frame more often than do Canadian media and others, while non-American media frame
climate stories around the Kyoto Protocol. This focus on science centers on the question
of whether climate change is real in the US media, as opposed to discussing solutions
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such as Kyoto. Based on her findings and the propaganda model, Good predicted that US
elites are the group with the strongest interest in maintaining the status quo with regard to
climate change. She noted that debate, criticism and dissent all play a role in maintaining
the status quo, as argued earlier by Herman & Chomsky.
The analyses presented here highlight that the story of climate change is being told
(even within the United States, albeit somewhat less frequently) and that there is
debate, criticism, and dissent. When the news frames move into more potentially
threatening territory, however, such as the linking of climate change with extreme
weather events or decreasing/different energy use, the story frequency plummets.80
Good finds the propaganda model to be a good analytical tool for analysis of the
imbalance of article volume and framing of climate related issues.
Several scholars cite the most notable weakness of the propaganda model as being
the lack of explanation given by the model for variation in coverage that is evident in
mainstream media.81 Others note that the fact that the way an issue is covered changes
over time is not accounted for in the model.82 Still other scholars argue that the
propaganda model is too structural and does not allow for the individual agency of
journalists. 83
These weaknesses are addressed and reconciled by these scholars in a number of
different ways. In 2009, Des Freedman84 addresses the critics of the theory by focusing
on an occasion of notable breakdown of the propaganda model in the UK. He examines
the lead up to the war in Iraq and the fact that the Daily Mirror, usually a tabloid about
celebrities and other less serious issues, turned its full attention towards editorializing
against Britain becoming part of US President Bush’s “coalition of the willing”85 by
joining the US in the invasion, and gathering signatures for a petition against it.
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Freedman argues that the propaganda model focuses on the sameness of the media,
whereas looking at the exceptions to this sameness is more enlightening:
Because they are about times at which established structures start to wobble, when
previously hidden tensions emerge and when new actors are called for, abnormal
circumstances are crucial in alerting us to the possibilities of both new kinds of
political action and new kinds of media coverage.86
He suggests that competition for different audiences and an attempt by the Mirror to
differentiate itself from competitors contributed to this seeming rebellion against the
typical kind of coverage.
Freedman does not accept the explanation included in the propaganda model for
such variance, that such events are a consequence of a divided elite, and serve only to
create the illusion of a dynamic and independent media. Freedman argues instead that at
certain times there is
a willingness on the part of large numbers of people to participate in campaigns
and movements that expose them to new ideas and generate this need for more
challenging media frames. Their experience, in other words, pushes them to
challenge received ‘wisdom’ and to make more demands of their media.87
Through this analysis Freedman arrives at the conclusion that the propaganda
model is effective in identifying systematic and everyday deficiencies in the corporate
media, but that it is not as useful in theorizing change and exceptions, those events that
open avenues for dissent.
We need an approach to the media that focuses on its internal contradictions –
tensions that are most clearly expressed in moments of crisis – that not only
explains the generally lousy performance of the mainstream media, but also
encourages us to mobilize with others in seeking to open up critical spaces, to
press for more accountability, and to inspire a democratic and genuinely diverse
media.88
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In this way Freedman acknowledges that the model works up until a certain point, but
that it does not allow for specific contexts--and as he says, the most interesting kind of
context--where the status quo is challenged.
In 2007, Colin Sparks89 provided a detailed criticism of the propaganda model,
reviewing its history of neglect as well as a tendency in critical scholarship to discuss a
similar conceptual framework while ignoring the existence of the model in the first place.
Sparks approached the propaganda model from a more Marxist framework, which
assisted him in making distinctions, such as: “On the grounds of economic theory, we
would expect capitalist-owned media to be united in opposition to threats from the
working class, but deeply divided in terms of the interests of different groups of
capitalists.”90
Sparks also argues that the great variety of audiences targeted by news producers
results logically in a greater variety of views that will be expressed in the mainstream
media than the propaganda model allows for. The disproportionate focus by the model on
the specific characteristics of the US media also makes it weaker according to Sparks.
Another important flaw in the propaganda model arises from Herman and Chomsky’s
assertion that journalists are middle class and thus aligned with the views of the elite.
Sparks positions journalists instead as part of the working class, and thus much more
active as potential agents of dissent than in the original model. These criticisms and
others lead Sparks, in a similar vein as critical scholars cited above, to propose a model
more open to change and accounting of a multiplicity of voices.
The central departure from the classical formulations of the PM is that, in place of
the stress it gives to the uniformity of the media, we now expect to find diversity.
The divided nature of the capitalist class, the presence of powerful critical currents
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which find legitimate public expression in a capitalist democracy, the need to
address the concerns of a mass audience, political differentiation as a marketing
strategy, all point to the necessity for any viable media system to include a range
of different opinions.91
In amending the model Sparks brings a comparison between the US and other
democratic countries, such as those in Western Europe. Sparks proposes that the
differences therein are the key to expanding the model, understanding the greater
diversity of news than the propaganda model originally theorized and in conceptualizing
how change can be realized even within a system that is so controlled by money and
power. “The degree to which the mass media in a capitalist democracy will be open to
dissenting voices cannot be specified in advance. It depends in part on the political
structure of the society, the nature of its media market, and the issues under discussion.”92
Under this readjustment Sparks proposes that the US is particularly constrained by the
forces proposed in the propaganda model, but not stuck in them. Evidence of some
diversity of viewpoint in the US media and a greater diversity in societies where there is
public service broadcasting, a wider range of official politics, indicates the fluidity of the
system. “If we modify the model to allow for the systematic representation of diverse
opinions within the spectrum of legitimate politics, rather than positing the unified
propaganda function of the media, then we can give a much better response to critics.”93
Sparks sees this modification of the model as an opening for journalists to
organize and revolutionize the media, taking over the media and attempting to run them
along different lines, although he concedes that this is a distant prospect. The general
tendency is for interested scholars to take this model and find where, when and how
deviations from Herman and Chomsky’s model occur, ultimately tying these back to the
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model as an explanatory device. This technique is especially relevant to this study in that
the debate over GMOs has evolved over time, and coverage is bound to vary over time
and certainly between the US and the UK, as other research has established. It will be
important to look at differences as well as consistencies over time and location. The
filters as presented in the original theory, in conjunction with more recent criticism and
development will inform this analysis greatly.
The propaganda model lays out a theoretical framework that is highly political,
and in certain parts, very specific to the time period in which it was developed. The
model contributes insight onto the original form of a media system that has been
changing at a rapid rate since the conception of the model, and thus while it contributes to
the theoretical basis for this analysis, it cannot alone structure a modern analytical
approach towards a media and information environment that has been largely affected by
the internet and more accessible alternative information sources. The propaganda model,
then, serves as a starting point from which to develop a framework under which to study
the most recent developments in the GMO food debate.

Agenda Building & Agenda Setting
The ability of corporations to significantly influence how they and their products
are covered by the mainstream media can be best examined through the theoretical lens
of agenda building. As exemplified by the case of Monsanto’s successful bid to block the
broadcast of Akre’s story, and further elaborated by Herman and Chomsky’s insightful
analysis, wealthy and powerful corporations have a disproportionate power to influence
what kind of stories the media publish and broadcast, and the extent to which this
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influence is a major organizing force in media production is the topic of extensive
research. Agenda building theory provides a theoretical basis for analyzing what powers
influence the news that the public consumes and in what ways. Agenda setting theory, in
turn, deals with the manner in which the media shape what the public thinks is important
and how these issues are discussed.
Temporally, agenda building occurs prior to agenda setting. Whereas agenda
setting relates to how the media agenda affects the public’s perception of issue
salience and how the public processes news information, the central point of
agenda building research is how some news items get on the media agenda while
others do not.94
A fundamental aspect of how agenda building and agenda setting play out in news
reporting is in how stories are framed.
Framing involves organizing and structuring information so that it is socially
shared and provides meaning to reality, i.e. issue or event. This involves deliberate
identification of an aspect of a perceived reality, and giving interpretation and
evaluation of that reality.95
The sources of information that a journalist accesses in crafting a story, the
language that the journalist uses, the sources that the journalist quotes, the tone that is
taken as well as what information is included or emphasized and what is left out or
passed over briefly, all make up the frame of the story. Even as journalists strive to report
news in an impartial way, framing theory posits that all articles are filtered through a
human lens and the choices that are made in composing the article/production have a
significant influence on how a reader will interpret the information presented in the
article. While the ostensible goals of journalism are to inform the public of newsworthy
information external forces and expedience often shape news much more. “As news
environments become more fragmented, public relations grows more sophisticated and
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editorial systems weaken, the impact of PR on news becomes greater and more
diverse.”96 The sources of information that are more available, seem more credible, or
seem to provide a more compelling news piece can thus have a stronger influence on how
a story is framed than other sources. In this way, agenda building theory posits, industry
organizations, activist groups and other organizations that are external to the media
provide conveniently packaged information that is easily converted into news stories, and
likely has an influence on how the information is framed.

Public Relations & Corporate Social Responsibility
Agenda building is closely tied to public relations, in that activist and industry groups of
all kinds include media relations prominently in their public relations strategy. Agenda
building is, then, often the result of coherent public relations strategies designed to
achieve specific organizational goals. The public relations (PR) textbook Strategic
Communications Planning for Effective Public Relations & Marketing, defines Public
Relations as “an organization’s efforts to establish and maintain mutually beneficial
relationships in order to communicate and cooperate with the publics upon whom longterm success depends.”97 This definition allows this analysis to establish a starting point
for how PR practitioners would like the public to conceptualize their practices. James E.
Grunig gives a more nuanced analysis of the role PR plays in the international arena,
defining several types of PR practice. He defines two-way asymmetrical model as one
that that “uses social science research to identify attitudes and to develop messages that
appeal to those attitudes that persuade publics to behave as the organization wants.”
Grunig goes on to point out that this model only
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seems to work reasonably well when the organization has little conflict with a
public. When the organization and the public disagree, however, the model usually
exacerbates the conflict and often leads to campaigning against one another,
litigation and regulation.
Grunig proposes that “the two-way symmetrical model, overcomes these deficiencies. It
describes public relations that is based on research and that uses communication to
manage conflict and improve understanding with strategic publics.”98 Evidence provided
here suggests that the biotechnology industry currently relies on one-way symmetrical
communication in that it uses very sophisticated methods to understand its publics and try
to get them to bend to the will of the industry, but seems unwilling or unable to make that
potential for change go in both directions.
Jonathan Matthews recounts an example of the biotechnology industry’s efforts to
shape press coverage of the GMO issue, while displaying a highly developed
understanding of the publics with which it is trying to communicate, a strong resistance
to internal change, and a focus on changing public perceptions of global attitudes towards
genetically modified organisms. Matthews describes a demonstration at the 2002 Earth
Summit in Johannesburg in which poor farmers from India, Indonesia and three other
developing countries marched and held signs decrying “the eco-agenda of the Green
Left.”99 The protesters were ostensibly outraged that green activists were depriving them
of the access to technology that could alleviate their poverty. Articles covering the protest
were printed in newspapers all over the world with titles such as “I do not need white
NGOs to speak for me.” What Matthews documents, however, is that the spokesman
quoted as a poor Indian farmer, Chengal Reddy, is a wealthy lobbyist for large
commercial farms in India. The media contact on the press release was Kendra Okonski,
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a wealthy US citizen and right-wing NGO representative who also previously “ran the
website counterprotest.net which specialized in helping right-wing lobbyists take to the
streets in mimicry of popular protesters.”100 It turned out that poor farmers sporting antienvironmentalist t-shirts and pro GMO signs did not, when approached by reporters,
know English well enough to know what they were representing and these props had
been given to them by the protest organizers and their travel expenses paid by groups
such as Monsanto-funded, AfricaBio. Matthews argues that this is just one example of
“the effort to position Monsanto’s soap box behind the black man’s face,”101 going on to
document repeated fake demonstrations with hired minority demonstrators and other
direct attempts by the biotechnology industry to construct the illusion of popular support
for the cultivation of GMOs. One of these techniques is the creation of supposedly
independent organizations “such as CropGen and the Agricultural Biotechnology
Council, both of which are run out of the office of the same central London PR
agency.”102 These organizations publish reports and are designed to be viewed by the
public as independent scientific organizations that support biotechnology based
independently on its scientific merits. This effort, according to Matthews, came out of the
realization that a major reason for the failure of public acceptance for GMO foods in the
UK was that the defense for these products was fronted by Monsanto and AstraZeneca.103
In “Marketing Science: The Corporate Faces of Genetic Engineering,” Fennell104
describes some of the tactics used by biotechnology companies to sell their arguments
about GM food as truth. She argues, “somewhat paradoxically, companies attempt to
juggle the multiple tasks of branding/selling a unique product while acting as a teacher to
the general public and presenting seemingly unbiased and objective knowledge.”105 She
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positions biotechnology companies as using PR to create a false sense of two-way
communication, while framing the issue as one in which “science is a sphere outside of
rhetoric and that any complaints stockholders like consumers have is the result of a lack
of understanding of science or expertise.”106 Fennel also cites numerous “reports of
biotechnology companies attempting to smother the dissemination of research and
engaging in questionable tactics while trying to influence policy.”107
In a 2001 study of the source material used in environmental journalism Curtin
and Rhodenbaugh108 examine whether the PR communication from corporations with a
strong interest in refuting scientifically grounded claims of the destructiveness of their
industries are more influential than PR materials from environmental organizations. They
conclude that “within the distribution channels examined here, backlash materials are
reaching journalists more frequently than are materials from environmental groups,
demonstrating that backlash groups are more effectively forwarding their agenda to
journalists.”109
Corporate Social Responsibility is a term used in public relations literature that
has become more important with increased public awareness of environmental problems
and the trend of consumers trying to vote with their pocketbooks and boycott
corporations whose actions are morally reprehensible or risky for human health and the
environment. Corporate social responsibility can range from funding of community
groups and projects to environmentally minded changes to corporate policy. According to
Hildebrand et. al.110
companies are increasingly interpreting CSR in terms of the interests of a specific
but large and diverse set of stakeholder groups (e.g. consumers, employees,
investors, communities, government, environment, etc.) and their efforts are
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shaped by the strong belief that its endeavours in the CSR domain can elicit
company-favouring responses from these stakeholder groups.111
Some see corporate social responsibility as the exercise of consumer power to keep
corporations in check, and thus as a positive development for society. This perspective is
contested for a variety of reasons.
Karnani,112 in his 2010 Wall Street Journal analysis of CSR, notes that the easiest
way for companies to “do well by doing good” are those practices that are just good
business. When companies’ bottom lines benefit from environmentally friendly practices
it makes sense for them to carry out these practices even without social pressure to
behave in a more environmentally friendly manner, but
in most cases, doing what's best for society means sacrificing profits. This is true
for most of society's pervasive and persistent problems; if it weren't, those
problems would have been solved long ago by companies seeking to maximize
their profits. A prime example is the pollution caused by manufacturing. Reducing
that pollution is costly to the manufacturers, and that eats into profits. Poverty is
another obvious example. Companies could pay their workers more and charge
less for their products, but their profits would suffer.113
It is in areas that are not so business-friendly that corporate social responsibility
fails to fulfill the necessary functions that a lack of government regulation leaves
unaddressed.
Vogel,114 in his 2006 analysis of the effects of CSR on labor conditions, points
out,
There is a systematic variation in the pattern of compliance with specific standards.
Compliance appears to have been greatest with respect to child labor and health
and safety conditions, and least strong in the areas of wages, overtime restrictions,
and freedom of association . . . [these areas] are more difficult to monitor, and
compliance usually increases production costs.115
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According to Vogel, many corporations have picked the low hanging fruit of CSR
practices that are economically attuned with the company’s other goals. While reporting
attempts to achieve the more costly and difficult to attain goals, they use the publicity of
what they have achieved as evidence that headway is being made and that they have
become newly dedicated to behaving in a socially responsible manner.
Debashish and Kurian116 argue,
while much has been made of ‘consumer power’ there seems little evidence yet of
fundamental changes in corporate practice, especially where such ‘dirty’ industries
as oil, gas and mining are concerned. What is evident in the wake of four decades
of environmental activism, and recent anti-globalization protests that have swept
the First World, is the need for a repackaging of corporate images to create public
goodwill.117
These authors argue that two-way symmetrical communication is a western-centric and
colonial concept, ignoring power differentials in society and favoring certain publics
above others. Within this framework, then, corporate social responsibility is impossible in
any real sense, according to the authors.
It is in the interest of the dominant organizational core that public relations
“manages” the corporate image through an asymmetric hierarchy of publics: (1)
the predominantly Western shareholders; (2) the Western consumer public/the
global middle-class consumer; (3) the Western activist public; (4) the vast numbers
of Third World workers who produce the goods for consumption by others; and (5)
the even greater numbers of Third World citizens too poor to consume. The first is
obsessive about profits and share values, the second consumes blindly, and the
third provides resistance from within the West, while the last two fall below the
corporate radar. Corporate PR efforts, therefore, focus on undercutting the protests
of the third public to appease the second public and directly benefit the first public.
Its agenda has no place for the colonised fourth and fifth publics.118
For these authors corporate social responsibility is simply another strategy to allow
corporations to continue to exploit less advantaged third world populations and thus
continue historical colonial practices.
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Clapp and Fuchs119 argue that the trend towards corporate social responsibility
results in corporations having a disproportionate influence over the focus and content of
the rules as well as which standards are widely adopted.120 These authors point out that
reporting efforts that reflect corporate social responsibility have been increasingly
adopted by major firms in the food and agriculture sector, which argue that it
demonstrates their commitment to sustainability…But the proliferation of private
certification schemes is seen by many to be pushing small farmers out of the
market, particularly those operating in the developing world, in favor of large
agribusiness and food processors.121
In all of these arguments the effectiveness of corporate social responsibility to keep
corporations from exploiting publics and damaging the environment is called into
question.

Research Findings From Agenda Building & Agenda Setting
A significant body of research exists examining agenda building, proposed by
Cobb and Elder in 1971, 122 and even more on agenda setting, proposed in 1972 by
McCombs and Shaw.123 A significant portion of this research looks at the effects of
public relations on how specific issues and corporations are covered by the media, and
subsequently, how this media agenda is translated into the public agenda, as reflected by
public opinion research.
Examining both agenda setting and agenda building effects, Kiousis, Popescu and
Mitrook124 conducted a quantitative analysis of public relations materials, media content
(the Wall Street Journal and New York Times), public opinion and financial performance
for 28 large companies. The most notable findings of the study with regard to agenda
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building are a positive relationship between the amount of PR materials provided to the
media and an increase of attention in print media, as well as “a positive correlation
between public relations messages tone and media coverage tone.”125 In terms of agenda
setting, the study found that
agenda-setting effects were found for news coverage and financial performance,
but only for Wall Street Journal content and not the New York Times. . . mentions
of corporate vision and leadership (managerial traits) in the Wall Street Journal
were significantly correlated with company revenues, profits, and assets,
respectively. On the other hand, mentions of corporate social responsibility in The
New York Times were correlated with the same financial indicators.
This variation in agenda-setting effects prompted the researchers to suggest that variation
in news outlets could be based on the nature and focus of the publication.126
Kyle Huckins127 also examined agenda building from a quantitative perspective,
but by way of a case study of one interest group’s changing agenda as reflected by its
official publication and how that was reflected in media coverage of that group in major
US newspapers. Huckins found highly significant correlations in changes of terminology
and tone between the interest group’s official paper and mainstream US media coverage
of the group, although no change in story construction was found. Both the study by
Kiousis, Popescu and Mitrook and the Huckins study support agenda building theory and
indicates that interest groups and corporations appear to have the power to influence how
much and how mainstream media cover them.
Zvi Reich,128 notes the increasingly fragmented news environment and the
resulting insufficient nature of traditional PR release studies in identifying the level of
influence that PR has over the news, choosing to use journalist interviews about their
recent stories and the various inputs they may have had from PR professionals in
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composing them. PR contacts such as phone calls and PR professionals setting up
interviews for journalists and other technical services were discovered to be common
exchanges for journalists and PR professionals. Reich finds that “only 40 percent of the
items involve no direct input of information and no more than quarter of them are totally
free of any kind of PR involvement, as far as reporters can tell.”129 Additionally Reich
notes that journalists tend to hide this level of PR contribution and balance the level of
PR input by finding at least one other source for their articles about 75% of the time.
Reich concludes with three assertions based on the findings:
(1) PR and journalism are highly interdependent occupations; (2) PR’s constant
advantageous access renders it a key player in blocking alternative sources
indirectly; and (3) PR gains excessive access to public opinion in non-transparent
ways that hamper public evaluation of the information and reassessment of source
credibility.130
The topic of health reporting is especially relevant to this study in that much of
the discussion surrounding GMOs regards the potential human health effects of
consuming GMO foods, and, more generally, is a scientifically focused conversation,
thus involving “experts” of various kinds and a significant amount of technical and
scientific information, much like health related issues.
Investigating health news coverage through journalist’s perspectives, Len-Ríos et.
al.131 interviewed a large sample of healthcare journalists from throughout the US, and
similarly examined the manner in which journalists come up with the ideas for health
related stories—whether from PR or non PR sources—and how they perceive the
acceptability of using PR sources in their stories as well as how they value expert sources
and source characteristics. The authors found that ideas for health related journalism were
more likely to come from other news reports, reader interest, and self-generated ideas
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than from PR sources. The significance of other news reports as seeding story ideas lead
the authors to suggest, “it could be that intermedia agenda setting amplifies the voices of
those organizations that successfully place their information subsidies.”132 The authors
also suggest that self-reporting could lead to journalists underestimating the influence of
PR on story concepts.
Andrea Tanner,133 also using a journalist interview format, explicitly examined
agenda building with regard to television health reporters. Noting that the technical
nature of health reporting influences what kind of sources these journalists access, Tanner
analyzes
what motivates these television news health reporters to cover a specific health
topic, why a health reporter chooses to use a particular source when covering a
health-related story, and how these sources of information affect a health reporter’s
decision-making process as he or she decides what will ultimately be broadcast to
the public.134
Contrary to the findings of Len-Ríos et. al., Tanner found that more than half of reporters
get ideas for reports from PR spokespeople that personally contact them, but also found
that the other significant sources are viewer call ins and other news reports. The study
also emphasized the lack of health and science training in many of these reporters,
resulting in a reliance on health professionals and experts to explain technical concepts.
Tanner also noted that
although only 13 percent of respondents said their health sponsor affects their
decision to cover a story, qualitative research from this study suggests that some
health reporters feel obligated to use story ideas pitched by their sponsor or use
sources only from the sponsor.135
These findings suggest that in more technical and scientifically based areas, journalists
are more dependent on industry representatives and experts of all kinds in order to
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compose their reports, additionally these experts are often sourced from organizations
and institutions that fund the journalistic enterprise. This indicates that through funding
and/or owning a media outlet, private interests may contribute to building the media
agenda in specific issue areas.
Wallington et. al.136 investigated how the structure of different news organizations
and individual characteristics of journalists affect source and resource reliance and angles
and priorities in health and medical science reporting. They asked a random sample of
health journalists about information sourcing and their goals and priorities in developing
stories, controlling for whether the media organization was publicly owned, owned by a
group or chain, and staff size, as well as experience level, education level and perceived
autonomy of the journalist within the organization. The study “showed that reporters with
a bachelor’s degree or less rely on press releases, local health care providers, and patient
advocacy organizations more often than reporters with master’s degrees or higher.”
Those with a masters degree or higher were more likely to use scientific journals and
non-government and non-industry sources.137 The study found no difference, however,
predicted by organizational size or other characteristics in the likelihood of a reporter
using industry scientists and spokespeople and scientists.138
The ultimate goal of PR is clearly not just to set the media agenda. PR
professionals operate under an assumption that the media in turn sets the public agenda,
and can affect how the public perceives particular issues and groups. Agenda setting then
is the other side of the coin, and conceptually equally important in understanding how PR
efforts set the public agenda through the media. Not only the amount of attention and
space devoted (or conspicuously not devoted) to an issue, but also the way it is framed,
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has much to do with the manner in which agenda setting theory proposes that the media
sets the public agenda. Largely, studies support this relationship through a combination
of content analysis and public opinion research. Extensive research has been compiled in
the last four decades showing the agenda setting effects of media exposure both
experimentally139 and through public opinion research,140 and more recent studies in this
area have aspired towards a more nuanced understanding of agenda setting.
In a 2012 study Corwin Smidt141 examines how different kinds of content in news
reporting affect the public agenda. In this study Smidt looked at coverage of political
elites, coverage of popular protests, or coverage of events related to a particular issue, in
this case Smidt focused on the issue of gun control so these events were occurrences such
as school shootings. Smidt finds that coverage of popular protest had more agenda setting
effect than the other two types of coverage, and argues that
it is commonplace for scholars to assert that the news media’s bias in covering
governing officials increases their ability to shape public opinion. However, these
claims overlook the possibility that the public agenda does not react similarly to all
types of news coverage.142
The implications of this research in terms of PR is that not all media coverage affects
how the public views issues in the same ways, indicating that some kinds of PR will have
less of an effect than others. This is especially interesting with regard to the fake protests,
discussed above, that were staged and manipulated by the biotech industry and other
interest groups in order to create the appearance of support for GMOs by poor farmers
participating in popular protest.
Besova and Cooley143 base their 2009 agenda setting research on the theory
positing that agenda setting effects vary depending upon the public’s familiarity with a
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particular issue. Using what the authors term an unobtrusive issue, one that does not
affect the daily lives of most members of US society, the study looks at coverage of
foreign countries in US (The New York Times) as well as the UK (The Times). “The
results of this study show a relatively clear relationship between media coverage of object
nations and how individuals [in the US and UK] perceive those nations, a finding
consistent with the previous literature on attribute agenda setting.”144 This study used
frames to analyze the coverage of foreign nations in the two countries, finding that
negative frames tend to have more significant agenda setting effect than positive frames,
which appeared to have very little effect.

Framing
Framing of biotechnology by the media has received a fair amount of attention by
scholars over the past decade. In a study examining coverage in the New York Times
(1971-2001) and the Washington Post (1977-2001) of biotechnology and genetics related
issues, Eyck and Williment145 approached the mass media as tools for legitimation. This
study focused on what actors and spokespersons were seen as legitimate sources of
information, based on more access to reporters for government and big business than for
other groups such as activists, consumers and unaffiliated citizens. The study also
examines the differences between articles about biotechnology in terms of food and in
terms of medicine, asking if articles framed the issue as progressive or some other frame,
such as economic. The study found that coverage of genetically modified food was
consistently more negative than coverage of biotechnology for medical purposes, and less
likely to be framed as progressive. Early coverage, between 1971 and 1991 tended first to
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fall within a progressive frame the majority of the time, especially if medicine was the
topic of the article, and second
scientists and government officials were used as sources in a significant minority
of these articles, but they were by no means omnipresent. Much of the reporting
did not rely on experts to support or oppose a specific view. The second point is
that the intersection of medicine and genetics was prominent from the start, while
food issues were not.146
The researchers found that during this period experts were not relied on much in that
there was little controversy in the majority of articles because the technology was by and
large seen as progressive and potentially profitable.
For the time period from 1992 through 2001 overall coverage increased
significantly, and the economic frame became more prevalent. Food topics were
discussed more (although medical topics remained the majority focus), more articles
advanced a position and metaphors such as “frankenfoods” (a term used by anti-GMO
activists to disparage GMO foods) were used more. Government representatives and
scientists were heard from less during the later period, leading the authors to suggest the
possible explanation that more newsworthy groups, such as activists were getting more
attention. The authors concluded that "First, sources do not enjoy a homogeneous,
hegemonic position, even those holding government positions. Trajectories can and do
change. Technologies are not necessarily considered monolithic but reported in ways that
reflect larger social issues.”147 This study relied largely on quantitative analysis, and thus
the authors did not significantly explore the use of language or how sources were
represented in a detailed manner, leaving some question as to the more latent details of
the coverage beyond descriptive statistics.
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Marks et. al.,148 in their 2007 study, also looked at coverage of medical vs.
agricultural biotechnology, comparing the coverage in the UK (London Times) and the
US (Washington Post) over the period from 1990-2001 in terms of risk based framing or
potential benefit based framing. The research finds more coverage for agricultural
biotechnology than medical biotechnology throughout the time period, with the public
debate spiking in 1999, with more coverage in that period in the UK than the US,
although both saw an increase. The authors
find that the two sets of technologies have been framed differently—more positive
for medical applications, more negative for agricultural biotechnology. This result
holds over time and across different geographic locations. [They] also find that
international events influence media coverage but have been locally framed. This
local newsworthiness extends to both medical and agricultural applications. We
conclude that such coverage could have led to differences in public perception of
the two sets of technology: more negative (or ambivalent) for agricultural, positive
for medical applications.149
While the authors find some variation in coverage of biotechnology between the US and
the UK, they attribute this to the tendency to give coverage a local frame, and don’t make
any strong distinctions between coverage in the US and the UK.
Catherine Crawley,150 basing her 2007 inquiry on an existing body of
research151152 that finds a pro-biotechnology bias in the national news in the 1990s, as
Eyck and Williment also found for this early time period, where voices besides
government officials and industry representatives are largely absent. This results in the
image of an American public receptive and even enthusiastic about biotechnology, and
leads Crawley to ask whether these same qualities exist in local news coverage of the
issue. Crawley establishes the basic premise that frames are often influenced by powerful
elites in society, and that the media tend to uphold social norms and dominant
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viewpoints, but she also cites research finding that traditional news values can be
exploited by less powerful groups to reframe an issue in ways that go against government
and industry elites’ preferred messaging.
Crawley looks at local coverage from Northern California—a region in which
agriculture is of high economic importance, and Missouri—the home of Monsanto
headquarters and strongly economically tied to the biotech industry, between 1992 and
2004, using quantitative analysis to examine word frequencies to define frames. The
study found that the framing of biotechnology issues varied on many different levels in
coverage between the two. Missouri had a higher concentration of frames regarding
economic significance and European fear of GMOs, while Northern California news
contained more frames regarding environmental impact and safety. Crawley also found
that government agencies were dominant news sources in both states, while in Missouri
private industry sources dominated more than in Northern California. Opposition groups
were featured more prominently in Northern California coverage than Missouri.
In her analysis of these findings, Crawley points out that “in this study, the
dominant news sources for the agricultural biotechnology story appeared to have the
financial or staff resources to devote to their various media campaigns,” concluding that
“Missouri’s more industry-oriented frames resonated with its more conservative leanings,
while Northern California’s more oppositional frames resonated with its more liberal
leanings.”153 With regard to the issue of the difference between national and local
coverage, Crawley states,
in contrast to those studies of biotechnology news content in the national, elite
press, this study suggests that a range of voices and perspectives about
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biotechnology do in fact exist in news media coverage of biotechnology in the
United States, at least in some community newspapers.154
Crawley questions how the flow of local news to national news occurs, wondering why
some important biotechnology events are covered locally but do not get any national
coverage.
Thomas Listerman,155 in a 2010 examination of media coverage in the US, the
UK and Germany focusing on two high circulation papers in each country, focused on
cycles in which media attention to biotechnology issues was high. He found that
the general tendency of the coverage was more often positive than negative in all
countries. The positive share of news items measured 53 percent in Germany and
Britain, and 67 percent in the United States. Although not significant at this
general level, increasing media attention led to a slightly more negative tendency
in German (−.071) and British (−.286) news, whereas the US coverage tendency
(.311) changed to the positive.156
Additionally this research found an emphasis on risk framing in the British discourse, and
economic-utility framing in the US.157 Listerman uses existing public opinion data to try
to explain the discrepancies between the countries and the corresponding discrepancies in
public opinion, but acknowledges the inability of the research to test causality. Instead
Listerman concludes more broadly, “it is likely that the national differences discussed
here are embedded in national culture and reflected in public opinion as well as in
opinion-leading press coverage. For example, comparable discrepancies exist between
the national regulatory systems.”158
Nisbet and Huge159 also focused on the connection between cycles of media
attention to biotechnology and shifts in how the issue is framed. These authors highlight
the Starlink corn contamination episode that occurred in 2000. At this time a genetically
modified corn, Starlink, which was only approved for animal feed and not for human
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consumption, was found by an independent environmental coalition to have contaminated
the food supply, including Kraft taco shells as well as those used by Taco Bell and other
corporations. The revelation, broken in the Washington Post, spurred massive recalls, and
increased media attention. It was also revealed that the EPA and Starlink knew about this
contamination as early at 1997 but didn’t act on it. Nisbet and Huge point out that,
one possible interpretation by journalists was that of a major political cover-up,
complete with the drama of possible congressional hearings. What did Aventis and
the EPA know, and when did they know it? And why did it take a coalition of
environmental groups to draw attention to the public health risk rather than
industry or regulators? As we will review, however, major news organizations did
not react to the issue as a revelation worthy of the scandal label, assigning
coverage to the politics desk and the front page. Instead, the press characterized the
controversy predominantly from an industry and regulatory angle, with coverage
delegated predominantly to business and science reporters, an editorial decision
consistent with several decades of news coverage of the technology.160
The authors note that technical reporting by business and science writers is less likely to
lead to issue expansion while political and front page reporting is much more likely to
generate controversy and public outcry. They note
the shift in news beats and media definition has important implications for the
amount of attention an issue receives. Any topic can become ‘politically relevant’
and rise into the coverage domain of the political reporter with dramatic politically
oriented frames replacing technically oriented frames.161
This analysis consists of a quantitative content analysis of New York Times and
Washington Post coverage of biotechnology issues from 1978-2004, focusing on framing
and attention cycles in general but also attempting to identify reasons for the
comparatively lower attention to and controversy around biotechnology in the US
compared to the rest of the world. The authors identify several periods of what they term
“non-decision making,” in which biotechnology decisions were insulated within
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government agencies and in which the media reported very little on biotech related
issues. Additionally, even in peak years of reporting on these issues (2000 and 2001 with
7 and 8 front page news stories respectively) biotechnology issues never became a major
agenda issue in either of the papers examined. The authors conclude,
Despite attempts to shift debate toward more dramatic frames by various
opposition groups, media discourse in the United States around plant
biotechnology has remained predominantly technical. Because the issue has
remained within administrative arenas, and because the issue has remained defined
in technical and scientific terms, it is likely that journalists have been unable to
place plant biotechnology into a larger narrative structure, giving greater meaning
to passing events, thereby facilitating an increase in coverage of the issue.162
The authors propose that a reason for the framing of the issue remaining technical is
possibly attributable to competition with what they term “celebrity” issues such as
presidential debates, terrorism and war. The authors highlight two trends that they predict
will change the character of debate, the first of those being that critics have started
building narrative fidelity through connecting biotechnology issues with other related
issues such as childhood obesity, animal welfare, the survival of traditional farmers, and
other food system issues. Second, the US is becoming more and more isolated in its
regulation of GMOs in comparison to the rest of the world, and international trade issues
may affect US regulation of GMOs.163
The research reviewed above regarding coverage of biotechnology creates a solid
foundation on which to base further inquiry. There is a preponderance of quantitative
analyses that show the big picture of trends in framing of the issue over time. The data
provided by these studies will be indispensable to the analysis proposed here, but the
present study will not contribute to this body of statistical data. What is lacking in the
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body of research on media coverage of biotechnology is closer analysis of the most recent
developments and how they have been represented by the media and other groups. This
analysis must be contextualized within the larger body of data, through a critical analysis
of framing, language use, sourcing of information etc., and with attention to the larger
societal forces and power structures that these elements serve. The combination of
content analysis of news articles with that of other available information sources from
both sides of the debate, will allow for an examination of how mainstream media sources
are treating new developments in light of the rhetoric coming from organizations with an
acute interest in shaping this coverage. This research aims to synthesize the relevant
findings of previous research with some closer textual analyses to create a more in depth
understanding of the current GMO debate in two different, globally significant and
powerful, national media environments.
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Chapter 4: Research Questions
Multinational corporations are undeniably some of the most powerful actors on
the global stage. Although often represented as negative societal forces by many
environmental and social justice promoting interest groups, their presence and dominance
is well established and irreversible due to the way the global market is currently arranged.
Multinational corporations can play a positive role in society, and can also negatively
affect society in significant ways, but it appears that they are here to stay for the
foreseeable future. For this reason, it is practical to study the manner in which society and
media interact with multinationals, and how activists and industry work to align media
messages with vision of how the world should look.
To this end, the biotechnology industry is an interesting case study in that the
stated goals of corporations such as Monsanto claim lofty humanitarian aspirations, while
the reality of the effects of the actions of the corporation are much more contested.
Additionally, the biotechnology industry is represented by a handful of large multinational corporations that use lobbying and political connections to a large degree to
achieve certain goals that diverge significantly from the popular opinion, as well as
public health, organizational and environmental goals of a large portion of the population.
This raises questions about the power of corporations to dominate public dialogue and
artificially construct what is seen to be objective scientific fact with regard to their
products.
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The biotechnology industry as well as those groups that oppose it claim to have
science on their side, and a positivistic scientific battle is one of the defining
characteristics of the discussion of how food production should proceed. Technical and
scientific language dominates this disagreement, and huge amounts of capital and
technology are at stake, a state of affairs that tends to position the argument in the realm
of elite intellectual discourse. The basic issue of food production and distribution, though,
affects every human being on the planet. In this way, the issues of power and science that
are brought up by an analysis of the biotechnology industry are of universal concern.
Since genetically modified food was introduced into US and UK markets in 1996,
the discussion about how to feed the world has evolved. The biotechnology industry has
developed communication tactics to cope with the various objections to its products, and
activist groups have developed their own tactics in response to those of the industry. The
US and the UK have had vastly differing public receptions of GMOs as well as different
political and legislative outcomes on the issue. The UK has historically rejected GMOs,
and with labeling, UK consumers are able to largely avoid them if they wish. 164 The US
in contrast saw little controversy in the early years as GMOs were allowed into the food
supply with no real public debate.165 The way that such issues are covered in the
mainstream media is expected to have a significant effect on how the public perceives
these issues, thus this study will examine the press coverage of genetically modified food
in the US and the UK over the last year. In order to efficiently analyze how coverage of
the issue has evolved, the study will examine articles from each of four publications from
Oct 1st, 2011 through September 30th, 2012. This interval represents the most up to date
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developments, and the newspapers were chosen for their ideological leanings as well
respected papers of record with high circulation.
Additionally, corporate power abuses and the effects of excessive corporate
power have been thoroughly discussed in the literature,166 167 168 169 170 making it clear
that the ability of corporations to impact politics in an unlimited manner with monetary
contributions will lead to the subjugation of the larger public interest to the interests of a
small group of elites.
Corporate social responsibility has been posited as the balancing power wielded
by the public to offset the excessive power of corporations in today’s society. In the case
of the biotechnology industry, invoking corporate social responsibility does not quite get
to the crux of the issues that groups opposing the industry’s goals have at the heart of
their arguments. The issue in this case rests on whether or not GMOs are fit for human
consumption or fit for introduction into the biosphere. In this case the biotechnology
industry and its detractors are at direct cross-purposes, and traditional efforts at achieving
corporate social-responsibility goals will not address these fundamental disagreements.
For such a case it is particularly relevant to examine how the mainstream media cover the
controversy and the different actors who try to control the discussion. The most powerful
interest groups lobbying on food issues, in terms of spending, represent the interests of
the biotechnology industry. Monsanto is the largest of the biotechnology corporations and
spent $6,370,000 on lobbying efforts in 2011.171 Another industry-sponsored group, the
Biotechnology Industry Organization, spent over $8,000,000 lobbying the federal
government in 2011. The Organic Trade Association, an organization, whose “mission is
to promote and protect organic trade to benefit the environment, farmers, the public, and
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the economy,” 172 spent about $85,000 lobbying the federal government in 2011.173 In
terms of spending and influence, then, the biotechnology industry is far more powerful in
the US than other groups, and is expected to have a more powerful voice, not only in the
US government, but in media coverage as well.
This is a timely subject in that issues surrounding GMOs continue to become
more contentious and more publicly visible around the world. At the same time, GMOs
have been available for human consumption in the UK and the US for about fifteen years
with drastically different public reception. This gives the researcher the opportunity to
study this movement in two distinctly different contexts. This direction of inquiry is
particularly important at this time in the context of the growing economic disparity seen
in the US, and the Occupy movement, which is directed towards a number of goals, the
most central of which is a push-back against corporate power over government. For this
reason the anti-GMO movement has joined forces with the Occupy protests as part and
parcel with the general spirit of the movement. Research that examines the
communication tactics of activists, corporations and the mainstream media can contribute
to a better understanding of how corporate-citizen interaction is evolving in the US and
the UK.
Communication tactics are at the heart of efforts of corporations to pursue their
objectives as well as the efforts of social movements whose objectives are in direct
opposition to corporate agendas. Shifting power dynamics can be examined through
analysis of media coverage of GMO related issues, allowing a deeper understanding of
the manner in which a public dialogue surrounding GMOs is evolving, and what tactics
are most effective in shaping that dialogue. This research, then, focuses on coverage of
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the biotechnology industry and activist groups who oppose the industry as well as those
that are backed by the industry, therefore the following questions will guide the research:

How does mainstream press coverage of genetically modified organisms, the
biotechnology industry, and groups actively promoting and discouraging the consumption
of GMOs compare between the US and the UK?

How does mainstream US coverage of biotechnology issues compare with presentation
and content of biotechnology issues by the Organic Consumers Association, AgBioWorld
and the Biotechnology Industry Organization?

How does mainstream UK coverage of biotechnology issues compare with presentation
and content of biotechnology issues by GM Watch, CropGen and the Agricultural
Biotechnology Council?

How does the language used in news coverage of GMOs, GMO activist groups and the
biotechnology industry in the US compare to that in the UK?
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Chapter 5: Methods

Sampling
The sample spanned the time period from Oct 1st, 2011 through September 30th,
2012 in order to look at the most recent developments on the issue. Previous studies with
broader foci and more comprehensive time periods provide context and serve as
references as to long-term trends. This time period was chosen to represent the most
recent coverage of the issue at the time of the study was proposed. The length of time was
chosen in order to get one full year of news coverage, so as to include all possible
seasonal variation in coverage. As coverage of GMO issues in the US and UK differ
based on the partially localized nature of reports on the topic, the time period was not
chosen with a particular event or issue as its target, but instead as a long enough period to
get a good understanding of the range of recent coverage, while allowing for close textual
analysis.
The content of the sample consists of:
(1) All of the articles addressing issues surrounding GMO in food in the NYT, the Wall
Street Journal, The Guardian and the Times from Oct 1st, 2011 through September 30th,
2012. The reason for choosing the NYT (Cir. 1,150,589) and the Wall Street Journal
(Cir. 2,096,169)174 to represent mainstream media in the US, and the Guardian (Cir.
230,108) and the Times (Cir. 405,113)175 in the UK, is that these pairings represent two
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relatively different politically positioned examples of high-circulation mainstream daily
newspapers. The NYT and the Guardian represent what many would see as more liberal
or left leaning newspapers176 (although both are owned by large national corporations),
and the Wall Street Journal and the Times representing a more conservative point of
view,177178 with the added parallel that the latter are both owned by News Corp, a massive
vertically integrated multinational corporation. For these reasons the newspapers are
papers of record in their respective countries, represent as balanced a range of
perspectives as you might find among mainstream media, and approximate a similar
sample group in both countries.
The papers were searched by online databases using keywords “genetically
modified,” “genetically altered” “genetically engineered,” “genetic engineering,”
“GMO,” “Frankenfish,” “Frankenswine,” “Frankenfood” “Enviropig,” “Transgenic,”
“bacillus thuringiensis,” “bt corn,” “bt cotton,” “bt soy,” “Roundup ready,” “Flavr Savr,”
“superweed” “colony collapse disorder,” “Monarch butterfly,” “agrichemicals,” “2,4-D”
and “glyphosate.” Articles that were retrieved with these search terms that did not
directly relate to genetically modified food, chemicals used in the cultivation of gm food,
or more generally discussing the corporations who are active in producing GMOs were
excluded for analysis.

(2) Articles/blog posts/news updates posted by the Organic Consumers Association
(US) and GM Watch (UK) on their websites from Oct 1st, 2011 through September 30th,
2012.
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These organizations were chosen as prominent examples of anti-GMO activist groups in
each country. Both organizations are active in promoting petitions, publishing blogs and
articles, and publicly speaking out against the biotechnology industry. Both of these
organizations publish far more material than any of the others, though, so a sample was
taken to represent the output of these groups. The articles were sampled through a
process of stratified random sampling by time period. Two articles posted during each
calendar week over the course of the year were randomly sampled using an online
random number generator from the website random.org. The number of articles posted
during each week were entered into the random number generator to produce two
numbers. The researcher then counted from the top of the list of articles for that week to
the article that corresponded to each randomly generated number and used those two
articles as representative of that week. Articles that did not directly relate to genetically
modified food, chemicals used in the cultivation of GM food, or more generally
discussing the corporations who are active in producing GMOs were excluded for
analysis and replaced by the same method. This method was chosen in order to get as
representative sample as possible, since the articles are closely clustered by topic, and in
a given week there are often numerous articles addressing one particular issue. For this
reason it was important to sample each week individually, as taking a random sample by
month or over the entire course of the year would be less representative of the subject
matter covered by the articles. Both sites have approximately 600-675 relevant articles,
thus 104 articles represents just over 15% of the total population of relevant articles on
the sites. Data is unavailable for Organic Consumers Association from Sept. 17th-31st, so
total article count is 100 for OCA. This has a negligible effect on results.
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The Organic Consumers Organization (OCA), based in the US,
deals with crucial issues of food safety, industrial agriculture, genetic engineering,
children's health, corporate accountability, Fair Trade, environmental sustainability
and other key topics. [They] are the only organization in the US focused
exclusively on promoting the views and interests of the nation's estimated 50
million organic and socially responsible consumers.179
GMWatch, based in the UK,
is an independent organisation that seeks to counter the enormous corporate
political power and propaganda of the biotech industry and its supporters. [They]
do this through [their] website, [their] lists, [their] Powerbase portal, LobbyWatch,
the BanGMFood campaign, social media, and other outreach and campaigning
activities.180
(3) Articles/blog posts/news updates posted AgBioWorld (US) and CropGen (UK) on
their websites from Oct 1st, 2011 through September 30th, 2012.
These organizations are both industry-funded nonprofits that seek to educate the public
about the benefits of biotechnology. Both organizations claim autonomy and distance
themselves from the biotechnology industry and associated organizations, while
documented incidents and evidence available elsewhere suggests that these organizations
are more closely linked with the industry than they claim. AgBioWorld is also a
publication that puts out significantly more material than others in the study, thus a
sample of these articles was taken as well. There were a total of twelve newsletters
published during the time period under examination, containing an average of twelve
articles each and published at odd intervals, so two articles were randomly sampled from
each newsletter using the same method described above for GM Watch and OCA.
Articles that did not directly relate to genetically modified food, chemicals used in the
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cultivation of GM food, or more generally discussing the corporations who are active in
producing GMOs were excluded for analysis and replaced by the same method.
The AgBioWorld Foundation is described on the website “About” page as
The AgBioWorld Foundation is a 501(c)(3) non-profit organization headquartered
in Auburn, Alabama, and is run by Professor C.S. Prakash of Tuskegee University.
The AgBioWorld community was established in January 2000 by Professor
Prakash and Gregory Conko of the Competitive Enterprise Institute, and the
foundation and AgBioView e-mail service rely upon the volunteer efforts of many
friends and colleagues. . . . As an organization that has emerged from academic
roots and values, we have chosen to go well beyond IRS charitable fundraising
limitations by restricting our sources of income so as to not create any perceptions
of bias or conflicts of interest. For that reason, the AgBioWorld Foundation does
not accept contributions from corporations that have direct commercial interests
involving agricultural biotechnology. Additionally, we do not accept program- or
research-specific contributions from agricultural or biotechnology related trade
associations or their philanthropic arms; contributions from such sources are
limited to support for general operating and administrative purposes only. At all
times, the AgBioWorld Foundation will rigorously adhere to both the requirements
and principles behind fundraising and disclosure for charitable organizations. 181
While AgBioWorld’s site states in no uncertain terms that it is not industry funded, the
affiliation of its two founding members with the Competitive Enterprise Group. The
Competetive Enterprise Group is described by the Center for Media and Democracy’s
Source Watch as an
advocacy group based in Washington DC with long ties to tobacco disinformation
campaigns. . . . It postures as an advocate of ‘sound science’ in the development of
public policy. However, CEI projects dispute the overwhelming scientific evidence
that human induced greenhouse gas emissions are driving climate change. They
have a program for ‘challenging government regulations’, push property rights as a
solution to environment problems, opposed US vehicle fuel efficiency standards,
and spin for the drug industry.182
According to Source Watch, the Competetive Enterprise Institute is one of the most
heavily corporate funded think tanks around, and GM Watch labels it as a “libertarian
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think tank, that co-founded AgBioWorld.”183 While AgBioWorld may not be directly
corporate funded, the fact that the co-founding organization and the two founding
members are heavily backed by corporate funding brings claims of neutrality by the
organization into question.
Additionally, a 2002 article in the Guardian reported that a PR firm that is
employed by Monsanto, The Bivings Group, which specializes in viral marketing, was
responsible for posts on the AgBioWorld message board slandering a couple of articles
published in Nature magazine, instigating an uproar directed toward Nature, and
ultimately resulting in Nature retracting the articles and publicly stating that they never
should have been published. The articles revealed contamination of Mexican corn by
GM varieties, which would greatly complicate the industry goal of achieving legal status
of GM crops in Mexico and neighboring countries. The posts were authored by two
people that do not appear to actually exist, and ultimately traced back to the originating
from the Bivings Group server. The Guardian article goes on to reveal that
even the website on which the campaign against the paper in Nature was launched
has attracted suspicion. Its moderator, the biotech enthusiast Professor CS Prakash,
claims to have no connection to the Bivings Group. But when Jonathan Matthews
was searching the site's archives he received the following error message: ‘can't
connect to MySQL server on apollo.bivings.com’. Apollo.bivings.com is the main
server of the Bivings Group. ‘Sometimes,’ Bivings boasts, ‘we win awards.
Sometimes only the client knows the precise role we played.’184
This evidence suggests that the website of the supposedly independent organization,
AgBioWorld, is hosted by the PR company employed by Monsanto. The above
evidence, joined with the vigorous and unwavering pro-biotech stance taken by
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AgBioWorld leaves little doubt that the organization operates as a front group promoting
the agenda of the biotechnology industry.
A parallel organization in the UK, CropGen, has a similarly opaque identity. The
CropGen website homepage states:
CropGen's views are entirely our own. None of the associates or experts is
employed by or receives research funding either from the biotechnology industry
or from any organisation campaigning against the use of biotechnology in
agriculture and the food industry. Most CropGen contributors offer their services
in the public interest.185
A CropGen mission statement, included a 2001 publication available elsewhere on the
CropGen website, though, describes the organization as a
consumer and media information initiative, CropGen's mission is to make the case
for GM crops by helping to achieve a greater measure of realism and better
balance in the UK public debate about crop biotechnology. At the heart of
CropGen is a panel of scientists and others who recognise that crop biotechnology
offers many potential benefits — benefits which have been largely absent from the
public debates to date. While ultimately funded by industry, CropGen's panel
members are free to express such views as they consider appropriate. The funding
companies cannot veto the panel's position on any issue.186
In 2000, when the organization was founded, The BBC reported, “UK biotechnology
companies are providing nearly £500,000 to a scientific panel ‘to help achieve a more
balanced debate about genetically-modified (GM) crops.’ ” The article goes on to
elaborate on the PR company employed to manage the group as well as the honorarium
each scientist on the council will be paid,187 contradicting the claim on the website of the
organization that the scientists volunteer their time for the cause. Additionally the Center
for Media and Democracy’s website, PRWatch.org, describes CropGen as “a front group
for corporate biotech interests, often coordinating its activities with EuropaBio, which
plays a similar role on a Europe-wide basis.” 188
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The significance of these supposedly independent groups in the debate over biotech
should not be overlooked. These groups are largely able to position themselves as
unbiased and independent, when in truth they are anything but. This puts them in the
potential position of being reported on by the media as concerned citizens and scientists
that agree with industry positions rather than industry groups, and it will be interesting to
see if this is in fact the case. As Monbiot argues, in a later Guardian column,
What is fascinating about these websites, fake groups and phantom citizens is that
they have either smelted or honed all the key weapons currently used by the
world's biotech enthusiasts: the conflation of activists with terrorists, the attempts
to undermine hostile research, the ever more nuanced claims that those who resist
GM crops are anti-science and opposed to the interests of the poor. The hatred
directed at activists over the past few years is, in other words, nothing of the kind.
In truth, we have been confronted by the crafted response of an industry without
emotional attachment.189
Monbiot, in this article, makes the argument that the Prime Minister of the UK’s latest
speech lauding biotechnology was filled with arguments formed and disseminated by
these very groups that hide behind neutral fronts but ultimately represent the biotech
industry, showing how policy makers and national rhetoric has been shaped by PR efforts
such as these.

(4) Articles/blog posts/news updates/PR releases posted by the Biotechnology Industry
Organization (US) on its blog website “biotech-now.com,” and the Agricultural
Biotechnology Council (UK) on its website, from Oct 1st, 2011 through September 30th,
2012. These organizations are both official biotechnology industry organizations, whose
websites publish original articles and press releases representing the public relations
agenda of the biotechnology industry. Articles that did not directly relate to genetically
67

modified food, chemicals used in the cultivation of gm food, or more generally
discussing the corporations who are active in producing GMOs were excluded for
analysis.

Data Analysis
This is a qualitative content analysis, conducted using thematic analysis. Thematic
analysis is a research technique in which the researcher searches for themes that emerge
from the data, which then become the categories for analysis.190 The researcher examined
the news coverage and used patterns and trends found in this body of data to then analyze
the data with regard to similarities and differences between coverage in the US and the
UK as well as similarities in language and content across news articles, activist news and
industry and industry front group articles and blogs.
Since thematic analysis is regarded as a rather loose heading that doesn’t indicate
a specific methodology and is interpreted widely by different scholars,191 this analysis
followed one example that has been developed by the amalgamation of techniques
developed by scholars over time. In order to maintain a desired level of structure and
clarity of methods, the steps outlined by Fereday and Cochraine were followed. These
steps are outlined in their chart, reproduced below:
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Figure 1: Coding Method

192

The code manual was developed based on research questions and theoretical
concepts from framing, agenda building and agenda setting, as well as Herman and
Chomsky’s propaganda model, especially their ideas concerning co-opting experts, flak,
worthy and unworthy actors and sourcing of news. In this study thematic analysis has
allowed for a necessary level of flexibility in analyzing the data, while this particular
methodology brought structure to the process.
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Chapter 6: Results & Analysis
The themes that emerged through the coding process are documented in the table
below. These themes are discussed in detail throughout the following analysis.
Themes
There are more pro-biotech mainstream news articles than anti-biotech news
articles (pg. 71-72).
Anti-biotech articles tend to be negative in tone whereas pro-biotech articles are
a combination of negative and positive. (pg. 75-76)
News Corp. papers tend to overtly promote industry frames and arguments while
the more “liberal” papers do so more subtly. (pg. 85-105)
Use of some frames (such as environment frame, legitimacy of science,
economic) to the advantage of anti- and pro-biotech arguments, dominance of
other frames by one side or the other (human health, effectiveness of technology,
humanitarian, UT/P). (pg. 83)
Depiction, in biotech and mainstream sources, of activists and anti-biotech actors
as uneducated, against science, technology, progress and the welfare of the poor.
(pg. 136-162)
Different levels of significance and credibility afforded to different scientific
studies by the mainstream media. (pg. 115-131)
Patriarchal attitudes toward the developing world and the poor who live there in
biotechnology industry sources and the mainstream press. (pg. 104-114)
Expert sources used by the main stream press are predominantly pro-biotech and
do not have full/truthful disclosure of their background. (pg. 97, 131-134, 152162)
A reliance of 3-5 frames by each mainstream publications, lack of coverage of
related events & studies, especially internationally, repetition of the same narrow
set of facts and perspectives. (pg. 166-167)
More volume of output, coverage of international news, topics and frames in
anti-biotech sources. (pg. 83, 104-107)
Table 1: Themes
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Orientation & Tone
The most basic elements examined were biotechnology orientation of the article
(is it clearly oriented as pro-biotechnology or anti-biotechnology), tone of the article, and
the geographic focus of the article.

Figure 2: Biotech Orientation

As Figure 1 above illustrates, and as one would expect, the anti-biotech activist
organizations publish articles that are largely anti-biotech, and a good portion that are
neutral. These article are sourced from many different places, but the neutral articles are
largely explained by articles from the mainstream press that the organizations view as
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relevant to their discussion of the issue. Out of the 36 neutral linked articles (linked
articles are those that are not authored by the source directly—in this case OCA—but
instead published on the site in whole or in part, and credited to another source. In the
case of these articles analysis has always been applied to the entire article to which the
site refers.) published by OCA, 28 were from the mainstream press, while the antibiotech articles were largely from alternative news sources (44 out of 56 linked antibiotech articles on the OCA website were from alternative news sources). Alternative
news sources are defined here as those which are not based on a profit-driven model. GM
watch follows similar patterns. The few articles published by OCA and GM watch that
are pro-biotech are those that the organizations reproduce as examples of the other side’s
arguments and how they infiltrate government and mainstream media. For example GM
Watch published an entry from George Freeman MP's blog with the editor’s note:
The Cameron Government are proving no less pro-GM than their New Labour
predecessors. Not only do they have a former biotech lobbyist heading Defra and
an agriculture minister keen to promote GM at every turn, but now this
announcement from David Willetts, the universities and science minister, and
George Freeman, the Government's ‘Life Science Adviser.’193
Notably, the official biotech industry organizations publish articles that are nearly
entirely pro-biotech, while their non-profit industry-funded counterparts both largely
publish pro-biotech articles, but also publish a small portion of neutral articles as well.
These articles follow a similar pattern to those of the anti-biotech organizations, in that
these neutral articles are largely linked from the mainstream press. All five of
AgBioWorld’s neutral articles were linked from mainstream press sources, while of
CropGen’s three neutral articles, two come from an EU government website and one is
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an original CropGen article that is reporting in a strictly factual manner on the
deregulation of GM salmon in the US.
As a whole, the mainstream media sources analyzed here all published more probiotech articles than anti-biotech articles, with a significant portion of neutral articles as
well. The Wall Street Journal published the fewest total articles on the subject, and
fulfilling its image as a pro-business publication, published no anti-biotech articles, five
neutral articles and six pro-biotech articles. Two of the six pro-biotech articles were
published in a “Life and Culture” section, one is an opinion piece, and one is a book
review, leaving two pro-biotech news stories. Its UK Murdoch owned counterpart, the
Times, published far more articles about food biotechnology, and from an initial glance at
the chart, the coverage looks a little more balanced. The Times published seven antibiotech articles, seventeen neutral and sixteen pro-biotech. All seven anti-biotech articles,
though, are reader letters, not written by the Times staff, while only seven of the sixteen
pro-biotech articles are reader letters, four are editorials and one a whimsical feature
about aliens coming to earth and demanding the EU end its stalemate on GM regulation.
This leaves four total news articles that are pro-biotech and none that are anti-biotech.
The more liberal media, the New York Times and the Guardian, are slightly
different from the Murdoch papers in their biotech orientation. The most significant
difference being that the New York Times published one anti-biotech article, two probiotech and fifteen neutral articles. This is the only paper with a significant majority of
neutral articles. The one anti-biotech article is an editorial promoting GMO food labeling,
one pro-biotech article is a letter to the editor while the other is an editorial. This means
that none of the actual news articles are noticeably promoting or criticizing food
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biotechnology. The Guardian published seven anti-biotech, nine pro-biotech and seven
neutral articles. The pro-biotech articles consist of two letters to the editor, two editorials
and five news articles. Of the seven anti-biotech articles, four are letters to the editor, one
is an editorial, and one is a short Features section article musing on the relative merits of
shiny potentially GM apples and the lumpy, tasty kind. This leaves one anti-biotech news
article and five pro-biotech news articles. The Guardian, in this respect, looks more like
the Murdoch owned pro-business papers in this sense than the ostensibly more liberal
New York Times.
Tone also plays a role in revealing the nature of the coverage, and the chart below
categorizes the tone of all the articles in the broadest possible sense: positive, negative or
neutral.
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Figure 3: Tone

Immediately evident is the fact that this chart resembles the Biotech Orientation chart
quite closely. While orientation and tone have clear connections in the patterns of the
literature, they are not, by definition, the same idea. While a positive or negative tone is
defined by the patterns of language and the fundamental positive or negative spin on the
content, orientation is strictly whether the article is noticeably embracing or rejecting
biotechnology, or maintaining a neutral stance. For example an article with a positive
tone that is anti-biotech, might be an article reporting on new biotechnology labeling law
that has been introduced, and the positive effects this will have on society etc., while an
article with a positive tone that is pro-biotech might be reporting on the increasing
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amount of land on which GM crops are grown and the spread of the technology
throughout the developing world. If they traded content, likely they would be the
opposite: the pro-biotech article would have a negative tone while discussing the new
labeling law while the anti-biotech article would have a negative tone when discussing
the spread of GM crops throughout the developing world. In this way tone is tied to the
framing and topic of articles as well as the positive or negative orientation of the article
towards biotechnology, but it is a distinction that allows a finer level of understanding of
the complexity of the literature.
A relationship is evident between articles that are neither pro- nor anti-biotech and
articles that are neutral in tone (81% of all articles with a neutral biotech orientation had a
neutral tone as well). This relationship makes sense in the context of how these concepts
relate to one another in that, if an article is neither embracing GM technology nor
rejecting it there is less at stake for the author who is reporting factual information while
trying to avoid revealing a point of view of any kind on the issue, thus a neutral tone is
taken. While this is common, it is not always the case, a notable example being when the
article is discussing draught or weed resistance to a agricultural chemical in the context of
GM technology, without taking a stance for or against biotechnology, the article will
often have a negative tone as a result of the dire circumstances for farmers and consumers
that it addresses.
It also appears that there is a relationship between activist anti-biotech articles and
a negative tone (79% of all anti-biotech articles published by OCA had a negative tone).
The New York Times also had a pretty clear-cut relationship—both pro-biotech articles
had a negative tone, while the only anti-biotech article had a positive tone, and all of the
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neutrally oriented articles were neutral in tone. In the cases of the Guardian and the
Times, all of the anti-biotech articles were negative in tone (and, as previously mentioned,
the Wall Street Journal published no anti-biotech articles). The overwhelming negative
tone of anti-biotech articles is unsurprising in that these articles are part of an argument
pointing out negative aspects of the technology. The activists, especially in the US, are
working against the status quo, a government that has a close relationship with the
biotech industry, making the case for labeling. In the UK, the literature reveals that
activists are fighting against a government that is pushing for deregulation of biotech by
trying to influence public opinion on the issue, as well as a strong mainstream media bias
in favor of the technology as figure 1 shows. Any anti-biotech opinion that appears in the
mainstream media is a defensive response to the media publishing a pro-biotech slant of
some kind, and thus has a negative tone.
There is a mix of positive and negative tones among the pro-biotech articles from
the Wall Street Journal, the Times and the Guardian, as well as all of the industry
publications. Eighteen of the twenty-two pro-biotech articles with a negative tone
published by the US biotech industry are about labeling, regulation, and/or are criticizing
the actions or statements (or scientific credibility) of those speaking out against biotech in
various ways. Thirty-two of forty (80%) pro-biotech articles with a negative tone
published by the UK biotech industry are about regulation and/or are criticizing
government bodies or those speaking out against biotech in any way. Half of all probiotech articles with a negative tone in the Times are directly critical of government
actions or anti-biotech activists, while 7 of 16 (44%) are about regulation of genetically
modified crops (these do overlap, leaving 6 unaccounted for). Both of the articles in the
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Guardian with a negative tone are about activism, and both criticize anti-biotech
activists. All three of the pro-biotech articles with a negative tone in the Wall Street
Journal criticize activists and address biotechnology regulation.
The pro-biotech articles with a positive tone tended to have a bit more varied
range of topics, although many referred to the increasing world population and the
environment. What nearly all of these articles had in common was a Utility of
Technology/Progress frame. Eight of nine (89%) from US industry groups, fifteen of
twenty (75%) from UK industry groups, both of the articles from the Wall Street Journal,
both of the articles from the New York Times, all four of the articles from the Times and
four of five from the Guardian were framed in this way.

The Utility of Technology/Progress Frame
The Utility of Technology/Progress is a frame that presents the central issue
surrounding biotechnology as its potential to improve human life, solve problems and
overcome current, potential or perceived obstacles to human happiness and survival.
Framing is significantly different than the topics of an article as they are referred to in the
discussion above regarding regulation and activism. An article may touch on many
different topics in different ways without framing the issue around every one of those
topics. The frame is a more subtextual element of an article, and is defined in a previous
section of this analysis in this way:
Framing involves organizing and structuring information so that it is socially shared
and provides meaning to reality, i.e. issue or event. This involves deliberate
identification of an aspect of a perceived reality, and giving interpretation and
evaluation of that reality.194
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Framing is a significant focus of this analysis, and in order to discuss the results
relevant frames must be defined for the reader. Frames were initially chosen based on
previously published research on framing of biotechnology, and more were developed
throughout the coding process. The central organizing ideas of an article define its frame
or frames. How does the author present the issue in terms of what is salient about the
issue? What kind of story does the author tell about the issue and what does the author
indicate that readers should care about? More than one frame was identified for many of
the articles.
Economic

Characterized by discussing GMOs and biotechnology in terms of
being a potential source of economic growth or risk for the various
actors involved.

Consumer
Choice

Characterized by focus on consumers’ ability to make decisions
about what they choose to purchase or consume.

Public
Opinion

Characterized by focus on the perception of the public or some
more specific group regarding biotechnology or some related
issue.

Public
Relations

Characterized by a discussion of the methods of persuasion being
used by a group or individual.

Government/
Society
Relationship
Legal

Characterized by a focus on how government interacts with the
public and private sector.

Regulation

Characterized by a focus on how something is regulated.

Morality

Characterized by the author portraying biotechnology as an issue
of moral significance of some kind, for example whether is it right
to meddle with nature, or better to leave it alone.

Characterized by a focus on whether or not
something is legal.

Humanitarian Characterized by a focus on needing to promote the welfare of
Human
Health

others, such as, but not exclusively, needy populations in the
developing world.
Characterized by the author addressing biotechnology as a human
health issue, highlighting health risks or nutritional benefits
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resulting from the technology.

Food
Security

Characterized by a focus on society’s ability to produce enough
food and/or maintain access to food for various populations.

Utility of
Technology/
Progress

Characterized by presentation of the issue as a matter of
technology with potential to improve human life, solve problems
and overcome current, potential or perceived obstacles to human
happiness and survival.

Legitimacy
of Science

Characterized by discussion of which scientific statements or
studies are legitimate and which are not, or by validation of
arguments based on their purported scientific basis and
disparaging ideas, arguments or spokespeople based on their lack
of scientific basis or understanding.

Effectiveness
of
Technology

Characterized by discussion of whether or not the technology
involved in GMO does or does not function in the manner that it
presumably should.

Environment

Characterized by presentation of the issue as a matter of
environmental consequence, such as biodiversity issues, global
warming or pesticide use.

Table 2: Frames & Definitions
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While figure 4 is useful in helping the reader appreciate how many different frames are
present in the sample of articles, it is too detailed to distinguish individual frames and
patterns beyond the very obvious, so the chart below, figure 4, includes only those frames
that are common in any of the sources, or that vary significantly from one source to the
next.
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Figure 5 presents a slightly clearer picture of the major patterns. The Utility of
Technology/Progress (UT/P) frame is easy to see as the most prevalent from the
biotechnology industry groups through the mainstream media. The frame is close to nonexistent in the anti-biotech groups’ articles, thus it is a frame shared almost solely by the
biotech groups and the mainstream media, with the least prevalent example being the
New York Times, where the frame is present, but not dominant.
The UT/P frame is often accompanied by the Food Security and the Humanitarian
frames. Additionally, every single time the industry broaches the topic of the increasing
world population it is in an article with a UT/P frame.
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Figure 6: Industry Frames

This relationship highlights one of the most dominant interrelated set of arguments made
by the biotechnology industry about its products: that they will be needed to feed the
increasing world population, that they will be necessary to respond to climate change,
and that they are a fundamentally important tool in helping the developing world provide
enough food for its starving population. This argument is characterized by strong, black
and white language about biotech’s place in the global food system.
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Figure 7: Geographic Focus

As is evident from the chart AgBioWorld and CropGen, both published many
articles with a foreign focus, although foreign includes all articles focusing on the US and
other developed countries in addition to the developing world. A January 2012 article on
the BIO (US) website begins with “Bill Gates has a terse response to criticism that the
high-tech solutions he advocates for world hunger are too expensive or bad for the
environment: Countries can embrace modern seed technology or their citizens will
starve.”195 Another BIO article states: “African nations must be open to new
biotechnology tools that allow farmers to grow crops that have even higher yields and a
higher nutritional content,”196 and another claims: “to provide for seven billion people,
the world will need a lot more than three billion acres of biotech crops, but it’s a good
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start.”197 AgBioWorld, the US industry funded non-profit, published an article in its
newsletter, linked from Pamela Ronald’s blog called “Tomorrow’s Table” that hopes that
“we will soon wake up and applaud applications of biotechnology that have reduced the
amount of insecticides in the environment or those that have the potential to save the
lives of thousands of malnourished children.”198 Another article from the AgBioWorld
newsletter claims “But with the world's population now at 7 billion and counting, the
rejection of genetic modification of crops on such spurious scientific grounds now
threatens the environment it claims to protect.”199 The UK biotechnology industry is
using the same public relations strategy on this issue: “for these tools to meet the
challenge of feeding the next billion people, all nations must ensure farmers have access
to these sustainable, safe, science-based technologies.”200 Claims a November 2011
Croplife press release published in a “news” section on the Agricultural Biotechnology
Council’s (ABC) website. An August 2012 ABC Press release quotes the organization’s
Chair, Dr. Julian Little: “Today’s figures highlight the challenges of maintaining global
food security . . . GM technology is one of a number of agricultural innovations which
offer farmers significant gains and increased yields.”201 CropGen, the UK industry’s nonprofit mouthpiece adds:
More and more Africans are becoming fed up with European attitudes to
agricultural biotechnology and the deleterious effect it is having on their own
ecnonmies (sic). Some African countries have important exports of fruit, flowers
and vegetables to Europe and have long been warned that they risk losing those
markets if they so much as dare to cultivate GM-crops anywhere in their countries.
Europe's opposition to genetically modified crops is robbing the developing world
of a chance to feed itself and could threaten food security [emphasis added],
warned Dr Felix M'mboyi of the Kenya-based African Biotechnology Stakeholders
Forum.202
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Another article published on the CropGen website, but linked from an article by Henry I.
Miller that was originally published by the Cato Institute, argues “unscientific, excessive,
stultifying regulation, nationally and internationally, is a major reason for the failure of
biotechnology to achieve its potential to bring greater food security to the poor.”203
The examples of quotes about the role of genetically modified food in saving the
world in various ways are vastly abundant in this sample since this is a major talking
point of the biotechnology industry, these are just a few examples. Beyond the message
that the industry is trying to get across about feeding the poor, in many of these quotes
there is also criticism, either explicit or implicit, of regulation on biotechnology. This
tactic aims to directly link regulation of biotechnology to the suffering of malnourished
populations all over the world.
These articles are consistently conjuring images of the poor and starving masses
in the developing world, while rarely, if ever letting these populations speak for
themselves or discussing their plight in a concrete, specific way. The African spokesman
quoted above, Dr Felix M'mboyi, is a US educated academic, Kenyan government
advisor, an international economic consultant, and is the director of the Center for
Strategic and International Studies in Washington.204 M’mboyi, while clearly very
accomplished, is not representative of Africa’s needy population. The quote from
CropGen about M’mboyi begins “more and more Africans are becoming fed up,” but the
article only goes on to quote M’mboyi extensively, these other masses of Africans who
are fed up remain silent. Of 77 articles that the UK industry sources publish, 33 of them
(43%) are linked from other publications. All of these publications are based in Europe,
the US or Australia. Not one of them is published in the developing world (in
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comparison, from the GM Watch sample of 104 articles, 102 (98%) of which were
linked and 17 (17% of linked articles) were published by media or other organizations in
Africa and India). The US biotech industry published 45 articles, 30 of which (67%)
were linked from other sources and 2 (7% of linked articles) of which were developing
world publications: one from the Times of India and one from Reuters Africa. The
industry uses the suffering of the developing world as a talking point, but does not
actively engage in these issues or talk specifically about local issues, small farmers or
their experiences with GM technology.
The article from the Times of India republished on the AgBioWorld website is
one called “Meet Farmer Chengal Reddy: He wants us to give up fear of GM crops.”205
The article begins,
On behalf of the farmers of India, let me say that this report totally fails to reflect
farmers' aspirations, and distorts the scientific significance of biotechnology including genetic engineering - for the national economy. Instead, it echoes
persistent canards by some environmental NGOs.

The criticism for NGOs and the arguments that follow regarding an increasing population
and the need for GM crops to increase yields and the global spread of GM crops sound
like industry talking points, and indeed, Chengal Reddy is not an Indian farmer, as the
article claims, he works closely with Monsanto, has appeared on their brochures and on
their website and given interviews and speeches at industry orchestrated protests.
Jonathan Matthews writes in a 2002 article,
Reddy is not a poor farmer, nor even the representative of poor farmers. Indeed,
there is precious little to suggest he is even well-disposed towards the poor. The
'Indian Farmers Federation' that he leads is a lobby of big commercial farmers in
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Andhra Pradesh. On occasion Reddy has admitted to knowing very little about
farming, having never farmed in his life. He is, in reality, a politician and
businessman whose family is a prominent right-wing political force in Andhra
Pradesh ~ his father having coined the saying, 'There is only one thing Dalits
(members of the untouchable caste) are good for, and that is being kicked'.206

These two spokespersons, Chengal Reddy and Dr M’mboyi are the voices from
the developing world that the industry chooses to nurture and amplify, neither of them are
poor and neither are farmers, although they claim to speak on behalf of poor farmers in
India and Africa. The voices of actual farmers in the developing world are conspicuously
absent from biotechnology publications. Sumpter and Tankard, in their analysis of spindoctors, argue, “the largest threat to the objectivity of journalism may come not from the
subjectivity of the individual journalist, which has often been the focus of concern, but
from professional spin doctors attempting to influence the newsmaking process at its very
core.”207 The selection of Reddy and M’mboyi as spokespeople, the manufactured
ambiguity about their identities, and the exclusion of certain other relevant spokespeople
are all distinctly recognizable as the efforts of spin-doctors, who try to influence the
selection of topics and the frames applied to those topics for the news media.208
The mandate of Monsanto, Syngenta, Dow and other biotech corporations, of
course, is not to save the world, but to produce profits for its shareholders. Susanne
Soederberg argues, “the corporation is a vehicle for capital accumulation, and this sets
defining parameters for its operations regardless of its ownership patterns.”209 Any
messaging the corporation uses is in the interest of serving the goals of capital
accumulation and market expansion first and foremost. Marc Williams, in his analysis,
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“Feeding the World: Transnational Corporations and the Promotion of Genetically
Modified Food,” explains,
investment in GMOs is predicated on reaping profits, which is dependent on
increasing market share in order to meet the high costs associated with GMO
research and development. . . . It is . . . resistance to GM foods that creates the
necessity for the development of corporate strategies designed to promote GM
food.210
This seems to be something that is forgotten by the press and various government
spokespersons when amiably amplifying PR messages about the need for biotechnology
in feeding the expanding world population. These publications are framing this issue in
ways that serve as PR mouthpieces for the industry rather than their supposed societal
role of informing the population about issues of critical interest. If they were simply
informing the public about the issue, the selection of biased sources, the exclusion of
important information about those sources, and the elaboration and emphasis on
information that is pro-GMO would not occur.
The chart below illustrates the frames of the mainstream news outlets examined
here.
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News Frames
18
16
14
12
10
8

Humanitarian
Morality
Human Health
Economic
Environment
Utility of Technology/Progress
Legitimacy of Science
Effectiveness of Technology
Food Security
Consumer Choice
Public Relations
Legal
Government/Society Relationship
Regulation
Public Opinion
Other

6
4
2
0
WSJ

Times

NY Times

Guardian

Figure 8: News Frames

The Utility of Technology/Progress frame is clearly dominant in coverage of
biotechnology, while it is the primary frame for the Times (42% of articles) and the Wall
Street Journal (64%) it is only second (22%) to the economic frame (61%) in the New
York Times and second (39%) to the Legitimacy of Science frame (48%) in the Guardian.
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The Wall Street Journal, for which the UT/P frame is by far the most dominant,
uses industry talking points commonly when discussing biotechnology. One editorial
reports on the coming release of a GM crop called DroughtGuard, and quotes a statement
from the Union of Concerned Scientists noting that millions of dollars in R&D have
produced a crop that doesn’t actually respond to drought any better than non-GM
varieties. The author of the editorial argues in response:
The claim is contentious on many levels but most significantly it misses an
important point. DroughtGuard is the first step in a new technology that has the
potential to benefit the environment and enhance food security. . . . to object to a
technology from the beginning because it’s expensive and its benefits are marginal
over existing technologies. 211
This argument attempts to invalidate any arguments regarding the effectiveness of the
technology by suggesting that although the technology does not currently work, it surely
will in the future, and by connecting this idea of progress with the imperative to produce
more food, it invokes food security as a reason to embrace an ineffective technology.
This line of reason is in line with industry talking points regarding how GM-technology
is the only hope in feeding the growing world population.
Another opinion piece in the Wall Street Journal states:
Despite opponents’ fears that the technology would poison people, spread
superweeds and entrench corporate monopolies, its now clear that the new crops
have reduced not only hunger but pesticide use, carbon emissions, collateral
damage to biodiversity and rain-forest destruction.212
This statement implies that it has been undisputedly concluded that there are no negative
health effects of GMO technology, an argument discussed in detail later in this analysis.
The article implies that “superweeds”—weeds resistant to the agricultural chemicals that
GM crops are engineered to tolerate—don’t exist, while farmers, the USDA and the
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biotechnology industry have all recognized that they do.213 214 The quote also breezes
over the idea that entrenched corporate monopolies exist in the industry, it is also a nearly
uncontested truth that they do.215 The second part of this quote reproduces industry
claims of reduced hunger and pesticide use, a highly disputed claim, in addition to the
concept, also pushed hard by the industry that GM-crops have a positive effect on the
environment. None of these claims is as clear-cut and fact-based as the author presents
them, and citing no evidence, the author leaves no room for debate, disguising industry
PR as undisputed fact. The article also includes a quote by Calestous Juma declaring that
he “holds ‘the regulation of genetic engineering responsible for the death and blindness
of thousands of young children and young mothers.”216 This tactic of blaming death and
blindness in the developing world on GM regulation not only acts to simplify the issue
vastly, but to precisely reproduce the arguments and humanitarian framing of the issue of
the biotech industry.
Articles in the Wall Street Journal that are not presented as opinion, but as
unbiased news also unquestioningly reproduce industry PR as fact. In an article about
stock value of Monsanto, titled “More Monsanto Magic Likely to be Reaped,” Spencer
Jakab tells readers, “Magic seeds exist only in fairy tales. But Monsanto Co. profits
handsomely by selling the closest thing that science can produce.”217 In another article,
this one putting a positive spin on Monsanto’s acquisition of vegetable and fruit seed
companies that “helped it become the world’s biggest producer of vegetable and crop
seeds by revenue”, Monsanto is presented, in the author’s words as “focused on breeding
seeds to help farmers [emphasis added] grow produce that tastes better or contain [sic]
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more nutrients.” This language implies that Monsanto’s main focus is helping farmers
rather than making profits, a claim that is straight out of the company’s PR. This phrase is
featured on the home page of its website: “Monsanto is playing a key role in helping
farmers address the challenges of water,” and “Our innovations help farmers produce
more food with fewer natural resources”218 The use of this language suggests that the
article was written with the help of a PR release from the company, but it is not presented
as a quote from the company, but as the article author’s own characterization of the
company’s actions.
The Times, with the highest use of the UT/P frame overall, has a similarly high use
of industry PR as unchallenged fact throughout its coverage of biotechnology. Editorials
include phrases such as: “It is delusional to hope that either of these goals – let alone the
larger one of feeding the whole planet – can be met without the increased use of GM
crops,”219 “It is time to drag EU policy on GM into the 21st century,”220 “But without
increased use of genetically modified crop varieties it seems inconceivable that food
production will ever be abundant enough to keep pace with population growth,”221
Shamefully, the EU remains mired in a stalemate on GM regulation that is an
affront to the hungry world. . . . Now new technologies can help by creating more
sustainable ways to produce more food. This is hardly the moment to stifle that
ingenuity by spurning the promise of GM science,”222
GM Food science is moving at an astonishing rate. And it needs to because it is,
potentially, the engine of the revolution in food production that the world
desperately needs if it is to cope with the lethal mix of global warming, the energy
crisis, water shortages and exploding population.223
These editorials repeatedly send the same message that growing population,
environmental changes and world hunger have no other answer than GM crops.
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These Times editorials are joined by letters to the editor with essentially the same
message and framing: a coalition of scientists from The Sainsbury Lab, the John Innes
Centre and the Institute of Biological, Environmental and Rural Sciences write in
Sir, At the end of this month the world's population will reach seven billion (report,
Oct 8). One billion are hungry, and one billion more are malnourished. In the next
decades, there will be more humans. Limited land and water, costly energy for
fertiliser, and climate change will ensure that more of them are hungry. Politics,
economics and lack of good governance exacerbate the problem, but science and
technology can contribute greatly to the solution. Why then is Europe regulating
one part of the solution - GM crops - as if they are a hazard?224
Two emeritus professors, one of plant science and one of microbiology, write in: “But the
prospects and need for biotechnology in agriculture, in a world with more than one
billion starving, perhaps outweigh all the others combined.”225 A letter from Martin
Livermore of The Scientific Alliance Cambridge226 reads “Rather than think how our
farmers can become more productive and make their contribution to food security in a
world of 9 billion people, our (largely scientifically illiterate) political elites are swayed
by the green lobby's emotional arguments.”227 Yet another letter from the John Innes
Centre argues, “we are seeing a revolution in biology - we have a choice whether we use
new technologies to create a more sustainable future in food production, or whether we
allow a fear of innovation to dictate a future using out-dated approaches that hurt our
environment.”228
Examples of pro-GMO framing of the issue as humanitarian, environmental and
rooted in food security with an emphasis on population growth are many. What is notable
about these letters to the editor is that they do not represent a varied cross section of the
population. All of these concerned advocates of biotechnology are direct stakeholders in
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the success of convincing the UK population of the greatness of GM technology. For
some reason these biologists and plant scientists offer themselves, and are positioned by
the platform offered them by the newspaper, as experts to speak about topics such as
global environmental issues, population growth and world hunger. The seemingly
uniform message from biologists and plant scientists presented by this coverage gives the
impression, as the biotechnology industry tries to argue, that there is scientific consensus
on the issue. These letters, though, are part of a coordinated PR campaign by the
biotechnology industry and their front groups, as discussed below in the section on the
Rothamsted Debate. While the biotechnology industry constructs the illusion of scientific
consensus on the topic, there are many notable scientists who disagree with the
biotechnology messaging and who have spoken out against it. Many of these scientists,
while held in high regard by the scientific community have become the target of ad
hominem attacks as a result of their objections. Some examples of these scientists are
Arpad Pusztai who was dismissed after 36 years at the Rowett Research Institute in
Scotland,229 Doug Gurian Sherman, plant pathologist of the Union of Concerned
Scientists,230 Don Huber, professor emeritus at Purdue University,231 Dr. Mae Wan Ho,232
Ignacio Chapela233 and others.
The New York Times uses the UT/P frame a bit more sparingly, and arguments
matching industry PR and language primarily appear in the opinion pieces. An editorial
by Roger Cohen that harshly criticizes what he sees as organic “ideology” based on his
irritation with constantly hearing “the O word” (organic). In the course of this diatribe
against organic food, Cohen criticizes the middle class, “oblivious, in their affluent
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narcissism, to the challenge of feeling a planet whose population will surge to 9 billion
before the middle of the century.” Cohen declare, “To feed a planet of 9 billion people,
we are going to need high yields not low yields; we are going to need genetically
modified crops.”234
Another instance of the alignment of arguments in line with industry PR published
in the New York Times is a letter to the editor from William Y. Brown, a senior fellow at
the Brookings Institute, a Washington think tank that receives funding from the Cato
Institute, Dow, Pfizer and a long list of other large corporations.235 The letter is a
response to an editorial by Mark Bittman promoting GMO labeling, in it Brown argues:
We need genetically modified organisms. They keep insects and weeds from corn
and soybeans. New crops can resist droughts, floods and heat coming with climate
change and provide vitamins and nutrients. Nothing erodes life and peace more
than poverty and hunger is its expression.236
This argument links coming environmental changes with a list of traits that have been
proposed by the industry—drought resistance, flood resistance and increased nutrient
content—none of which have been actualized on any scale, in a way that makes them
sound like current characteristics of genetically modified crops. The author also makes
sure to link the use of GM crops to poverty alleviation to give it a humanitarian frame.
This is a perfect instance of industry arguments presented within the parameters of
industry framing.
Beyond editorials and letters to the editor the New York Times largely does not push
these industry arguments. Articles with a UT/P frame tend to give a more nuanced
picture, and attribute any such arguments to industry and government spokespersons.
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New York Times articles that are framed in this way include an article describing funding
and approval problems of a GM salmon under consideration by the FDA237 as well as a
GM apple developed in Canada that is seeking FDA approval.238 Both articles quote the
developers of these products extensively and discuss their economic benefits, but neither
frames these issues as humanitarian, food security or environmental issues. Instead the
UT/P frame is joined by economic and public opinion frames in these articles.
The Guardian, while using a UT/P frame relatively often as well when discussing
the technology, does so in a much more nuanced way, similar to the New York Times. A
characteristic way for this publication to construct this frame is illustrated here:
with the global population rising quickly towards an expected 9bn in 2050, food
demand is rising fast. Poppy said: ‘The research demonstrates that, when managed
properly, GM crops can enable you to intensify agriculture sustainably.’ But he
noted: ‘GM crops are neither all good nor all bad and GM is not going to feed the
world overnight. But it is a very powerful tool.’239
A more pointed promotion of GM crops, more in line with industry arguments, was
published in a pro-biotech editorial by Johnjoe McFadden, Professor of Molecular
Genetics at the University of Surrey, that argues:
Feeding nearly 10 billion people by 2050 while fuelling their cars and clearing up
their waste threatens to exhaust the planet's handling capacity. Synthetic biology
may provide some answers. Scientists have already developed genetically
modified crops that can provide higher yields.240
Beyond these examples The Guardian articles tend to combine the progress frame with
the effectiveness of technology frame as well as the food security, these articles are by
and large about the Rothamsted Wheat Trial debate, and although they incorporate
Industry PR in certain ways, discussed below, they are not focused on the starving third
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world with the strong humanitarian frames and industry language that the Times and Wall
Street Journal implement.
One notable example of the Guardian amplifying industry PR in a similar way to
the Times and the Wall Street Journal is its unproblematic coverage of the statements of
industry “ambassador” Mark Lynas. On October 21, 2011 the Guardian ran a story
revealing leaked PR documents revealing,
Europe's most influential biotech industry group, whose members include
Monsanto, Bayer and other GM companies, is recruiting high-profile
"ambassadors" to lobby European leaders on GM policy.
Leaked documents from a PR company working for Brussels-based EuropaBio
claim to have "had interest" from Sir Bob Geldof; the chancellor of Oxford
University and BBC Trust chairman, Lord Patten; former Irish EU commissioner
and attorney general David Byrne; and "potentially" the involvement of former UN
secretary general Kofi Annan and pro-GM science writer Mark Lynas [emphasis
added].241
These PR documents cite a plan to gain credibility through these spokespersons who
already hold respected positions in society without revealing their connection with the
industry or their “ambassador” status.
The lobbyists have offered to write, research and place articles in their names,
arrange interviews and speaking engagements with the Financial Times and other
international media, and secure for them what could be lucrative speaking slots at
major conferences. In addition, EuropaBio says it will introduce them to the
highest-level European bureaucrats and MEPs in order for them to make the case
for GM.242
After breaking this story in October, a March 9 article, reporting a national poll on
attitudes toward GM food and claiming that the UK is coming around on the issue ends
with a quote by Mark Lynas saying “Mark Lynas, an environmentalist and author who
ripped up GM crops in the 1990s but became a supporter of the technology, said:
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‘Opposition to GM was perhaps understandable a decade ago, but today it is a
mistake.’ ”243 In the article breaking the news about the PR release Mark Lynas is
referred to as a “pro-GM science writer,” suddenly five and a half months later he is “an
environmentalist and a writer who ripped up GM crops in the 1990s.” There is no
recognition of the article, published by the same news outlet, revealing the industry’s
plan to recruit him as a pro-industry spokesperson. Suddenly he’s just the logical person
conveniently available to comment in favor of biotechnology.
Another Guardian article, this one from May 23, 2012, also about changing
attitudes about biotechnology in the UK and Europe, quotes a range of different people,
and includes a long quote from Mark Lynas as well:
Mark Lynas, an anti-GM protester in the late 1990s who now admits to a
Damascene conversion to the merits of the technology, believes the protesters have
misjudged the public attitude to GM. "I think there are several reasons why GM is
making a comeback. First, the blanket opposition to GM per se as a technology is
obviously untenable in any scientific sense - there is no reason why it should
present any new dangers in food, and, indeed, may well be safer than conventional
breeding in crops."
The experience of seeing GM crops grown and sold in other parts of the word goes
a long way to prove this, he says: "With the passage of more than a decade since the
widespread commercialisation of GM crops in North America, Brazil and
elsewhere, hundreds of millions of people have eaten GM-originated food without a
single substantiated case of any harm done."
But the world's priorities and needs are also fast changing, says Lynas. Issues such
as climate change and population rise mean we just don't have the luxury any more
as a species to ignore or decry this technology: "It is increasingly obvious that
unnecessarily ruling out crop-improvement technologies harms the interests of
humanity when our challenge is to feed over nine billion much richer people by
mid-century on a similar cultivated area to today and without enormous increases in
fertiliser and pesticide use."
Lynas believes that the opposition to GM is now more driven by ideological than
scientific objections: "Most of the remaining opposition to GM is really a displaced
fear about big corporations dominating the food chain, which is why every
argument about GM seems to be reduced down to one word: Monsanto. In which
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case we should be encouraging publicly-funded, open-source GM such as that
conducted at Rothamsted and the John Innes Centre, not threatening to rip out their
crops." 244
This rhetoric matches the biotechnology industry PR perfectly, and Lynas, a writer,
fashions himself an expert on the issue, while Guardian journalists deem him a relevant
person to consult, again without acknowledging the article revealing EuropaBio’s plan to
use him as a mouthpiece.
Additionally, there is also no evidence that Mark Lynas ever ripped up GM crops in
the 1990’s or had much to do with the anti-GM movement. Zach Kaldveer, in his critique
of the excess of media coverage of Lynas’ “conversion” writes,
More disturbing is the fact that NOBODY in the movement's early years has much
of a recollection of Lynas at all. . . . In fact, there is little evidence to suggest Lynas
was anything more than a peripheral, bit player in what was rapidly transforming
into a vibrant international movement. Of Lynas's 50 published articles on "green
issues" for the UK's Guardian only one mentioned GM crops and of the roughly 90
articles he wrote for the New Statesman , the topic of GMOs is nowhere to be found
-- until that is, he wrote a pro- GMO one in January of 2010. Further undermining
Lynas's claims of helping co-found the movement was his admission last year that
the single anti-gmo article he did write for the Guardian in 2008, he 'dashed off in
20 minutes without doing any research.'245
Even without this extra information about the Guardian coverage of biotechnology issues
in which Lynas is quoted without any recognition of the October 2011, the article is
sloppy journalism at best, or it is indicative of an intentional effort by the Guardian to put
a positive spin on the issue of GM food. According to Tankard et.al. news is framed
through selection, emphasis, elaboration, and exclusion. 246 This selection of
spokespersons, and the exclusion of available information about these spokespersons is
an important part of how the Guardian frames this issue, and it echoes of the
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biotechnology industry’s careful choice, and cultivation of the images of, certain
spokespersons. The willingness of these journalists to accept Lynas’ account of his
history as an anti-GMO activist without corroborating this claim, and their willingness to
overlook evidence of his association with the biotechnology industry, are important
aspects of how this story is framed by the Guardian. Herman and Chomsky explain the
attraction for the mass media in quoting opinions of sources such as Lynas:
Another class of experts whole prominence is largely a function of serviceability to
power is former radicals who have come to “see the light.” . . . for the establishment
media the reason for the change is simply that the ex-radicals have finally seen the
error of their ways. . . . it is interesting to observe how the former sinners, whose
previous work was of little interest or an object of ridicule to the mass media, are
suddenly elevated to prominence and become authentic experts.247
This attraction to the repentance narrative is evident in mainstream media coverage of
Lynas, and explains the media’s portrayal of Lynas as an expert despite his lack of any
other kind of credential to suggest him as a source of information on the issue.

Framing Biotechnology in India
Referencing the need for biotechnology in the developing world is an important
part of the biotechnology industry’s sales pitch for its products, and India is a country
where GM food is a topic of much controversy. The manner in which all of these groups,
then, discuss events surrounding biotechnology in India, is an apt case study to examine
the treatment of the developing world in biotechnology news. The debate surrounding btcotton and GM crops more generally in India is an issue that further illustrates the
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tendency of the mainstream media to reproduce frames and PR messages of the
biotechnology industry. India comes up relatively often in both the pro-biotech and antibiotech arguments. Articles from the Organic Consumers Association sample that
mention India include an article linked from the Huffington Post reporting:
India announced last month it is pursuing charges against Monsanto for "stealing"
an indigenous crop -- eggplant -- and using it to create a modified version without
permission, a violation of India’s decade-old Biological Diversity Act. It’s the first
prosecution of a company for the act of "biopiracy" in the country, and possibly
the world.248
The next mention of India in the OCA sample, from the Ecologist, is about a Permanent
People’s Tribunal accusing biotech companies of human rights abuses:
The world's major agrochemical companies, Monsanto, Dow, Bayer, Syngenta,
DuPont and BASF, will face a public tribunal in early December accused of
systematic human rights violations. They are accused of violating more than 20
instruments of international human rights law through promoting reliance on the
sale and use of dangerous and unsafe pesticides including endosulfan, paraquat and
neonicotinoids. 249
Another article presented by OCA, this one from the Hindustan Times, leads with
the lament:
India’s Bt cotton dream is going terribly wrong. For the first time, farmer suicides,
including those in 2011-12, have been linked to the declining performance of the
much hyped genetically modified (GM) variety adopted by 90% of the country’s
cotton-growers since being allowed a decade ago.250
This article references an internal advisory from the Indian government agricultural
ministry to cotton growing states that cites decreasing cotton yields, increasing cost of
input and a link between farmer suicides and bt-cotton.
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Another article from the Institute of Science in Society, reports a lawsuit against
Syngenta for withholding evidence in a previous German trial regarding the death of
livestock after eating bt-corn. Subsequently,
in 2009, the farmer learned of a feeding study allegedly commissioned by
Syngenta in 1996 that resulted in four cows dying in two days. The trial was
abruptly terminated. Now Gloeckner, along with a German group called Bündnis
Aktion Gen-Klage and another farmer turned activist Urs Hans, have brought
Syngenta to the criminal court to face charges of withholding knowledge of the US
trial, which makes the company liable for the destruction of the farmer’s 65
cows.251
The article references another report from Science in Society that
at least 1,820 sheep were reported dead after grazing on post-harvest Bt cotton
crops; the symptoms and post-mortem findings strongly suggest they died from
severe toxicity. This was uncovered in a preliminary investigation conducted by
civil society organisations in just four villages in the Warangal district of Andhra
Pradesh in India. The actual problem is likely to be much greater.252
Another article from the Times of India, published on the GM Watch website
reports:
MUMBAI: The Maharashtra government has banned the sale and distribution of
the genetically modified Bt cotton seeds of Maharashtra Hybrid Seeds Company
(Mahyco), a partner of US multinational Monsanto, in the state with immediate
effect for supplying inferior quality seeds. . . . Certain Bt cotton variants are
suspected of toxicity, damaging public health and environment, and agriculture
activists have been demanding a complete ban on Bt technology in India. Protests
have marked the 10th anniversary of the introduction of Bt cotton in the country
this year with angry farmers and social activists asking policy makers for a
comprehensive review of the technology that was meant for irrigated areas but was
pushed in all cotton-growing states.253
In still another article from another Indian news source, Tehelka, reports on a
national conference in New Delhi, hosted by a coalition of prominent environmental and
agricultural groups and including seed providers, government officials, farmers etc.
Today, approximately 90 percent of the total cotton cultivation in the country of
11.14 million hectares is covered by Bt cotton. This seems to be the basis on which
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our policymakers have come to the conclusion that Bt cotton is a success story. But
that’s only half the picture, the other half which comprises of dirty tricks used by
the companies to first lure desperate farmers using advertisements promising high
yields and reduced use of synthetic chemicals along with systematic removal of non
Bt seeds from the market is hardly seen by the policymaker. . . . The macroeconomic studies showed another interesting factor. If we take the 10 years of Bt
cotton in India, the rate of growth of cotton yields was highest in the period 200207 when Bt cotton area grew from zero to 41 percent of the total cotton area. In the
next five-year period, when the area under Bt cotton increased to almost 90 percent.
The growth in yield has stagnated and even slumped. So it proves that Bt cotton
adoption alone is not the reason for increase in growth.254
The object of this long list of quotes is not to make the case against GMOs, but to
illustrate the range of stories presented by OCA and GM Watch about India (as well as
the variety of their sources), that report on the experiences of Indian farmers with btcotton.
Biotechnology Industry sources present the issue very differently. A search for
India in articles from the US industry organization, Biotechnology Industry Organization
(BIO), pulls up a story written by Ab Basu, Executive Vice President (Acting), Food and
Agriculture, BIO. Basu writes about growing up in India:
I saw first-hand the fear and chaos that comes from food insecurity. India – at that
time – had the world’s largest food deficit. Now, India is a leading food exporter.
That’s a great story to tell, and it’s because India adapted to technology and began
using crop varieties that produced better yields. It is critical we provide farmers
around the world with the same scientific tools and knowledge available that
American farmers have. And let’s keep the food debate focused on basic human
needs.255
This quote does a number of different things. The reference to his childhood in India
gives the author credibility--he must know about India, he has first-hand knowledge, and
he must care about Indian people. Without having to cite sources he has also credited the
increase in cotton production in India to the biotechnology industry without discussing
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sordid matters of Indian farmer suicides or statistics that illustrate the point specifically.
With his last sentence, he has placed focus of the debate on a very limited scope of
analysis, basic human needs, while framing his argument in a humanitarian way, and
implicitly criticizing activists who argue about all kinds of different factors surrounding
GMOs. What he has not done is discussed the actual conditions and experiences of Indian
farmers. The only other mention of India in the ABC literature during the period of this
analysis is a few times India is mentioned as part of a larger picture regarding increases in
the adoption of GM crops worldwide.
The UK’s Agricultural Biotechnology Council (ABC) mentions India twice over
the course of the year to say “India planted 10.6 million hectares of biotech cotton during
2011”256 and later, “GM is used extensively in North and South America but is also
popular in India, China, Australia and several African countries.257”
CropGen also only mentions India by way of passing and mentioning how many
acres of GM crops they grow. The most in depth discussion of India:
India celebrated the 10th anniversary of Bt cotton, with plantings exceeding 10
million hectares for the first time, reaching 10.6 million hectares, and occupying
88% of the record 12.1 million hectare cotton crop. The principal beneficiaries
were 7 million small farmers growing, on average, 1.5 hectares of cotton. India
enhanced farm income from Bt cotton by US$9.4 billion in the period 2002 to
2010 and US$2.5 billion in 2010 alone.258
BiotechNow articles touch on the topic more often. They include passing
mentions of increasing yields in India, one quote from the head of an African think tank
saying vaguely Africa must learn from the mistakes of India, another article claims that
India’s lack of confidence in biotechnology comes from the UK and the US: “Much of
the same lack of confidence of biotech foods exists in India and throughout the world
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because of the European Union spreading its unfounded concerns about biotech foods
and a fringe U.S. scientific community spreading negative quasi science.”259 This
argument calls into question the ability of Indian citizens to think for themselves as well
as calling into question science that goes against the biotechnology industry’s arguments
about its products and grouping any scientist whose findings aren’t in line with industry
findings into the category of a “fringe scientific community.” This is a pattern that is
discussed in more detail below.
The AgBioWorld sample also includes the previously discussed article by
Chengal Reddy. In a search in all of the articles published by AgBioWorld (not just those
sampled to limit the number of articles to a manageable number) during the time period
under consideration, there are 3 additional scientific analyses, all three arguing that btcotton has brought increases in profits and yields for Indian farmers.260261262
Another brief article from the Times of India appear in AgBioWorld’s coverage,
reporting solely on the opinion of a Russian Biotechnology researcher visiting India who
argues that Bt-eggplant resistance in India comes from pesticide companies who know
they will be obsolete if it is approved (clearly a fallacy since the purveyors of the
pesticide also sell the seed). “Professor Gaponenko, who is in the city to attend the
ongoing Science Conclave at IIIT-A, told TOI that genetically engineered crop is the only
viable alternative to feed the ever increasing population of the world, which traditional
seeds cannot cater.”263 This scientist offers up the industry argument of needing
biotechnology to feed the growing world population.
The last AgBioWorld article addressing India is from US group International
Service for the Acquisition of Agri-Biotech Applications (ISAAA), and presents this
argument from Prof. G. Padmanaban:
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‘The debate for and against GM technology has raged all over the world and
people have taken extreme positions one way or the other and it appears to me that
this is not an issue that can be settled through arguments,’ he said. ‘Ultimately it
has to be a political decision, based on a clear perception of its utility and a careful
risk-benefit analysis and not be guided by populistic (sic) movements.’264
This argument calls for ignoring what the population at large thinks and asking
politicians to make decisions “based on science.”
All of the instances of the biotech industry broaching the topic of India above
involve arguments about increasing yields and profits of Indian farmers from Bt-cotton,
no other issues are discussed by industry sources. The industry sources do not discuss the
protests mentioned above against GM crops, the ban on GM-cotton, also mentioned
above, or the lawsuit brought against Monsanto for biopiracy, it maintains the limited
scope of looking at quantitative data from industry friendly sources regarding yields and
farmer income. Promoting this macro-economic frame as the most legitimate frame
within which to understand these issues limits the scope of conversation about the issue
to a circumscribed set of arguments that the biotechnology industry is prepared to engage
with. Biopiracy is not a concept the biotechnology industry has any interest in people
thinking about as it brings up many complicated questions about intellectual property and
rights of indigenous populations to their own history and knowledge. This is another
example of Tankard’s framing through selection in that the selection of certain frames
over others has a significant impact on the ways that readers are encouraged to think
about a particular issue.
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An article published by GM Watch reveals that the biotechnology industry is
attempting to spread this PR message in India as well. In an op-ed from The Hindu, P.
Sainath recounts:
Three and a half years ago, at a time when the controversy over the use of
genetically modified seeds was raging across India, a newspaper story painted a
heartening picture of the technology's success. ‘There are no suicides here and
people are prospering on agriculture. The switchover from the conventional cotton
to Bollgard or Bt Cotton here has led to a social and economic transformation in
the villages [of Bhambraja and Antargaon] in the past three-four years.’ (Times of
India, October 31, 2008).
So heartening was this account that nine months ago, the same story was run again
in the same newspaper, word for word. (Times of India, August 28, 2011). Never
mind that the villagers themselves had a different story to tell.265
The article goes on to recount residents of Bhambraja testifying in a government hearing
that, in fact 14 farmers had committed suicide in the village since the introduction of btcotton, and that farmers were giving up farming or switching to soy. Detailed interviews
with the farmers featured in the news story reveal that even the first time it was printed in
2008, it was deceptive about increases of farmer profits and other details. The author also
references
a study of the 365 farm households in Bhambraja and the nearly 150 in Antargaon
by the Vidarbha Jan Andolan Samiti (VJAS) [that] shows otherwise. ‘Almost all
farmers with bank accounts are in critical default and 60 per cent of farmers are
also in debt to private moneylenders,’ says VJAS chief Kishor Tiwari.266
This account, published by the Hindu, highlights the (perhaps intentional) blindness of
the biotech industry to the actual conditions of Indian farmers, and implies willingness of
biotech corporations to fabricate stories and evidence in the interest of selling their
products.
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Press coverage of India regarding biotechnology from the US mainstream sources
examined in this analysis is rather limited. The New York Times mentions India once, to
note that the country has GMO labeling laws in place,267 The Wall Street Journal
mentions India four times, twice to note that corn yields in India are significantly lower
than in the US,268 269 once to mention the rising affluence in reference to the need to
produce more food,270 and once to praise Norman Borlaug’s introduction of hybrid
wheat: “whose yield was so enormous that struggling countries such as Mexico and India
became self-sufficient by raising the crop.”271 As far as these sources are concerned,
events in India are irrelevant to biotechnology news and discussion. Without knowing
why that is the case, the outcome is clearly that events in India are not framed as
important or central to the issue of GMO.
An article in the Guardian reports:
Genetic engineering has failed to increase the yield of any food crop but has vastly
increased the use of chemicals and the growth of "superweeds," according to a
report by 20 Indian, south-east Asian, African and Latin American food and
conservation groups representing millions of people.272
The article reports the main points of the report, citing the arguments that biotechnology
companies own most of the available seed, that use of biotech crops increases use of
pesticides, that superweeds are popping up that are resistant to Roundup and other agrochemicals. Potential health risks are brought up as well, as well as the claim, from the
report, that “scientists are loth to question the safety aspects for fear of being attacked by
establishment bodies, which often receive large grants from the companies who control
the technology.” The account is followed by a quote from Monsanto arguing that because
of the amount of GM food consumed already it must not be a health risk. The article ends
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with a few other quotes from the report about the biofuels taking food that is needed to
feed the developing world, and finally that “GM companies have put a noose round the
neck of farmers. They are destroying alternatives in the pursuit of profit.” While the
article covers a number of topics and claims of anti-biotech activists, it is strictly an
account of what is in the report, making neither the author of the article nor the
newspaper in any way accountable for the content. There is no corroboration of the
claims or context given, just the content of the report and Monsanto’s quote countering
one of the points.
India is also mentioned in an editorial by Robert Newman. In a larger article
questioning the issues of democracy and agency of citizens of the developing world
surrounding philanthropy, Newman comments:
The biotech agriculture that Lord Sainsbury was unable to push through
democratically he can now implement unilaterally, through his Gatsby Foundation.
We are told that Gatsby's biotech project aims to provide food security for the
global south. But if you listen to southern groups such as the Karnataka State
Farmers of India, food security is precisely the reason they campaign against GM,
because biotech crops are monocrops which are more vulnerable to disease and so
need lashings of petrochemical pesticides, insecticides and fungicides – none of
them cheap – and whose ruinous costs will rise with the price of oil, bankrupting
small family farms first. Crop diseases mutate, meanwhile, and all the chemical
inputs in the world can't stop disease wiping out whole harvests of genetically
engineered single strands.273
General arguments made by Indian groups against GM technology is the limit to which
he discusses this topic.
The last article that mentions India is in the Society pages, and it is an article by
Aruna Roy, detailing recent legislation in India, its Right to Information Act, and
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comparing it to similar, but according to Roy, inferior legislation in the UK, the Freedom
of Information Act. Roy recounts:
There is greater provision in Indian law for access to information from private
companies, including those running outsourced agencies. One example of
information obtainable in India that would not have been possible to obtain in the
UK or the rest of Europe was when a subsidiary of Monsanto was forced to reveal
information related to trials of genetically modified crops, which the company had
claimed was protected by commercial interest.274
There is no further mention of India in the Guardian coverage of biotechnology.
The Times mentions India in several articles that address biotechnology. One is
just in passing, in an editorial in which Matt Ridley fantasizes about a time in the future
where population growth has decreased even in India to the point where the younger
generation doesn’t know how to support the much larger older generation. One in a letter
to the editor in which the author laments: “Look at the GM research and related industries
in China and India. In maybe 20 years there will be a wringing of hands: GM, a
technology invented in the UK by the elucidation of the structure of DNA - but
developed by others.”275
Another mention of India in the Times is an article in the Business section
reporting on the ban of GM in India’s largest state, citing the lack of economic benefit
reported and the possible connection to farmer suicide according to “campaigners.”276 A
second article about Indian suicides also appears in the Times relating the story of two
farmers in India who committed suicide and their families. The article reports:
Kishore Tiwari, a campaigner monitoring the crisis in Vidarbha, blames the
changes in farming practices pushed by India's Government and by Monsanto, the
US agribusiness giant that produces drought-resistant GM cotton seeds that
farmers in the area use. ‘This is a manmade crisis,’ he said, pointing out that 20
years ago farmers grew food as well as cash crops, making them less reliant on
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market prices, and did not need to take out debts to buy seed and fertiliser every
year.277
While the US mainstream media sources analyzed here do not acknowledge any
claimed connection between farmer suicides and bt crops during the period of analysis, or
report on the ban of these crops in India’s largest state, the UK media has reported on
these issues a fair amount. One possible reason for this imbalance is Britain’s long and
complicated history as a colonial occupier of India, and the subsequent economic and
political ties. News of India would be culturally and politically more important in the UK
than the US for this reason. What news outlets in neither country report on, though, is the
biopiracy charge from India’s government, or the German farmer suing Syngenta for
withholding evidence of consumption of bt-crops poisoned livestock in their own feeding
trials. Nor is the Permanent People’s Tribunal accusing Monsanto, Dow, Bayer,
Syngenta, DuPont and BASF of Human rights abuses. There is no mention of the
preponderance of lawsuits internationally against Monsanto or other biotechnology
companies.

Gaps in Coverage & the Human Health Frame
The New York Times reports one in this period on the suit brought by US farmers
against Monsanto attempting to escape their eventual litigation against them when their
crops become inadvertently contaminated with the company’s patented seeds. Readers
who depend on these newspapers for their knowledge of this subject would not be aware
that in addition to this case there are many other lawsuits against these companies
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regarding the legitimacy of their patents and safety of their products all over the world.
No mention was made in any of the four mainstream news sources of the supreme court
of Brazil ordering Monsanto to pay a multi-billion dollar settlement to Brazilian farmers:
In April 2012 a Rio Grande Do Sul judge ruled that Monsanto's fees were illegal
and noted that the Roundup Ready seed patent had already expired in the country.
The company was not only ordered to stop collecting the royalty fees but to also
return all such fees collected since 2004. Such collected royalties amount to $2
billion. Monsanto appealed the ruling but was dealt another blow on June 12 when
the Brazil Supreme Court decided unanimously that whatever the Rio Grande Do
Sul courts rule on this matter should apply to the whole of Brazil. This caused the
number of plaintiffs to balloon to five million and the total royalty owed to rise to
$7.5 billion.278
These news outlets do not report lawsuit of the French farmer who sued Monsanto over
adverse health effects from contact with the weed killer Lasso, and won, as reported by
Reuters and on the OCA web site in February 2012.279280
Many of these lawsuits that are not reported by the four mainstream news sources
examined here have something in common: they are claiming negative health effects of
agricultural pesticides or genetically modified crops. One of the more significant frames
identified in the material from the anti-biotechnology organizations was the Human
Health frame. Below is an enlarged chart of the anti-biotech group frames:
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Figure 9: Anti-Biotech Group Frames

As the chart illustrates, the human health frame is by far the most significant of
the OCA articles and one of the four most significant frames from the GM Watch sample
The human health frame is inconsequentially small or non-existent in all of these
mainstream press articles, as evident from figure 9, above.
It is important to note that frames used frequently by both pro-biotech and antibiotech groups are used in different ways by the two groups. While an environment frame
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used by the biotechnology industry is promoting the benefits of biotechnology for the
environment, the anti-biotech groups use this frame to emphasize the environmental risks
and observable negative effects of GM crops on the environment, one side says GM
crops increase use of pesticides the other says they decrease the use of pesticides, both of
these arguments fall under the environment frame. The biotechnology industry uses the
legitimacy of science frame almost constantly, repeating endlessly that there is a
scientific consensus regarding the safety of genetically modified food. As Herman and
Chomsky postulate:
a propaganda model suggests that the ‘societal purpose’ of the media is to
inculcate and defend the economic, social, and political agenda of privileged
groups that dominate the domestic society and the state. The media serve this
purpose in many ways: through selection of topics, distribution of concerns,
framing of issues, filtering of information, emphasis and tone, and by keeping the
debate within the bounds of acceptable premises.281
Keeping the debate within the bounds of acceptable premises is the key operating factor
here, the biotechnology industry as well as various other establishment bodies have
declared a scientific consensus that there are no health risks from GM crops, so to report
on those would be outside of the bounds of acceptable discussion, and could potentially
result in flak towards the mainstream press. This results in an uncontested message of the
safety of GM crops and their principle inputs across the mainstream media.
For example, in reporting about the issue of GM labeling the Wall Street Journal
explains,
The U.S. Food and Drug Administration says genetically modified foods aren’t
any less safe than conventional foods, and it doesn’t require labeling. Some
scientists argue the foods require further study but say that there are no known
health risks associated with them.282
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In this explanation the author has communicated that there is no scientific work that has
warned of possible health risks of GM food, just a few suggestions that more work might
be done on the issue, he has also dispensed with the issue of possible health effects in
order to go on to frame the labeling debate as a political matter and one revolving around
public opinion first and foremost.
In addition to the lawsuits against the biotechnology industry, anti-biotech
organizations publish articles on a significant number of scientific studies that question
the safety of roundup and genetically modified crops, and most of these studies do not
make it into the mainstream media. When these studies are covered by the mainstream
media the biotechnology industry undermines the legitimacy of the authors and the
validity of the studies to such a degree that the result is to further reinforce the
biotechnology industry’s message of scientific consensus on health effects.
The Times reports on studies linking neonicitinoids to bees’ colony collapse
disorder, the Rothamsted wheat trials and finally a grant given by the Gates Foundation
to the John Innes Centre in Norwich to study crops that could take nitrogen out of the air.
According to the article, it is hoped that the study “will benefit struggling maize farmers
in sub-Saharan Africa.”283 Beyond that no scientific studies are reported on and the
references to human health are few: one editorial refers to the issue briefly, “the argument
[against cultivation of GM crops in Europe] would carry more weight if there were
substantial evidence of GM crops harming human health or suppressing biodiversity, but
there is very little of either.”284 In two instances articles actually vaguely refer to human
health benefits of GM crops, on in a letter to the editor in which the author claims,
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without providing any further clues as to what he is referring, “well evidenced health and
output benefits achieved through changing to GM cotton, rice and bananas or the
potential for other crops.”285 The other mention of health effects of GM food occurs in a
letter from Dr. Giles Oldroyd, a plant biologist at the John Innes Centre, in which he
claims, “GM also allows improvements to our food, such as increased levels of healthpromoting components.”286 The Times, as this evidence shows, barely recognizes that
controversy exists over potential negative health effects of GM crops, while suggesting in
a general way that they may actually improve human health.
On June 21, 2012 the Guardian reports on a Chinese study that reports
environmental benefits of Bt-crops. The article introduces Bt-crops as “Plants engineered
to produce a bacterial toxin lethal to some insects but harmless to people.”287 By stating
that Bt-toxin is not harmful to people without attributing a source of this information or
identifying it as an industry claim, it is represented as an undisputed fact. This, presumes
information provided by the biotechnology industry is true and ignores a study reported
repeatedly in OCA and GM Watch materials,288 and published in reproductive toxicology
in May 2011, that finds:
Cry1Ab toxin was detected in 93% and 80% of maternal and fetal blood samples,
respectively and in 69% of tested blood samples from nonpregnant women. There
are no other studies for comparison with our results. However, trace amounts of
the Cry1Ab toxin were detected in the gastrointestinal contents of livestock fed on
GM corn. . . . To our knowledge, this is the first study to highlight the presence of
pesticides-associated genetically modified foods in maternal, fetal and nonpregnant
women's blood. 3-MPPA and Cry1Ab toxin [b-t proteins] are clearly detectable
and appear to cross the placenta to the fetus.289
The authors of the study express concern about the effect of this toxin in reproductive
disorders and conclude:
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Given the potential toxicity of these environmental pollutants and the fragility of
the fetus, more studies are needed. . . . Today, obstetric-gynecological disorders
that are associated with environmental chemicals are not known. This may involve
perinatal complications (i.e. abortion, prematurity, intrauterine growth restriction
and preeclampsia) and reproductive disorders (i.e. infertility, endometriosis and
gynecological cancer). 290
The article reports findings of a Chinese study that reports spillover benefits of the
use of bt-crops to nearby non-GM crops. The article quotes the research team leader:
‘Insecticide use usually kills the natural enemies of pests and weakens the
biocontrol services that they provide,’ said Professor Kongming Wu at the Chinese
Academy of Agricultural Sciences in Beijing, who led the research team.
‘Transgenic crops reduce insecticide use and promote the population increase of
natural enemies. Therefore, we think that this is a general principle.’291
The article reports the study unproblematically, in an upbeat tone, framing the issue as a
positive environmental story, promoting the usefulness of GM-crops, failing to cite
anyone who may disagree with the findings and failing to cite repeated reports, noted by
GM Watch and others, of the increasing failure of the bt-technology to resist the pests it
is designed to resist.292 293 294
A subsequent letter to the editor from Emma Hockridge, Head of Policy of the
Soil Association, addresses the article and reveals that these findings are, of course,
contested:
Your article (GM crops deliver green benefits, study suggests, 14 June) reports on
a study that finds Bt cotton is a better habitat for such predators than cotton that
has been sprayed with pesticides. What it doesn't cover is other recent research in
China that has discovered increased insect resistance and increased numbers of
pests developing in and around these GM cotton crops. Studies show problems
occurring with secondary pests in Bt cotton, which are not only affecting the
cotton but also damaging surrounding crops. This suggests "spillover" problems
rather than "spillover" benefits.295 The study that Hockridge refers to is one
published in February 2011 in Environmental Monitoring and Assessment.296
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While it is notable that this letter is published, it doesn’t change the message of the
original article that GM crops provide environmental benefits through the reduction in
pesticide use. This message is one that the biotechnology industry focuses on in materials
published by the four pro-biotech organizations examined. It is also part of a strategy that
is laid out in a previously cited internal Monsanto memo regarding a new public relations
campaign that the company launched in 2002 called “Good To Grow”: “Monsanto’s
future is inextricably linked to global acceptance of biotechnology . . . pesticide reduction
has shown it is a powerful message.”297
Another study reported on by the Guardian, already discussed above, is the report
by “20 Indian, south-east Asian, African and Latin American food and conservation
groups representing millions of people.” The report criticizes many aspects of GM
technology, but when it comes to suggestion of health risks, a quote from Monsanto is
provided stating:
Monsanto disputes the report: ‘In our view the safety and benefits of GM are well
established. Hundreds of millions of meals containing food from GM crops have
been consumed and there has not been a single substantiated instance of illness or
harm associated with GM crops.’298
The piece goes on to quote Monsanto’s argue that GM crops provide “substantial
economic and environmental benefits,” but no response is given to the main arguments of
the study regarding control of global food supply, indebtedness among developing world
farmers, attacks on scientists who speak out about possible negative effects of GMOs, or
appearance of superweeds. These aren’t points with which the industry is willing to
engage with. These two are the only relevant studies the Guardian reports on beyond
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public opinion surveys, studies on a connection between neonicitinoids and bees’ colony
collapse disorder and the Rothamsted wheat trials, discussed in detail below.
Other mentions of health effects of GM crops in the Guardian are few, but the
instances include an editorial in which Leo Hickman notes:
Monday, Europe's food safety agency ruled against a temporary French ban on a
strain of GM maize made by the US company Monsanto, saying there was ‘no
specific scientific evidence, in terms of risk to human and animal health or the
environment’ to justify it. But the protesters feel the public is still on their side”299
This quote puts the argument in terms of science vs. popular opinion, a stark contrast that
doesn’t acknowledge existing scientific studies that question the health effects of
consuming GM crops as contributing to public opinion. This has the effect of positioning
public opinion as based on irrational objections to GM crops that fly in the face of
science.
In another quote referencing human health, the same article quotes Colin Ruscoe,
Chairman of the British Crop Production Council, arguing “GM offers the promise of a
number of beneficial traits: ‘Some crops could be climate change resistant. They could be
both salt and drought resistant. Or they could be enhanced with extra health-giving
properties such as omega-3 oils.’”300 This quote references possibilities of future GM
crops but none of these functions have yet been realized in practice, and thus are based on
speculation rather than scientific evidence.
Another article from the Guardian comment section by James Randerson claims:
“Scary health effects that were always the most potent fears for average consumers
(though perhaps also the least credible) have failed to materialise.”301 Still another
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comments, “and while there is little evidence that the consequences of GM will match the
prophesies (particularly the potential health risks to consumers)”302 These quotes, as a
whole, imply that there is no scientific debate around possible health risks associated with
consuming GM food, while there could very well be some benefits down the line. This is
exactly the message the biotechnology industry would like to convey about its products.
The Wall Street Journal reports on one scientific study relevant to this analysis.
The article, titled “Beijing Suspends Researcher Over Modified-Rice Study,” reports,
China's national health watchdog suspended one of its researchers after
announcing it hadn't approved or participated in a 2008 Sino-U.S. study that
examined the effect of genetically modified vitamin-enriched rice on 24 children.
There is no indication that the children have been harmed, but the agency's
response is likely to further entrench widely held public skepticism in China over
genetically modified grains amid broader food-safety concerns.303
This passage frames the issue not as one of research ethics or of the health of the subjects,
but of importance of public opinion regarding genetically modified grains and food
safety. The article goes on to compare Chinese law prohibiting human consumption of
GM foods with the commonness of GM grain in the US, presumably to demonstrate the
unreasonable nature of Chinese regulation, and then discusses the potential market for
genetically modified crops that China represents. The article proceeds to report that the
study found that the genetically modified rice provided vitamin A just as well as spinach
to the children in the study. The details of the researcher’s suspension are given, followed
by the conclusion of the article in which the author seemingly gives as much evidence to
absolve the researcher of any wrongdoing that can be scraped together:
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Ms. Tang had earlier said the tests had been preapproved, the state-run Xinhua
news agency reported. She wasn't available to comment.
The project involved feeding the children modified rice, spinach and carotene
capsules over a 35-day period. The center said it has asked Tufts to investigate the
case.
public-relations deputy director Jennifer Kritz said on Tuesday that the university
is conducting a review of the protocols in the research and declined to comment
further until after it is completed. She said made "every effort to abide by Chinese
law" as well as to ensure the safety of human research subjects.304
This article frames the story in such a way as to imply that Chinese law regarding GMOs
is unreasonable as well as hard to comply with and that Chinese officials are potentially
lying about having approved the study in the first place. The major issue presented as
being at stake here is the image of GM foods and the fact that the study proved the health
benefits of so called “Golden Rice.”
No other studies regarding the safety or health effects of GM foods are addressed
in the Wall Street Journal coverage. Mentions of health risks in the coverage are limited
to those such as the example cited above, that convey the image of a scientific consensus
surrounding the issue. The Wall Street Journal tends to frame any mention of possible
health effects of GM food in terms of public opinion on GM crops, much like the article
reporting the Chinese Golden Rice study above. For example, one article about the GMO
labeling debate reports, “opponents of the initiative say the labels would mislead
consumers into thinking there are health risks associated with the products.”305 Another
article notes,
Monsanto frequently has been criticized by some consumer and environmental
groups that argue its biotech corn and soybean seeds are detrimental because they
encourage farmers to apply more of certain herbicides, breed insect resistance and
have unknown human health effects.306
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This quote is in the context of discussing Monsanto’s newest foray into the vegetable
market and the company’s economic prospects and stock value, in an overall economic
frame. Thus the mention of consumer and environmental group criticism is a suggestion
of a potential economic pitfall for the company due to public opinion, rather than any real
engagement with these health and environmental concerns.
The New York Times also reports on studies connecting neonicitinoids to bee die
off. Additionally, in an article reporting the rejection of a request by the Natural
Resources Defense Council for the EPA to ban agrochemical 2,4-D, the evidence
presented on scientific studies of the issue is as follows:
The group cited various studies suggesting that exposure to 2,4-D could cause
cancer, hormone disruption, genetic mutations and neurotoxicity. It also said the
E.P.A., in previous assessments, had underestimated how much people, especially
children, might be exposed to the chemical through dust, breast milk and skin
contact.
In its ruling, the E.P.A. said that while some studies cited suggested that high
doses of the chemical could be harmful, they did not establish lack of safety, and in
some cases they were contradicted by other studies.
The agency in particular cited a study, financed by the 2,4-D manufacturers and
conducted by Dow, in which the chemical was put into the feed of rats. The study
did not show reproductive problems in the rats or problems in their offspring that
might be expected if 2,4-D were disrupting hormone activity, the E.P.A. said.307
This account of the scientific controversy downplays the studies regarding the health
effects of 2,4-D cited by the group, not detailing the evidence in a way that would allow
readers understanding of the methods or results, nor providing a way to access these
particular studies, while giving significantly more detail on the industry funded study
from which the agency concludes that the chemical is not unsafe.
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Roger Cohen’s anti-organic editorial also mentions a study, this one the widely
reported Stanford study that, according to Cohen,
concluded, after examining four decades of research, that fruits and vegetables
labeled organic are, on average, no more nutritious than their cheaper conventional
counterparts. The study also found that organic meats offered no obvious health
advantages. And it found that organic food was not less likely to be contaminated
by dangerous bacteria like E.coli. The takeaway from the study could be summed
up in two words: Organic, schmorganic. That's been my feeling for a while.
Cohen added another claim about the Stanford study, stating that he trusts “the
monitoring agencies that ensure pesticides are used at safe levels -- a trust the Stanford
study found to be justified.”308 These findings, reported here as if representative of the
final say on organic vs. conventionally grown food, was also reported on by the Organic
Consumers Association in an article by Jim Riddle of the University of Minnesota
Southwest Research and Outreach Center on September 11, 2012. The author notes,
The Stanford study was striking in several regards: 1) No new research was
conducted - the Stanford team simply reviewed existing studies; 2) The review
included research conducted under different sets of organic standards; 3) The
review included research conducted prior to 2002, when USDA National Organic
Program Regulations took effect; and 4) The review concluded that organic foods
consistently contain fewer pesticide residues and antibiotic-resistant bacteria, and
significantly higher levels of beneficial nutrients in organic milk.309
The New York Times editorial presents the study in a way that suits the author’s outlook
on the issue, which is irritation at what he sees as the excessive amount of references to
organic food in his every day life. This is perhaps pardonable given the tone and personal
nature of the article, but it nonetheless simplifies the issue and unproblematically presents
a very limited view of the results of a study that has received a significant amount of
criticism in its methods310311 and the way in which its results have been presented by the
media. The controversy over this study is widely reported on by anti-biotech groups and
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pro-biotech groups, but since the focus of the story is not on genetic modification, most
articles in the mainstream press addressing the study, including one by the New York
Times, were not included in this sample, thus this controversy, while interesting, will not
be a focus of this analysis. The editorial in question here was selected because the author
goes on to argue that the world needs GM crops and pesticides over organic farming in
order to feed the increasing world population, thus, based on the relevance of this
material, the article made it into the sample.
Another study to receive a significant amount of press attention is reported on by
the New York Times in a September 20, 2012 article by Andrew Pollack, titled “Foes of
Modified Corn Find Support in a Study.” The title of the article politicizes the study
immediately, rendering it not important science news to inform the public about but a
controversial tool for “foes” of the technology. The article leads with,
Rats fed either genetically engineered corn or the herbicide Roundup had an
increased risk of developing tumors, suffering organ damage and dying
prematurely, according to a new study that was immediately swept up into the
furor surrounding crop biotechnology when it was released Wednesday.
The study, conducted by a prominent opponent of genetically engineered crops,
was immediately criticized by some other scientists, who said the methods were
flawed and that other research had not found similar problems.312
The article goes on to detail the notably longer time period of the study than others as
well as some of the basic methods of the study, which, according to the article, was
published “the peer-reviewed journal Food and Chemical Toxicology.” The author then
quotes Brude M. Chassy, Emeritus Professor of food science at the University of Illinois
arguing “‘This is not an innocent scientific publication. . . . It is a well-planned and
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cleverly orchestrated media event.’” Chassy has in the past been quoted on the
Biotechnology Industry Organization publication, BIOtechNOW, saying of GM crops,
the science and results are clear: products of biotechnology are probably safer than
any others. There is no scientific controversy or doubt about the real-world
outcomes. They are all positive, good for consumers, farmers and the
environment. . . . There is a well-financed and organized global opposition to GM
crops that spreads misinformation and fear. . . . Make no mistake about it, this isn’t
a grassroots opposition. It is a small handful of people that profit from higher
prices for organic and GM-free foods. They are paid to block GM crops that can
benefit certain countries and companies.313
Not only do these comments sound paranoid, his accusations of a global conspiracy
coordinated by a few powerful actors are unsupported by any evidence provided here or
discernably elsewhere. Additionally, to state that all outcomes are positive for
consumers, farmers and the environment is a lie in the face of evidence of even one
farmer committing suicide after growing failed Bt-crops in India, or the appearance of
weeds and pests resistant to Roundup and Bt-crops. Whether or not GM crops are
benefitting the food system overall, to state that there are no negative outcomes is
arrogant at best. As a spokesperson Chassy is an interesting choice, then, for the New
York Times to cite as a supposedly neutral and credible scientist in the position to criticize
the motives and methods of another. The New York Times article goes on to provide any
further evidence it can find of the fallibility of the study:
Some critics pointed out that the new findings contradicted other studies. One
review of long-term studies, published earlier this year, concluded that those
studies did not present evidence of health hazards.
Dr. Chassy said that people and livestock had been eating genetically modified
grains for years without evidence of the high death rates and tumors in the study.
''Curious that no increase in tumor incidence has been reported in animals eating
large amounts of such grains,'' he said.
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David Spiegelhalter, a professor at the University of Cambridge specializing in the
public perception of risk, said the numbers of animals in each group was too low to
draw firm conclusions.
Another red flag for some scientists was that higher doses of the crop or the
herbicide did not cause more harm than lower doses, which would have been
expected if the crop or the chemical were truly harmful.
Dr. Séralini's work has been questioned before. A review of one of his studies by
European authorities concluded that his statistical methods ''led to misleading
results'' and that his study had not raised new issues about the safety of the crop.314
Such a long and detailed exploration of the possible flaws of a study published in a
respected peer reviewed journal, as this study is, is an unusual undertaking for a
mainstream newspaper such as the New York Times to take on. Taken one at a time, also,
the claims are not unusual for scientific studies as a whole: for instance the point that
there are other studies that contradict the conclusions of this study—well there usually
are conflicting findings in bodies of scientific literature. If the author of the article is
interested in informing readers about various findings on the issue and the scientific
uncertainty surrounding it, then the findings, methods and reputation of the groups
conducting this opposing study would be discussed here as well. Instead the existence of
possible conflicting evidence is offered up solely to provide evidence to undermine the
credibility of the Seralini study. As far as the use of unscientific, casual observation of
Chassy having never heard of incidence of tumors in livestock eating GM grain—casual
observation is not usually presented as a legitimate contradiction of scientific evidence.
Also cited as evidence of the lack of credibility of the study is the point that Dr. Seralini’s
work has been questioned before—in a field so embroiled in controversy is it evidence of
bad science that a scientist’s work has been questioned in the past? Seralini is quoted
once in the article, saying “the results are really alarming,” in a quote given to another
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group in a telephone news conference. He is not consulted to respond to critics of his
methods or findings, nor is anyone else consulted who might support them. The only
other quotes are from Chassy, one other critics of the study, with an additional reference
to “another red flag for some scientists” implying a general dismissal of Seralini’s work
with no clue given as who these other scientists might be. The scientific legitimacy frame
implemented by the author of this article appears to be geared entirely towards
undermining the credibility of the study rather than providing information about it in any
real sense.
This analysis is not intended to settle the question of whether Seralini’s study is
conclusive in proving health risks of GM food, but solely to point out the unusual nature
of the New York Times article going so far in attempting to undermining a scientific
article published in a peer reviewed journal. In contrast, in the 2,4-D article analyzed
above, the New York Times reported on an industry funded study taken by the EPA at
face value in proving that 2,4-D is not dangerous to human health. Although the article
gave some detail as to the methods, no conflicting reports on the legitimacy of the science
was provided, while studies cited by the group asking the EPA to ban the chemical were
breezed over without any detail.
The release of the Seralini study was quite close to the end of the time period of
this analysis, so the entire controversy (which lasted months) will not be included in this
analysis. The available evidence within the parameters of this analysis time frame gives
enough of a snapshot of the subsequent arguments to illustrate the controversy. Of the
four pro-biotech organizations the Agricultural Biotechnology Council (ABC) is the only
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one to have published material on this topic within the time frame of this analysis. The
press release argues that many studies have found GMOs safe, they are “rigorously tested
for safety, and that farm animals and humans around the world have eaten many GMO
meals without incidence of harm.” Nature reveals, though, that only about a dozen other
long term studies have been done that have not found such results, and these studies on
different GM crops than those in question in the Seralini study: “the rats were monitored
for two years (almost their whole lifespan), making this the first long-term study of maize
containing these specific genes.”315 This reveals that this study has never been done by
the industry or anyone else, so reassurance that such studies have been done before with
different results is simply not true. The New York Times, though, in its article cited above
claims “Some critics pointed out that the new findings contradicted other studies. One
review of long-term studies, published earlier this year, concluded that those studies did
not present evidence of health hazards.” This claim, that the research contradicts other
studies, then, is used in the loosest possible way. The research perhaps “contradicts”
other studies done on other GMO foods and/or possibly over a significantly shorter time
period, since most studies on GMO toxicity for government approval are done for 90
days, not two years. This further reveals a bias in the New York Times article towards
undermining the importance of the findings, in line with biotechnology industry PR, over
transparently reporting on the results.
The ABC press release also states that although the organization has not yet studied
the research closely,
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Media reporting this story should be aware that some of the researchers behind the
study are closely associated with anti-GM campaigning groups. . . . The funding of
the research should be carefully considered, as should the commercial motivations
of parties involved and the motivations of political figures associated with the
study.316
This is an attempt to undermine the credibility of the research even without the
organization having examined the study, and saying nothing about the methods or results,
but preemptively the research should be dismissed because of the researchers ties with
groups and funding. Following that logic we would have to reject any research funded by
the biotechnology industry or those associated with the industry, which would be the
greater body of scientific research on the topic since the industry limits the research that
can be done on its products based on its patent rights. An article from Yale Environment
360, details this industry obstructionism. The article reports on an anonymous letter to the
EPA from 24 scientists warning that the industry exercises so much influence over
research that scientists could not do their jobs properly.
In a paper co-authored (non anonymously) by nine of the 24 researchers and
published last month in GM Crops, the scientists elaborated upon their grievances.
Research restrictions, they wrote, preclude public scientists ‘from meeting their
obligations to the American crop producer and ultimately the consumer.’ The
system, as it now stands, ‘sets up an uneven relationship where industry partners
may unduly influence the way research is designed and disseminated.’ Even once
an agreement has been successfully negotiated, they wrote, there’s no guarantee
the company won’t withdraw its participation if the results appear to be
unfavorable to its product.317
Given the level of control that the industry wields over research on its products, it is
patently absurd for its spokespersons to argue that research should not be trusted based on
a bias against the industry that another researcher holds, or the funding of that outside
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research. Nonetheless these challenges to the legitimacy of the researcher, despite peer
review approval and publication, made it into mainstream media coverage of the study.
The industry is, in fact, correct in pointing out that funding and association of
researchers affects the outcomes of research in this area. A study, published in Food
Policy, examined 94 objectively chosen articles written on studies that
involved or considered consumption of the GMO product by animals or humans
with the intention of measuring a biological response or involved data collection
on participants or from an uncontrolled or natural environment without the
intervention of the investigator.318
The study concludes,
through statistical analysis of a selected population of studies in the described area,
it could be shown that a combined analysis of COIs [conflicts of interest] through
professional affiliations or direct research funding are likely to influence the final
outcome of such studies in the commercial interest of the involved industry.319
Indeed this is precisely the reason it is important to consider studies conducted by
scientists not affiliated with the biotechnology industry.
GM Watch published many retorts to media coverage of the Seralini study, one of
which, titled “Study Backlach a Barrel of Red Herrings” and originally published by the
Organic Council of Ontario, responding to criticisms of the actual research, some of
which were included in the New York Times article, above: “What Dr. Clark found was
that many of the criticisms about the study design could equally be said of studies used in
the biotech sector to request GM food approvals.” 320 The article goes on to detail
criticisms of the study that were used to undermine its credibility—the type of rats used,
the number of rats used, and the unlimited food they were allowed—and points out that
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they match the methods of the industry. The main thing that didn’t match was the two
year trial period rather than the 90 days used by the industry.
Dr. Clark also notes in her paper the use of ‘third party authorities’ in response to
the new study. A third party authority is a respected person, such as a leading
member of the community, whose views on a controversial subject are accepted
simply because of their position. ‘Most of the academic and institutional
commentators participating in the attack on Seralini’s work have never conducted
original research into the health effects of GM crops,’ writes Dr. Clark.
‘Nonetheless, the authority of their titles accords the aura of impartial purveyors of
sound, scientific reason.’321
It is beyond the scope of this analysis to attempt to determine the veracity of the scientific
claims on either side of the argument, but what is apparent is that the New York Times, in
its coverage of the study, disregarded arguments in defense of the study that link the
methods to those that the industry itself uses, and instead chose to amplify only those
voices that challenged the legitimacy and integrity of the study.
The way that newspapers choose to report some science stories and not others,
and the choices, when reporting these science stories to either present the conclusions in
an entirely unchallenged way, or presenting the conclusions with a collection of
handpicked evidence and quotes contradicting those conclusions, goes a long way in
leading readers to certain conclusions about the “truth” of the matter at hand.
This technique allows newspapers to present some scientific studies as if they are
uncontested truth, picking which of these studies to print and which of these studies not
to print spins a powerful narrative of truth that excludes a lot of uncertainty and scientific
debate around these issues that would disturb the industry message of scientific
consensus. When a newspaper does, then, choose to contest the conclusions in a study, it
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sends a strong message to the reader downplaying the findings of the study and ultimately
damaging the reputation of scientists conducting the study. This damage, whether based
in reality or not, can then be used by powerful interests to discredit subsequent studies by
the same scientist, as seen in the case of Seralini.
This treatment of science stories is consistent with Tankards conception of
framing, as referenced above, as “a central organizing idea for the issue that supplies a
context and suggests what the issue is through the use of selection, emphasis, elaboration
and exclusion.”322 These science stories are framed to emphasize a particular point of
view, that of the biotechnology industry through the systematic decisions that are made
about which stories will be reported and which won’t—an example of framing through
selection and exclusion—as well as when and how to elaborate on the details of scientific
studies for example and who supports or contests their findings—an example of framing
through elaboration and emphasis.
Insight into why reporters make the choices they do in framing of stories like the
Seralini study can be found in Herman and Chomsky’s analysis of “Flak and the
Enforcers.” Herman and Chomsky explain, “flak refers to negative responses to a media
statement or program. It may take the form of letters . . . phone calls, petitions, lawsuits,
speeches and bills before Congress and other modes of complaint threat and punitive
action.”323 If the flak is produced by groups with substantial resources, the authors go on
to explain, it can be costly or uncomfortable to the mainstream media. If initial reactions
by powerful groups such as biotechnology industry organizations and their spokespersons
are demonstrably negative, as was the case with the Seralini study, it is not unlikely that
the New York Times would heavily qualify their reports on the study with the input from
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these voices in order to avoid potential flak produced by coverage of the study. Indeed,
the Propaganda Model elaborates, “if certain kinds of fact, position, or program are
thought likely to elicit flak, this prospect can be a deterrent.”324 The New York Times
might have received flak in researching the article about the study, or have perceived that
flak from the biotechnology industry was inevitable, and thus framed the story in the way
they did in order to minimize flak towards the publication itself by portraying the
research as not necessarily legitimate.

The Scientific Legitimacy Frame
The article about the Seralini study in the New York Times is an example of the
Legitimacy of Science frame. In this context the frame was used to challenge the
legitimacy of a scientific study that contradicted industry science. Another use of the
frame is to emphasize the superior legitimacy of science overall as a framework for
evaluating the value of the technology over other types of arguments, as illustrated in this
quote from AgBioWorld coverage:
The Bt eggplant decision was not science-based, even though there are scientists
like Dr. Swaminathan who supported the moratorium. In general, one can say that
the objections of these scientists to the deregulation of Bt eggplant were based on
ethical positions, not on science.325
The biotechnology industry uses the scientific legitimacy frame extensively throughout
its literature as illustrated by figure 6. The frame is particularly prominent in the materials
from the industry-funded non-profits, representing the most important frame (46% of
articles) in the AgBioWorld coverage and second only to the UT/P frame (43%) in the
CropGen coverage (35%).
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The industry uses the scientific legitimacy frame for a number of different
purposes, one of which is to discredit those who speak out against or contradict the
industry in any way. Challenging the credibility of scientific studies, as illustrated above,
is one part of this tactic, another is to characterize those who disagree with industry
messaging as anti-science or as holding these views as a result of their lack of scientific
education. Examples of this from AgBioWorld coverage are plentiful: “Luddite
objections to technological progress can really threaten mankind's survival particularly
when there is no valid reason for objection to the science involved,”326 and
with every potential scientific advance, especially one that involves genetic
modification - or ‘messing with nature’ as the environmental zealot would have it there is often a small group of underemployed, stunt-loving and trust-funded
activists all too keen to don a naff costume and put a stop to it,327
and
occasionally you just have to stop and ask yourself what the public has against
scientific progress.”328 CropGen articles mimic this tactic: “Germany, to its shame
in view of its earlier scientific reputation and standing as well as to its ultimate
disadvantage, wants to bury its head in the sand,329
and
One wonders how long this pantomime can go on as the European Union fails
once more to develop anything close to a sensible attitude to agricultural
biotechnology in the face of entrenched economic and political positions and, it
seems, a woeful lack of scientific understanding,”330
and “Responding to the bleating of activists, policymakers have subjected the testing and
commercialization of genetically engineered crops to unscientific and draconian
regulations, with dire consequences.”331 Examples of this tactic in the literature are far
too numerous to provide an exhaustive list here.
The literature published by the anti-biotechnology activist groups, though, does
not support this anti-science characterization of their arguments. The dominance of the
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Human Health, Economic, Environment and Effectiveness of Technology frames in these
groups’ literature, as illustrated by figure 9, indicate a reliance on science to make
arguments within these frames. In fact, less scientific frames such as the moral (OCA 2%,
GM Watch 6%) and humanitarian (OCA 4%, GM Watch 3%) frames are less frequent in
this literature than in biotechnology industry literature with Humanitarian frame
occurrence of UK 13% and US 20% and Morality UK 8% and US 9%. The frames
themselves are not conclusive evidence of this, but examination of the literature confirms
this theory. Examples that support this are numerous, from OCA: “The new industry
approaches to controlling weeds in soya, maize and cotton mean that dependence on
glyphosate looks set to continue despite mounting scientific evidence about its safety for
farmers, people, wildlife, the soil and water supplies,”332 and “Even as increasing
scientific evidence concludes that biotechnology and its arsenal of genetically modified
crops may be doing more harm than good, companies like Monsanto are still pushing
them hard and they are getting help from the U.S.”333
Monsanto strong-armed the EPA into accepting a 20 percent refuge requirement,
even after an independent scientific panel convened by the agency had
recommended a 50 percent buffer. In a Nature article from the time, available here,
scientists involved in the panel express rage at the EPA's cave-in.334
GM Watch articles follow a similarly scientifically driven set of arguments:
The judge also noted in his ruling . . . ‘The defendant [Monsanto] created improper
and misleading advertising because they hyped a product, the sale of which was
banned in Brazil, and did not clarify that its alleged benefits are much disputed in
scientific circles, including serious studies with findings opposite to those
advocated by Monsanto,’ he concluded,335
and
Independent studies have shown that basing health assessments on flawed
scientific assumptions is not only arrogant, but foolish. Scientific studies dating
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from the 1990s have identified Bt toxins as potent immunogens, with Cry1Ac
inducing immune responses in mice similar to the cholera toxin,336
and
The reason we cannot get a reality-based conversation started on GMOs is because
we have precious little independent science on their effectiveness or safety. We
know so little about GMOs' safety or efficacy because global ag biotech firms like
Monsanto, Dow and DuPont actively suppress science under the heading of
protecting ‘confidential business information.’ Companies routinely deny
scientists' research requests and suppress publication of research by threatening
legal action, a practice one scientist describes as ‘chilling.’ ”337
These examples are also too numerous to fully catalog here, since references to science
and litigation are the largest portion of this literature as the framing chart for anti-GM
groups shows.
The mainstream press, though, tend to perpetuate the anti-science, uneducated
image of anti-GMO campaigners that the biotechnology companies promote. This
phenomenon is highlighted by the separate debates going on in the UK and the US over
genetically modified food. Figure 10, below, illustrates the different frames in all of the
UK and US coverage combined:
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Frames by Country
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Figure 10: Frames by Country

Figure 10 illustrates the major differences between the information produced by the US
organizations and the UK organizations. One notable difference is the presence of 18
articles (10%) with a consumer choice frame in the US, vs. four in the UK. The human
health frame is also more important in the US, at 43 (24%) articles vs. 28 in the UK
(11%). In the UK The UT/P frame was the strongest with 67 articles (30%), and
legitimacy of science was second at 63 articles (26%) (vs. 22 articles (13%) in the US.
The most important current event going on during the study time frame involving GMOs
in the US was the GMO labeling debate that was building towards the November 2012
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election in which GMO labeling initiative, Proposition 37, was on the California state
ballot. The anti-biotech activist groups framed this debate as an issue of consumer choice
and human health (explaining the higher incidence of these frames in the US than in the
UK), and by the industry as an economic and public opinion issue. The most important
GMO related event going on in the UK was the GM wheat trial being conducted by
Rothamsted Research. This debate was framed by the biotechnology industry as a public
opinion issue as well as UT/P and legitimacy of science (explaining the higher incidence
of these frames in the UK than in the US). Beyond subject matter, these two debates are
very representative of current attitudes and state of the public debate on GMOs in each
respective country. Both debates are marked by the characterization of anti-biotech
activists by the biotechnology industry as representing an anti-science faction, as
discussed above, thus these debates will also serve to illustrate the adoption of these
attitudes by the mainstream media.
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The US Labeling Debate
Figure 11, below, shows the number of articles from each source (in orange) that
discusses labeling in any way.
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Figure 11: shows number of articles with a labeling topic in orange with the grey representing the rest of
the articles that do not discuss labeling

This chart illustrates the comparatively higher focus on GMO labeling in the US sources.
Some of the UK sources have a slightly higher level of labeling discussion, for CropGen
this is a result of three articles about labeling in the US and three about labeling
elsewhere (France, Japan, Codex Alimentarius GMO labeling parameters). The GM
Watch articles, though, largely take up the US labeling debate while also mentioning
labeling elsewhere (South Africa, UK labeling rules on GM in animal feed etc.)
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The Organic Consumers Association has more articles, in quantity (35) and by
percentage (35%) than any of the other sources. This is because the OCA was a strong
supporter of GMO labeling, publishing many petitions, opinion pieces, any mainstream
coverage of the issue etc. During this time California Prop. 37 was an issue the OCA was
pushing hard. For the OCA the top 3 frames were Consumer Choice (14, 40%),
Economic (10, 29%), and Human Health (10, 29%). Consumer Choice was the main
frame the group was promoting, while the Economic frame was a frame that the group
adopted primarily in order to refute the arguments made by the industry, that the law
would make consumers grocery bills rise.
The US biotechnology industry, with less overall focus on labeling, used the
economic frame (8, 67%) and the legitimacy of science frame (5, 42%) when discussing
the issue, with very little adoption of the consumer choice frame, (1, 8%), and a little
more use of the slightly different, public opinion frame (2, 17%).
The Wall Street Journal includes one article on GMO labeling in its food
biotechnology coverage. The article is titled
“Corporate News: Foes of Genetically Modified Foods Seek Vote on Labeling in
California.”338 This title immediately positions those pushing for GMO labeling as foes
of the industry, othering them and giving them a negative connotation. The article goes
on to use a neutral tone and a public opinion frame. The article introduces the measure by
saying that it would require labeling of products with GM ingredients, says the backers of
the initiative say that have double the votes to get it on the ballot, talks about other states
who have proposed labeling in the past, none of which passed, discusses the lack of fuss
Americans have made thus far about GMOs comparing them to Europeans and others
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who remain “skeptical” and require labels. The FDA is cited as saying they are no less
safe than conventional foods. The article then informs readers who the opponents of the
measure are, and explains their argument,
Opponents of the initiative say the labels would mislead consumers into thinking
there are health risks associated with the products. ‘Food manufacturers who
believe their customers want such information can label their products if they
choose to do so,’ Monsanto spokeswoman Sara Miller said.
The article ends with another reference to the critics of GE food, telling of their
confidence they could win, the favorable venue California provides and the opinion polls
that show an overwhelming majority of Americans support labeling. While the reasons
not to have labels from the opponents of the measure are mentioned, nowhere in the
article does it explain what the supporters’ arguments for labeling are.
The New York Times covers the labeling debate in more depth than the Wall Street
Journal, with five articles mentioning the labeling proposition. The first article begins
with a description of farmers in a courtroom who are hoping to get a court ruling that
would prevent Monsanto from suing them if GMOs contaminate their crops. This image
is followed with similar content to the Wall Street Journal article, with explanations of
the proposal, information about GMOs, public opinion, other countries’ labeling laws etc.
The article includes a similar quote to the Wall Street Journal example on health effects:
“no known health risks are associated with eating transgenic foods (though many
scientists say it is too soon to assess the effects), and the Food and Drug Administration
classifies them as safe. But consumer resistance to transgenic food remains high.” This
ordering of information makes it sound as if all evidence shows GMOs pose no risks but
illogical consumers want labeling anyway for some reason. This implies a lack of
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scientific understanding of these consumers. A quote responding to this idea is given,
“‘You don't have to be a technophobe or think corporations are evil to not want G.M.O.'s
in your food,’ said Ashley Russell, a college student who attended a rally sponsored by
Food Democracy Now after the Manhattan court hearing,” but no arguments as to why
labeling is desirable for consumers or for those promoting Prop. 37 appear in this article
either. Readers are then told, “for the most part, the spread of transgenic seeds into the
American food supply has been purposeful, carried out by farmers and scientists who see
enormous advantages in hardier plants.” This downplays the instrumental role of the seed
and chemical companies in spreading the use of the technology, making it sound as if
farmers and scientists, the experts in agriculture, all made the conscious decision to
transfer the majority of US staple crops to GMO.
Bill Gates devoted most of his annual letter on agriculture from the Gates
Foundation to the need for advanced technology. He later said that most people
who object to transgenic agriculture live in rich nations, responsible for climate
change that he believes has caused malnutrition for the poor.
This implicit criticism towards activists and those that oppose GMOs is included without
question as to the legitimacy of making those groups responsible for the suffering of the
underprivileged. The article then addresses the problem of organic crops being
contaminated with GMOs and again back to the farmers who are seeking recourse to
avoid Monsanto suing them for GMO contamination, although the article assures us that
“But the real issue here is not patent law; it's contamination. The point made by the suit is
that, according to the regulations that govern American agriculture, it's these unwilling
farmers who must prevent Monsanto's products from trespassing onto their land.”339
While this article goes over a lot of information and topics, it is careful not to criticize
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patent law, to explain the benefits of GMOs and to avoid discussing the role
biotechnology industry players had in marketing intimidating and litigating to compel
farmers to adopt the technology. The article also glosses over why consumers might want
GMOs labeled and any problems about the technology other than contamination. Overall
the article gives the impression that this whole drama is because rich spoiled Americans
don’t want GMOs in their organic food, causing huge logistical difficulties for farmers
and starvation in the developing world.
A subsequent article, focusing more closely on the labeling debate begins with the
image of a woman sneaking through the grocery aisle labeling foods with homemade
stickers that say “Warning: May contain GMO’s.” The article explains that Americans
have been eating GMO’s for years and
Regulators and many scientists say these pose no danger. But as Americans ask
more pointed questions about what they are eating, popular suspicions about the
health and environmental effects of biotechnology are fueling a movement to
require that food from genetically modified crops be labeled, if not eliminated.
Again the language here sets up the juxtaposition of the views of scientists and regulators
vs. the flimsy “popular suspicions” of consumers. The article then repeats the usual
background info about GMOs, other states that have proposed labeling etc., discussing
the amount of money likely to be spent on political ads for and against the proposition
and who the supporters and opponents are. The first instance of an argument for the
labeling is provided halfway through the article, “Supporters of labeling argue that
consumers have a right to know when food has been modified with genes from another
species, which they say is fundamentally different from the selective breeding process
used in nearly all crops,” although this doesn’t elaborate on the reasons that supporters
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suggest consumers might want to know. “‘It just makes me nervous when you take
genetic matter from something else that wouldn't have been done in nature and put it into
food,’ said Ms. LaPier, 44, a mental health counselor whose guerrilla labeling was
inspired by the group Label It Yourself.” This quote furthers the non-fact based, nonscientific nature of quotes from those in favor of labeling. This vague nervousness
inspired by GM crops as the driving force behind the opposition is exactly the image the
biotechnology industry perpetrates. This quote is followed by the information that “The
F.D.A. has said that labeling is generally not necessary because the genetic modification
does not materially change the food,” and further,
Farmers, food and biotech companies and scientists say that labels might lead
consumers to reject genetically modified food -- and the technology that created it
-- without understanding its environmental and economic benefits. A national
science advisory organization in 2010 termed those benefits ‘substantial,’ noting
that existing biotech crops have for years let farmers spray fewer or less harmful
chemicals, though the emergence of resistant weeds and insects threatens to blunt
that effect.340
This argument for these “benefits of GMOs” that consumers supposedly are ignorant of,
without any mention of the various publicly acknowledged problems such as weed and
pest resistance that make these functions considerably less effective, combined with a
litany of repetitively vacuous quotes from those promoting labeling creates the
impression, that the industry promotes, of silly activists and ignorant consumers all
emotionally responding to scary new technology without any real reasons for their ideas.
The subsequent labeling article is centered on the amounts of money donated for
and against the labeling laws and the reactions of consumers to those donations.341 While
this article doesn’t discuss the financial motives that the biotechnology industry has for
trying to avoid labels, it does point out, with reference to organic brands and why they
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might donate to the labeling campaign, “what is left unsaid is that it may also be a
marketing advantage for organic companies, distinguishing them from conventional food
producers.” Another quote warns of financial consequences for consumers:
last week, the organization released a study it had commissioned that estimated the
initiative would add $1.2 billion in costs for California farmers and food
producers. Ms. Fairbanks said that the higher costs could add as much as $350 to
$400 to an average family's grocery bill. In addition, she said, the opponents
believe the labeling would heighten what they call unfounded concerns about the
safety of genetically engineered crops.
These arguments, as well as the usual information about how Americans have been eating
GMOs for more than a decade and the reassurance that “regulators and many scientists
say they pose no danger,” juxtaposed again against vague arguments about consumers
deserving to know, but not elaborating on why they would want to know, again frames
the issue as largely based on popular opinion vs. scientific fact, with the possibility of
paying more money for something for which the value is unclear.
The next article on the subject is an editorial by Mark Bittman called “G.M.O.’s:
Lets Label ‘Em.” Bittman makes several detailed arguments including that most people
want labeling, that it would create more competition and perhaps promote research on
GMOs that the industry currently controls, and finally that it is a right to know law:
genetically engineered food is so terrific, persuade us; if it's not, well, fine. . . . I
want to know - quite technically, in all the detail available - how my food is
produced, and I'm far from alone. We'd be able to make saner choices, and those
choices would greatly affect Big Food's ability to freely use genetically
manipulated materials, an almost unlimited assortment of drugs and inhumane and
environmentally destructive animal-production methods.342
Bittman largely stays within the bounds of arguments that would appeal to most anyone
and makes a pretty good case for labeling without really getting into any details about
why people object to GMOs. While this is a convincing and measured argument, it likely
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appeals more to people that agree with Bittman already and not to those who are
unfamiliar with arguments against GMOs that are largely not covered in the mainstream
media.
Bittman’s editorial is followed by a letter to the editor, ostensibly responding to
his arguments, but instead of addressing Bittman’s idea about the effects of labeling—
essentially that they would certainly not ban GMO’s, and that if they are needed to feed
the world as proponents argue it wouldn’t stop them. Instead his critic makes all of the
common claims about GMOs, omitting any of the possible down sides:
We need genetically modified organisms. They keep insects and weeds from corn
and soybeans. New crops can resist droughts, floods and heat coming with climate
change and provide vitamins and nutrients. Nothing erodes life and peace more
than poverty, and hunger is its expression.343
The lack of details regarding the debatable nature of these claims and the research that
contradicts them in Bittman’s editorial, the previous 3 articles about labeling or this
letter, leaves these claims unchallenged in this coverage despite the activist focus on the
questionable efficacy of the technology in doing what it claims, the observed increase in
the use of agrochemicals with the adoption of GM crops by some scientists, the human
health effects of the pesticides involved in this kind of farming and the level to which
they contaminate drinking water and out bodies, are all left unmentioned. To a reader
without any other background knowledge about the issue, it would seem driven by a
bunch of paranoid, wealthy, organic eating yuppies who are demanding extra labels at the
cost of higher food prices for everyone and the continued suffering of those starving in
the developing world.
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The labeling arguments made in the Organic Consumers Association also focus
on the consumer choice frame, with a much richer context than appears in mainstream
media coverage. OCA publishes many different articles about a variety of topics, largely
news about negative effects of GMOs internationally, failures in the fields, scientific
studies challenging their effectiveness, questioning the veracity of industry claims
regarding their economic value to farmers, and refuting the claim that alternatives will
not be able to feed the increasing world population. This context is important for
understanding why labeling would be desirable. Additionally, the body of OCA articles
that mention the labeling measure also have a strong human health frame, which does not
appear in mainstream media coverage, as demonstrated above. For instance,
‘Californians have a right to know what's in the food we eat and feed our children,’
says Robyn O'Brien, author and founder of the Allergy Kids Foundation. ‘I support
labeling genetically engineered foods because allergy-sensitive people can exercise
caution with essential information to make informed decisions about what they
eat,’344
and
‘Genetic engineering adds completely new elements into our food. Because the
FDA has failed to require labeling of GMO food, this initiative closes a critical
loophole in food labeling law. It will allow Californians to choose what they buy
and eat and will allow health professionals to track any potential adverse health
impacts of these foods.’ says Andy Kimbrell, Director of the Center for Food
Safety. ‘Genetically engineering food can cause unintended consequences and
because there have been no long term studies, we are unsure of how GMOs may
affect our health.’345
OCA coverage includes logical arguments such as these that frame the scientific
uncertainty about health effects and allergies in a way that is reasonable and cautious
about potential risks, not based on vague anxiety as the mainstream media and the
biotechnology industry imply.
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The mainstream media dispenses with any human health issues implied by the
labeling controversy with the repeated statements of safety from the FDA and most
scientists, not delving any more deeply into these arguments than that. Stripping the
argument for labels of all of this context, as the mainstream coverage largely does, and
just offering the argument of consumer choice, undermines the logic behind the labeling
argument for those readers who do not have at least some knowledge of the issue beyond
the explanation given by the labeling articles analyzed above, weakening the labeling
argument for a mainstream audience.
The mainstream media in the UK did not pick up on the US labeling debate at all
during the time period under analysis. The only mention of the US labeling debate is in a
letter to the editor published in the Times, contradicting the popular claim found
repeatedly in the Times coverage that in the US and the rest of the world there is no
controversy about GMOs. The letter in question cites US protests in favor of labeling as
evidence of growing worldwide concerns about the environmental and health effects of
GMOs.346 The lack of mainstream mention of the US GMO labeling debate in UK news
coverage has the effect of downplaying controversy about GMOs elsewhere in the world
and largely allows claims that the EU is the only place left in the world where GMOs
aren’t embraced to go unchallenged in this coverage.

The UK Wheat Trial
While GM Watch published a sizeable number of articles on the US labeling
debate, the Organic Consumers Association is more oriented towards the domestic
biotechnology debate, and thus there are no mentions of the Rothamsted wheat trial
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controversy in the OCA sample. The New York Times mentions it in passing once in one
of the GMO labeling articles, in order to illustrate Europeans’ attitudes on GMOs in
contrast to those of US Citizens, and Wall Street Journal does not mention it once. This
controversy is a very national one, in tone, tactics and language, and nearly consumes the
UK mainstream coverage of GM food entirely.
The role of GM Watch in the debate is almost solely to respond to coverage of the
controversy in the UK media, in contrast to the role of antagonist that OCA played in the
labeling debate at the same time. On March 1st, 2012 GM Watch published an
announcement of a new campaign “called ‘GM Wheat? No Thanks!’ – to protest the
Government’s approval of an open-air field trial of GM wheat at Rothamsted Research in
Hertfordshire,” calling on “individuals, farmers and food businesses to pledge not to use
or buy GM wheat, and demands that research money to be directed to more sustainable
food production methods.”347 The campaign description makes no mention of the planned
protests, which were not orchestrated by GM Watch. Each subsequent article in the GM
Watch sample is in response to media coverage of a protest of the wheat trials.
The Times first mention of Rothamsted is an October 13 letter to the editor called
“GM Science Plea” from a group of scientists at the Rothamsted Research Centre and the
John Innes Centre. Both of these groups are mentioned in unrelated articles as having
received a grant to study GM crops. The letter goes through the usual arguments about
the growing population and the need to feed it, and then goes on to criticize EU GM
regulation: “Irrational and unwarranted obstacles that obstruct the deployment of this
useful technology retard innovations that will increase yields and reduce the
environmental impact of agriculture,” and further to criticize environmental and activist
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groups who opposed GMOs: “Irresponsible and perhaps well-meaning pressure groups
are preventing delivery of agrichemical-free solutions to crop pests and diseases.”348
Shortly after, on October 20th, a letter from Professor Anthony Trewavas is
published defending GM crops. The letter is a rebuttal to another reader letter claiming
that GMOs promote monocultures from Patrick Holden at the Sustainable Food Trust.
The letter ends with another jab at anti-GM activists: “I found it impracticable to get GM
opponents who lack any scientific training to understand the importance of acting on
established, evidence-based knowledge.”349
This letter was followed by a November 1st editorial by Matt Ridley, in which he
assures readers that population growth will slow and we will be able to feed the world
population, unless the worst happens: “The greens may win the argument for renewable
energy and demand vast acreages for their expensive toys - Renewistan, as the inventor
Saul Griffith calls it. The Luddites may prevent innovation from raising food yields and
drive us back to land-hungry organic farming.”350 This letter follows the formula of
claiming a need for GM crops, warning about dangerous green activists and calls those
who oppose GMOs Luddites, in other words anti-science.
These are followed, on November 7 by an article co-written by professor Chris
Leaver and professor Vivian Moses, objecting to what they see as a neglect in
government and a Times article, to the benefits of agricultural biotechnology: “but the
prospects and need for biotechnology in agriculture, in a world with more than one
billion starving, perhaps outweigh all the others combined and there the Government is
totally silent, as indeed are you in your leading article.”351 The article generates flak
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against the journalist and the government for not properly championing agricultural
biotechnology.
On March 12 a letter is published written by a Martin Livermore from the
Scientific Alliance Cambridge. The letter mentions food security in a world of 9 billion,
and then gives the inevitable anti-science speech:
political elites are swayed by the green lobby's emotional arguments. Such
entrenched attitudes make Europe increasingly out of step with its competitors. We
try to stop the clock on the continuing trend towards more efficient farming while
farmers in Asia and the Americas avidly take the best technology on offer. We set
unachievable targets for renewable energy while China forges ahead with building
new power stations to run factories in sectors we can no longer compete in.352
The accusation that anti-GM and environmental activists base their arguments on their
emotions appears yet again here.
The next Pro-GM letter is written by Dr. Giles Oldroyd, identified as a plant
biologist at the John Innes Centre, and makes a similar argument:
We are seeing a revolution in biology - we have a choice whether we use new
technologies to create a more sustainable future in food production, or whether we
allow a fear of innovation to dictate a future using out-dated approaches that hurt
our environment.353
Finally, a May 23 opinion column by Colin Blakemore, regarding the Rothamsted
wheat trials, argues for tightening laws against activism in the name of feeding the
growing world population,
GM food science is moving at an astonishing rate. And it needs to because it is,
potentially, the engine of the revolution in food production that the world
desperately needs if it is to cope with the lethal mix of global warming, the energy
crisis, water shortages and exploding population. . . . The Government knows that
our future recovery depends on discovery and innovation. It wants more of our
children to study and make their careers in science. But unless it makes criminality
in the name of anti-science unacceptable, how can it expect young people to
devote their lives to a career that can be ruined by those with no mandate other
than hatred of science?354
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Here we see the same formula: we need GM crops to feed the world, activists are ruining
it, and activists are against science. Here the author goes the extra step in suggesting that
the government make activism illegal.
These letters appear to be the work of a diverse group of scientists all interested in
promoting the public good. They all use the same arguments and agree with one another
because that must be the scientific consensus on the issue and it must be the truth. What
the bylines on these letters and editorials don’t reveal is that the majority of these letters
are written by members of a group called Sense About Science. Anthony Trewavas, Matt
Ridley, Chris Leaver, Vivian Moses, and Colin Blakemore are all associated with the
group. Chris Leaver is on the board of trustees and the rest serve on its advisory
board.355356 Martin Livermore, a PR consultant, and Vivian Moses are also part of the
Scientific Alliance, a corporate front lobby group started by a PR agency. The two
organizations have a history of working closely with one another.357 The two letters that
were not directly connected through their authors to Sense About Science were the
Science Plea from the group of scientists from the John Innes Centre and Rothamsted
Research and the letter by Giles Oldroyd of the John Innes Centre, also a signatory on the
first letter. Jonathan Jones, the first signatory on the letter shows up all over the sense
about science website, doing interviews, serving on panels etc. Jones has also been
accused of hiding his business ties to Monsanto and other biotechnology companies.358
The John Innes Centre and Rothamsted Research were both recipients of grants to study
GM crops during the period under analysis. There is also evidence that Rothamsted
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Research is working with Sense About Science on a PR campaign to win public
sympathy in the UK for the wheat trial. As GM Watch points out:
the head of Rothamsted's GM wheat team, Prof. John Pickett, appeared in a
Newsnight debate, he was flanked by Tracey Brown, the media-savvy head of the
lobby group Sense About Science which has been at the heart of the PR campaign.
It is Sense About Science who kicked off the high profile 'Don't Destroy Research'
campaign with a highly emotional appeal from the Rothamsted researchers on
YouTube linked to an online petition calling on the protesters not to damage the
trial.359
George Monbiot wrote a column in 2003 about a group, subsequently referred to
as the Revolutionary Communist Party (RCP), who moved “from the most distant fringes
of the left to the extremities of the pro-corporate libertarian right. While its politics have
swung around 180 degrees, its tactics - entering organisations and taking them over appear unchanged,” Monbiot explains, citing their 1988 launch of a publication called
Living Marxism (LM). Monbiot catalogs the group’s activities:
LM described its mission as promoting a ‘confident individualism’ without social
constraint. It campaigned against gun control, against banning tobacco advertising
and child pornography, and in favour of global warming, human cloning and
freedom for corporations. It defended the Tory MP Neil Hamilton and the Bosnian
Serb ethnic cleansers.
Monbiot then presents a complicated web of associations linking Living Marxism to
Sense About Science:
Let us begin with the Association for Sense About Science (SAS), the lobby group
chaired by the Liberal Democrat peer Lord Taverne, and whose board contains
such prominent scientists as Professor Sir Brian Heap, Professor Dame Bridget
Ogilvie and Sir John Maddox. In October it organised a letter to the Times by 114
scientists, complaining that the government had failed to make the case for genetic
engineering. In response, Tony Blair told the Commons that he had not ruled out
the commercialisation of GM crops in Britain. The phone number for Sense About
Science is shared by the "publishing house" Global Futures. One of its two trustees
is Phil Mullan, a former RCP activist and LM contributor who is listed as the
registrant of Spiked magazine's website. The only publication on the Global
Futures site is a paper by Frank Furedi, the godfather of the cult. The assistant
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director of Sense About Science, Ellen Raphael, is the contact person for Global
Futures. The director of SAS, Tracey Brown, has written for both LM and Spiked
and has published a book with the Institute of Ideas: all of them RCP spin-offs.
Both Brown and Raphael studied under Frank Furedi at the University of Kent,
before working for the PR firm Regester Larkin, which defends companies such as
the biotech giants Aventis CropScience, Bayer and Pfizer against consumer and
environmental campaigners. Brown's address is shared by Adam Burgess, also a
contributor to LM. LM's health writer, Dr Michael Fitzpatrick, is a trustee of both
Global Futures and Sense About Science.360
This characterization of Sense About Science as an industry funded lobby group
run by ideologues with some decidedly non-mainstream ideas about global warming,
ethnic cleansing, gun control, child pornography etc. puts an interesting slant of the
arguments published in the Times as the opinions of an unaffiliated group of concerned
scientists. It also creates the impression that the “scientific consensus” the industry claims
to have on GMOs is something that a lot of effort has been put into fabricating.
The Times, for its part, not only supports the PR efforts of Sense About Science in
publishing these pieces, but prints several editorials, presumably reflecting the opinions
of the editorial board of the paper, based on their lack of bylines, echoing the views
expressed by Sense About Science representatives.
A leading opinion article from the Times, April 5, 2012 titled “Grain of Sense;
The world is capable of feeding a growing population with the help of science,” argues
Mouths are born hungry. The world's success in feeding itself for 10,000 years is a
testament to man's ingenuity. Now new technologies can help by creating more
sustainable ways to produce more food. This is hardly the moment to stifle that
ingenuity by spurning the promise of GM science.361
Another lead editorial, titled “Against the Grain; Threats to destroy GM crops amount to
vandalism in the service of superstition,” addresses the Rothamsted wheat trials and
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paints those opposed to the trial as operating on superstition, the enemy of science. The
editorial states, in an authoritative tone,
GM crops are no more hostile to nature than are horticulture or the domestication
of animals. The scientists at Rothamsted are conducting a wholly responsible
experiment with scrupulous concern for human and environmental benefits. Yet
some campaigners against the Rothamsted experiment aim to ‘decontaminate’ the
crop of GM wheat. That is a euphemism for destroying it. Fortunately, the police
presence thwarted them from accomplishing what in any normal endeavour would
be termed vandalism in the service of ignorance. The value of scientific research
lies not only in practical benefits but in its ethos. Knowledge depends on inquiry.
Scientists should be defended in pursuing it.362
Vilifying protesters, calling them anti-science, ignorant and superstitious, the Times
editorial board seems to have taken up the PR points of Sense About Science with great
gusto.
The Guardian is no less enthusiastic about the Rothamsted wheat trials and
condemnation of activists protesting against it. On March 9th, 2012, the Guardian
published an article claiming a “swing on GM foods,” framing the results of a poll, in
which the number of those concerned about GM foods decreased by only 5%, in this proGM light. The article reports:
The poll comes as European countries prepare to vote on a Danish-led proposal to
allow states to ban the cultivation of GM crops on a country-by-country basis, with
Britain expected to vote in favour. There is British political support for a new push
on GM, with agriculture minister Jim Paice telling farmers in January that GM
crops could greatly help food production, and the shadow environment minister,
Mary Creagh, calling for more money for GM research.363
A quote by Maurice Maloney, the chief executive of Rothamsted and one by Mark Lynas
round out the article.
A retort, written by Bryan Wynne of the ESRC Centre for Economic and Social
Aspects of Genomics at Lancaster University, points out the oddity of the spin put on the
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article, and of the whole PR effort in which scientists seem to be lining up to make
arguments about political and socioeconomic subjects that stretch the limits of their
expertise:
The percentage of the public who say they agree that GM food "should be
encouraged" actually drops by nearly a half over the last decade, from 46% in 2002
to 27% in 2012. In my book that would be a shift in the opposite direction from
that spun by your headline. The CEO of the Rothamsted Research Institute's
statement that "the large number of 'neither agree nor disagree' answers suggests
scientists have much work to do in public engagement, if the UK public are to
benefit to the same extent as the 29 other countries who currently grow GM crops
commercially" raises a further question - why is a public scientist making
presumptive political statements in favour of GM?364
The Guardian continues to insist that public opinion on the debate has shifted, though. A
subsequent article by Leo Hickman, in the Features Pages informs readers,
In stark contrast to the widespread anti-GM mood a decade ago - an age when GM
was being described in the popular press as a ‘Frankenfood’ and protesters dressed
in bio-hazard suits routinely trampled on and pulled up test crops - it appears that
the scientists have been far more successful this time at garnering sympathy and
understanding of their work and motives. And there are signs from Europe, too, that
attitudes are - albeit glacially - starting to shift.365
The article goes on to discuss the protests to the trial, quoting the protesters extensively,
to the author’s credit, and then quoting arguments from Mark Lynas (the “anti-GM
protester who saw the light,” discussed above) and other industry spokespersons at
length.
Another news article on topic, on May 28, claims,
Much of the early opposition to GM crops was aimed at multinational companies,
especially Monsanto, whose heavy-handed approach to public concern stoked
resentment and mistrust. . . .The public sector scientists at Rothamsted Research,
who are growing an experimental GM wheat crop with no commercial backing, are
a different breed.366
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This attempt to distinguish the researchers from Monsanto and other seemingly evil
corporations is part of the PR campaign for the project, and as GM Watch points out, a
deceptive stance:
It is also hard to square the claims of the GM wheat being free of patents and
commercial interests with what Prof. Pickett told Farmers Weekly about how
companies were 'very interested' and were 'keeping a watching brief' and that 'it
could be that we generate very good intellectual property for commercial
development in the interests of the UK and European agriculture and business.'
During the Newsnight debate, Prof. Pickett claimed the wheat trial had a public
mandate because of its approval by the public funding body for the biological
sciences, the BBSRC, which has backed the trial to the tune of one million pounds.
But the BBSRC has a long history of alignment with industry, with a director of
the GM giant Syngenta sitting on their council along with a consultant for Dow
Agro Science.
And this industry alignment is perfectly illustrated by Rothamsted itself, which
partners up with corporations like Bayer, Syngenta and Dupont. It also has an
Institute Director who not only drives a Porsche with a GMO number plate but has
a c.v. to match. It is Maurice Moloney’s GM research that lies behind Monsanto’s
GM oilseed rape. He is the inventor of more than 300 patents and prior to
Rothamsted, he also successfully launched his own GM company in Canada SemBioSys Genetics Inc., in which Dow Agro Science were investors. This was
flagged up by the BBSRC when they appointed Moloney in a press release
praising his 'effective translation of research into successful business activity.'367
Nonetheless, the Guardian depicts Rothamsted as wholly different and apart from evil
corporations like Monsanto. In the same article, the author claims: “The Rothamsted
scientists have won public support. In stark contrast to the 1990s, the media
overwhelmingly condemned the campaigners' threat of vandalism.” This is a strange
argument that equates public support with media treatment of an issue. Perhaps the media
is condemning the protesters, but does this mean that the Rothamsted scientists have
public support? A subsequent editorial by a different environmental editor of the
Guardian follows a similar line of logic:
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more interesting than their failure to vandalise the plants is the important turning
point in the GM debate that this trial has revealed. Media reporting and comment
has been mostly neutral and positive about the experiments, or actively hostile to
the protesters - a far cry from the days of ‘Frankenfood’ headlines. What has
changed?
This article again contrasts the Rothamsted researchers positively against Monsanto and
concludes:
Despite acres of coverage and glorious sunshine, the protest failed to really take
off. There were an estimated 200 people at the event. But their seemingly fanatical
opposition to the GM trial set against the reason and openness of the scientists has
cast the whole GM debate in a new light.368
The same theme is taken up again in the last article about Rothamsted, a leading
editorial without a byline. The editorial tells us “It is beginning to feel as if the scientists
are winning the GM argument.” The article goes on to praise the PR of Rothamsted, its
ability to distance itself from Monsanto and it’s GM plea video that it released on
YouTube in advance of the trial. This coverage, although less overtly taking up industry
talking points as the Times did, still paints a rosy picture of the UK and Europe “finally”
“growing up” and coming around to what, supposedly, the rest of the world has been on
board with for years. None of this coverage, as mentioned above, acknowledges the fight
over GMO labeling going on in the US, international protests against Monsanto, as
detailed by GM Watch, the lawsuit against Monsanto for biopiracy in India, or the
struggles in the US with the appearance of GM resistant weeds and the associated move
of seed companies and farmers towards the use of 2,4-D since Roundup is becoming
ineffective. Similar to the labeling debate, the Rothamsted wheat trial debate remains
insulated and framed in a very limited manner, minimizing the scope of conversation
around these issues. The press latches on to the redemption story of the UK coming
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around to GMOs and repeats it over and over again. Both the labeling and Rothamsted
debates feature a lot of repetition of the same facts and arguments, making it appear to
readers that they have already heard all the relevant information about the story. This
creates a mythology around these stories as the same pieces of information and ways of
describing situations are recycled so that everyone is speaking the same language. In
many cases even if it is a point of view that is repeated enough times, it becomes a shared
knowledge and “true” in a social sense through repetition. Similarly, if a frame is
repeated enough it becomes an integral part of how an issue is approached in general.
Reese discusses the repetition and routinization of frames, which “suggests that a frame
has become second-nature, well entrenched and built into the way of doing things.”369 In
this way a certain way of approaching an issue becomes the “natural” way of
understanding it at the cost of other perspectives.
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Chapter 7: Discussion & Conclusions
As Herman and Chomsky theorize, “the mass media are drawn into a symbiotic
relationship with powerful sources of information by economic necessity and reciprocity
of interest.”370 The biotechnology industry has vast resources at its disposal that it uses to
create front groups to pose as independent bodies, stage fake protests in favor of
biotechnology and produce flak against the mainstream media when it fails to properly
amplify its PR messages. The mainstream press has pressing deadlines, limited monetary
resources that have diminished even more dramatically in recent times and a strong
motivation to avoid legal entanglements with powerful actors such as the biotechnology
industry. All of these factors put the mainstream press into a position of adopting industry
frames and viewpoints over those of less “dependable sources” like activists and
scientists who speak out against industry science. Herman and Chomsky’s argument that,
“partly to maintain the image of objectivity, but also to protect themselves from
criticisms of bias and threat of libel suits, they need material that can be portrayed as
presumptively accurate,” supports this.371 This creates a bias towards quoting
biotechnology industry sources over those with opposing viewpoints and potentially
deters journalists from exposing material such as that published by organizations like GM
Watch and OCA, that questions the veracity of claims made by the industry.
This is partly a matter of cost: taking information from sources that may be
presumed credible reduces investigative expense, whereas material from sources
that are not prima facie credible, or that will elicit elite criticism and threats,
requires careful checking and costly research.372
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If journalists use biotechnology industry information in reporting biotech related stories,
fact-checking is not as important since they will not be sued for libel by those who
disagree or know that these claims are false. If news outlets report claims made by groups
such as the OCA or GM Watch, a significantly greater level of research and
corroboration of these stories is necessary.
Cost is an important factor impacting how journalists source and report news, as
Herman and Chomsky acknowledge, and even more so since the propaganda model was
developed. Since that time media outlets have been losing financial stability, significantly
more media consolidation has occurred and news outlets have had to pursue different
models in finding ways to make their businesses profitable. This has resulted, among
other consequences, in cost cutting measures including having fewer journalists reporting
in person. 373 International news coverage and correspondents have been cut and there is
more pressure, with reporting via the Internet, to report news faster than ever.374 While
larger papers, such as those examined here, do not suffer under as extreme financial
pressure as some of the smaller ones that have closed and undergone mergers, they have
been affected by these trends in notable ways including closure of environment desks375
and acceptance of funding from vested interests.376 Shortening of deadlines and loss of
revenue have exacerbated the mass media sourcing issues theorized by Herman and
Chomsky in 1988, making many of the authors’ arguments more relevant rather than
obsolete with time.
Herman and Chomsky discuss twenty four companies who make up the top tier of
media giants in the US in 1988,377 in 2013 there are now six corporations that own 90%
of the US media between them.378 Of these corporations Herman and Chomsky write,
164

“they are closely interlocked, and have important common interests, with other major
corporations, banks, and governments.”379 In light of the level of consolidation and the
size of these corporations, then, it makes sense that mainstream media corporations
protect the interests of the biotechnology industry, another industry dominated by a
handful of massive, powerful corporations.
This analysis has demonstrated that the two papers owned by News Corp. tend to
take up the biotechnology industry’s perspective and PR materials much more blatantly,
while the adoption of industry frames and biases by the New York Times and, in many
cases, the Guardian is more subtle and often balanced by a multiplicity of perspectives.
The latter two papers were just as likely to omit important information as the News Corp
papers, but their coverage of events tended to be more “balanced,” in the conventional
news sense, than that of the Wall Street Journal and the Times. The New York Times and
to some extent the Guardian seem to fit theories about how journalistic norms operate to
inadvertently skew coverage a certain way, while the Murdoch papers’ intent to promote
one perspective over another is more blatant and feels intentional at times. The Guardian
demonstrably publishes messaging of the biotechnology industry more blatantly than the
New York Times in many instances. Perhaps a contributing factor to this skew is the
recent funding provided to the Guardian by the Gates Foundation, one of whose central
efforts currently is to push biotechnology in the developing world in a humanitarian
context. The foundation is noted, after all, for its unabashed efforts to steer media content
in the service of its humanitarian projects.380 Whatever the explanation may be, the
finding, demonstrated here, that the two papers with a reputation for embodying the very
epitome of the “liberal media” have a significant bias toward adoption of biotechnology
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industry PR, including frames, subject matter and perspective, is a much more surprising
finding than the fact that the conservative, pro-business media serve this function to an
even greater extent. This finding contributes to a body of research, including that by
Herman and Chomsky, that seeks to dispel the myth of the “liberal media,” revealing a
more accurate understanding of media as propaganda tools for legitimizing the status quo
and representing the interests of elites. This renders the labeling schema of “liberal” vs.
“conservative” a characterization of surface content, and largely a distraction from the
much more fundamentally important ways that the supposedly liberal and conservative
media promote the same underlying ideology.
Agenda building research focuses on the concept of public relations setting the
agenda for “the news media because the source in source–reporter interactions is often
either a public relations practitioner or a practitioner’s client. That is, news is shaped by
the sources on which a newsroom relies.”381 This research largely supports agenda
building theory in demonstrating the mainstream media’s dependence on the frames and
language of the biotechnology industry, while marginalizing the frames used by those
groups who work to oppose the biotech industry agenda. This research has found that the
stories that are not reported are just as important as the stories that are reported in
revealing this relationship
The number of frames implemented by the mainstream media and how they are
used is a key factor in illustrating the agenda building function of the biotechnology
industry on the mainstream media. Framing scholars have found that mainstream media
typically use no more than five frames in reporting on a particular issue,382 a trend
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consistent with the findings of this research. In this sample the media primarily used the
Economic, Utility of Technology/Progress, or the Legitimacy of Science frames for most
articles. Other frames that are taken up by one or two but not all of the news outlets are
Food Security, Environment, and Humanitarian frames. The Economic frame is one used
frequently by all the sources examined here (except for, notably the Guardian), an
unsurprising finding based on the commonness of economic framing in our daily lives
and the manner in which western society is structured around money, as exemplified by
our measures of success, for instance salary, or on a larger scale, GDP. Reese notes that
“frames must be shared in order to be useful and noteworthy organizing devices,” and
considering the extent to which they are shared “helps us determine whether they are
personal and idiosyncratic, social and shared, or if broadly and deeply shared,
cultural.”383 The economic frame falls into the latter category. For this reason, as well as
its pervasiveness in the literature, in that it is so common and put to so many uses, its use
in and of itself does not reveal a lot about a body of articles.
The UT/P frame is one primarily used in promoting biotechnology and is
common among industry and mainstream news sources but not among anti-GMO
industry groups. Legitimacy of science is also a frame used by both sides in challenging
their opponent’s approach, data, and evidence for their arguments, but the frame appears
more often in the mainstream media with the industry use of marginalizing those opposed
to the biotechnology industry agenda as “anti-science,” rather than in contesting industry
funded science or government decisions, as used by anti-GMO groups. The Humanitarian
frame is one used more by the biotechnology industry as the reason for urgency in
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adopting its products, and food security is largely implemented in the same way. The
notably absent frame in mainstream media coverage and in biotechnology industry
sources is the Human Health frame. This frame is used extensively by biotechnology
opposition groups, but fails to be adopted by the mainstream media, in conjunction with a
much wider range of frames generally implemented by these opposition groups that also
do not get adopted by the mainstream media. The limited scope of frames within which
the issue is discussed by the mainstream media results in the public reading the same
frames repeated over and over, having the effect of obscuring the fact that other frames
and perspectives exist. This is how readers are trained to think about the issues such as
genetically modified food in certain ways deemed acceptable and beneficial by the
powerful interests that shape the conversation.
Entman argues,
framing essentially involves selection and salience. To frame is to select some
aspects of a perceived reality and make them more salient in a communicating text,
in such a way as to promote a particular problem definition, causal interpretation,
moral evaluation, and/or treatment recommendation for the item described.384
Frames, according to Entman, then, define problems, diagnose causes, make moral
judgments and suggest remedies.
Through this theoretical lens, biotechnology industry frames define the problem
as insufficient progress in commercialization and slow adoption of GM technology,
which is keeping the world from realizing its food production potential, and thus
perpetuating the starvation and suffering of millions of people. The causes of which are
identified as excessive government regulation and irrational public opposition. The moral
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judgment is towards anti-science activists who are inhibiting progress while denying
choice to consumers and necessary technology to the developing world. There is also a
moral judgment of spoiled consumers in the developed world whose decadent desire for
organic food leads to the starvation of the developing world. The remedy for this mess is
to completely deregulate GMOs since they are no different in health and environment
effect from GMOs and conventional food, thus regulation is just creating problems and
no benefits. The further implication of the framing of this problem and its solution
implies that consumers should have no say in this process since it is an entirely scientific
issue, and thus not the right place for democratic debate.
The anti-biotechnology groups’ frames broadly identify the problem as the
takeover of the food supply by GMOs. The cause of the problem is consolidation of the
industry and companies’ resulting ability to control seed supply in addition to
government policy. This is manifested by excessive power that seed and chemical
companies have over resources and government decisions while the public lacks power to
affect change. These frames present moral judgment on a system in which government
decisions serve the interests of corporations rather than in the interest of consumers,
which is powered by the translation of money into the ability to win favor with
politicians. The root moral problem is the lack of democracy inherent in a system where
money wins over public opinion. The solution proposed by this framework is, in one
sense, depicted as a cluster of smaller measures—such as US labeling and inhibiting
GMO R&D locally—that are seen as progress towards a better level of fairness and
choice, but ultimately do little to solve the larger problem presented through the anti169

biotechnology framing. While larger solutions, implied by the nature and gravity of the
problem as depicted by these frames, are rarely explicitly stated. Solving the underlying
problems that are laid out by anti-GMO frames would involve a radical shift in societal
power structures. Voicing these kinds of solutions immediately pigeonholes the
spokesperson as a radical, or anti-capitalism, and certainly too fringe to be taken
seriously by the mainstream. Thus these arguments are generally left unspoken by the
politically active anti-GMO groups seeking to enter the mainstream debate.
Mainstream media tend to adopt the general framework of the biotechnology
industry over that of the activists. The industry framework is built within the existing
societal framework of capitalism and glorification of business in creating wealth and
progress, while the oppositional framework challenges societal norms in a way that is
dissonant with mainstream media news reporting norms. These opposing frameworks
describe a debate larger than that over biotechnology, and are representative of a larger
opposition between social justice groups and corporations. Thus media treatment of this
debate has larger implications beyond the fate of the global food supply.
Mainstream media often focus on smaller problems such as community conflict
resulting from a disagreement between those who want GMO labeling and those who
don’t. The cause of this problem is a group of activists who are agitating for labels and
corporations who don’t want those labels. The moral judgment rests with the perceived
motives of these groups and the solution will come with the November election as far as
mainstream media are concerned. This much narrower focus leaves little room for
grander idealistic narratives but the subtext of this frame accepts the status quo of the
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legitimacy of money as a vehicle to influence political decisions. The framing shies away
from any discussion of the material consequences of the decision, focusing more on the
political and economic fight than the meaning such a decision holds for consumers and
humanity.
Notably, the coverage of the Rothamsted debate in the UK embraced the larger
industry narrative recounted above to a degree beyond that of depicting a narrow conflict
of two sides disagreeing. The Times coverage fully embraced industry PR over more
conventional news framing, and thus acted overtly as a tool of propaganda for the
biotechnology industry. Arguably, this deviation from norms in the service of business is
an outcome of ideologically driven news ownership, and one that is likely to become
more the norm and less the exception if news outlets continue to be acquired and funded
by wealthy powerful ideologues such as Bill Gates, Rupert Murdoch and David and
Charles Koch.
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Chapter 8: Implications and Limitations
Taking the New York Times, the Wall Street Journal, the Times and the Guardian
to represent the mainstream media limits the generalizability of this research, since these
papers do not fully represent the mainstream coverage of this issue in the US and the UK.
While these papers are probably largely representative of the coverage, arguments about
what was missing from the coverage might be contradicted by coverage in other
mainstream media sources, and thus the findings of this study do not represent the
mainstream media of the US and the UK in total.
Additionally this research did not address the role that Internet news and social
media has in affecting news consumers’ points of view and their full scope of news
consumption. Most news consumers in the US do not rely solely on the New York Times
and/or the Wall Street Journal, and the same applies to the Guardian and the Times in the
UK. While these papers are still culturally significant, and thus worth examining, future
research on the issue should analyze the public’s opinions, perceptions and level of
knowledge about genetically modified food in conjunction with what sources they
consult for their news on the topic.
Future research should also examine this issue from the point of view of
journalists and scientists, interviewing these two populations about their roles in
constructing news coverage such as that examined here. Interviewing scientists on their
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role (or lack thereof) in this process would shed light on how certain experts get quoted
while others are left voiceless. In this way research can model how the “mainstream
scientific consensus” is constructed.
This research is significant in adding to a body of literature noting important
differences in how the parent company of a news organization affects the quality and bias
of coverage of different issues. In this case the News Corp owned papers were found to
have much more biotech industry-biased coverage than the New York Times or the
Guardian. Further research should be done to analyze an array of different news sources’
treatment of biotechnology, organized by owners of the six major news corporations, and
those outside of that ownership. This would allow researchers to identify patterns of
GMO criticism or support as a characteristic of particular publications, as it seems that
publications tend to choose a side on the issue and do not portray a "balanced" view of
the issue, whichever side they come down in favor of. This would provide insight into the
idea of journalistic balance and the implications of news ownership consolidation. It is
essential to understand the consequences of media ownership and consolidation as the
media market continues to be deregulated and powerful, elite ideologues such as Rupert
Murdoch, and now the Koch Brothers, are buying up media outlets with the express
purpose of “making their voices heard.”385
The manner in which the media cover a particular issue has a significant
relationship with public opinion on that issue. Past research has shown that public
opinion in the UK has historically been strongly against GMOs and this resulted in
mandatory labeling of GMOs. Labeling, in conjunction with strict regulations on which
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GM crops are grown in the UK and, more generally in the EU, has largely allowed UK
consumers to be able to avoid GMOs if they want to, making the issue far less pressing
for the general public than it is in the US. The US has never had mandatory GMO
labeling, and as awareness of issues surrounding GMOs and their ubiquitous presence in
the US food supply has grown, a consumer movement for labeling and against GMOs has
been gaining momentum in the US. These contrasting trajectories have lead to
significantly different political climates surrounding the issue in the two countries, as
consumers are pushing most strongly against the status quo in the US and the
biotechnology industry is pushing most strongly against the status quo in the UK. A
significant difference was identifiable between the two countries’ media coverage, but
further research would benefit from the inclusion of public opinion research on the topic
that specifically addresses individual sources of news (as addressed above) and opinions
on biotechnology in the two countries.
This analysis is also important for activists trying to affect the US, UK and
international conversations surrounding biotechnology, since understanding the way that
information is included and omitted in mainstream media coverage of the issue is an
important tool in an effort to have a voice in mainstream news coverage. Another area
where more research should be done is in comparing how biotechnology is covered in
India, Latin America, Africa and elsewhere in the developing world in contrast to the
patterns of media coverage in the US and UK as examined here. This research has
indicated that coverage patterns are substantially different between the developing world
and those countries with economic and political power and strong economic interests in
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biotechnology, such as the US. The Indian media in particular were demonstrably less
sympathetic to biotechnology corporations and more likely to cover controversial aspects
of the issue. Including international patterns of media coverage in this kind of analysis
would allow a much deeper understanding of the linkages of money, corporate power,
public relations and the spread of biotechnology around the world.
This research also details the way in which scientific studies are treated
differently by activists, industry groups and the mainstream media, emphasizing the
increased level of politicization of science that has occurred as part of the growing power
of industry to shape mainstream notions of scientific knowledge. The level of control
over resources that the biotechnology industry wields allows it unprecedented levels of
control over what studies are conducted and how, as well as how these studies are then
interpreted and reported to the public. Additionally, when that mechanism of control
breaks down, the industry has the power and resources to influence how, if at all, the
media reports on scientific studies that contradict industry claims, undermining the
legitimacy of scientists who dare to oppose the official narrative. The position of the
biotechnology industry is unique in many ways, in that it has proprietary claims over its
technology and is able to prevent unfavorable independent research on its products. This
allows it more control over scientific claims surrounding its products than, say, the oil
industry has over the climate science debate. Nonetheless the evidence presented here of
manipulation of scientific knowledge by various interested parties is indicative of a larger
trend towards the politicization of science. This is in stark contrast to the way in which
science has been treated historically, as evidenced by the original intent behind the
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creation of government agencies such as the FDA. The creation of the FDA was an
attempt to rationalize American government by basing government decisions on objective
fact obtained through scientific analysis rather than on politics. It appears the integration
of government with science has had the opposite effect, having made science more
political rather than making politics more objective. The politicization of science has far
reaching implications for the role that science plays in affecting government decisions
and the legitimacy of arguments that pit science against democracy.
Agenda building theory functions on a set of assumptions about journalistic
practice that has become outdated since its inception. The agenda building strategies of
large, well-financed industries have evolved, while the resources of the media have
shrunk significantly. This leaves a news ecosystem that is aptly summed up by the
statistic, provided by the Pew Research Center, that the ratio of PR practitioners to
journalists is somewhere around 4-1.386 An indicator of how this imbalance between the
number of reporters and PR professionals is playing out is revealed by this quote, from a
2011 Gateway Journalism Review article:
Now, journalists say, the experts find them. When a story breaks, public relations
practitioners will conduct interviews with sources within their organizations and
email the transcript of the interview to a large list of reporters. ‘What used to take
me a half hour, can be done in 10 minutes. Everybody gets the same quotes. It's an
instant news release,’ said Richard A. Serrano, a reporter in the Washington
Bureau of the Los Angeles Times.”387
This level of packaging of experts and news, and the willingness of many journalists to
accept this kind of assistance, imply a model of agenda building that is different in many
ways and more pronounced than that originally theorized by agenda building scholars.
The role of PR professionals in the news creation process is becoming much larger and
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much more accepted, even welcomed, than previously theorized. The findings of this
research, as well as that of other scholars and casual observers, highlight the need for an
updated theory of agenda building that takes into account this changing relationship
between the reporter and the PR professional.
While framing was a useful device in characterizing the content of news coverage
of GMOs, this analysis shows that there is significant variation in the ways that a frame is
used differently in the interest of promoting a certain point of view. The examples,
discussed above, in which each side used a particular frame to its own advantage and
with its own particular set of rules, challenges the efficacy of simply counting rates of
frame usage to reveal the nature of a particular debate. More context than a tally of which
outlets use what frame is needed to understand the essential nature of the coverage of a
particular issue, especially in the case of extremely common frames such as the
Economic frame. This need for another level of analysis beyond framing is the rationale
for the combination of frame categorization with the aggregation of information on tone,
geographic focus, topic, and orientation toward the subject matter, as well as the
implementation of close textual reading, that this research includes. Future framing
studies should take this into account and combine different elements of interest with
frame analysis in order to create a clearer interpretation of the implication of framing
data.
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